|
|
·|û¡Ghung120110149413 µoªí®É¶¡:2020/6/24 ¤U¤È 02:11:23
|
¥«³õº¨£·sÃÄ(¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸) Àø®Ä¤ÀªR p=0.009 6634 ªYÄ£ ªÑ¥»: 3.832»õ ¥Dn·~°È: ¨xŦ¯e¯fªvÀø¤Î¯kµhªvÀø¬ÛÃöÃĪ«¬ã¨s¤Î¶}µo ¸³ºÊ«ùªÑ¤ñ¨Ò: 21.7%(¼W¥[¤¤) ¥~¸ê«ùªÑ¤ñ¨Ò: 0.22%(¼W¥[¤¤) Ä~Äò©¹¤U¬Ý...! ============================================================================= ²£«~01¡GSNP-610 (ªvÀø¯×ªÕ¨x¯e¯f·sÃÄ) ¾AÀ³¯g: «D°sºë©Ê¯×ªÕ¨xª¢ ²£«~Àu¶Õ: 1.¥Ø«e©|µL¼Ð·ÇªvÀøÃĪ« 2.¥«³õº¨£·sÃÄ(First-in-class) 3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x 4.µL¦w¥þ©Ê°ÝÃD ¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C Ävª§¤O: 1.¦h«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢ 2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A°§C¨x¯× 3.¥i´£¥X¨uÃĥӽСAÀ³¥Î©óªvÀø§³®W«æ©Ê¯×ªÕ¨x ¬ãµo¶¥¬q: 1.¤w³q¹LUSFDA¤ÎTFDA¼f¬d¶i¤JÁ{§É¤G´Á 2.Á{§ÉÀø®Ä¤Î·sªvÀø¾÷ÂàÅçÃÒ Àø®Ä¤ÀªR¡G 1.²Ä¤@´ÁÁ{§É¸ÕÅç¡Gµ²ªGÅã¥Ü¤HÅé¨Ï¥Î¦w¥þ¡A©Ê½è¨}¦n 2.²Ä¤G´ÁÁ{§É¸ÕÅç¨ä¤¤¤ÀªR¡G17¦ìNASH ¯f¤H (p=0.009) ============================================================================= ²£«~02¡GSNP-630 ¾AÀ³¯g:«D°sºë©Ê¯×ªÕ¨xª¢ ²£«~Àu¶Õ: 1.¬°Àu¤Æ(Optimized)¤§·s¤Æ¾Ç¹êÅé(NCE) 2.¥«³õº¨£·sÃÄ(First-in-class) 3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x 4.§@¬°²Ä¤@¥N²£«~¤W¥««áªº±µÄò¦û¦³¥«³õ¤§²£«~ ¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C Ävª§¤O: 1.¦h«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢ 2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A°§C¨x¯× 3.Àu¤ÆªºÀø®Ä±j«×¡B§@¥Î®É¶¡ 4.µL¦w¥þ©Ê°ÝÃD ¬ãµo¶¥¬q: 1.Á{§É«e 2.¹w©w¥Ó½Ð¬ü°êFDAIND¡B§Ö³t³q¹D(fasttrack)¡C 3.¥Ó½Ð¬ü°ê¬ð¯}©ÊªvÀø(breakthrough therapy)ªº»{©w¡C Àø®Ä¤ÀªR¡G 1. ¥Ø«e¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.05 ============================================================================= ²£«~03¡GSNP-810 (µL¨x¬r©Ê¤îµh·sÃÄ¡B¸Ñ¬r¾¯) ¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃÄ (¸Ñ¼öÂíµh¾¯) ²£«~Àu¶Õ: 1.¦w¥þ¤Æ¦Xª«·s²Õ¦X¡BµL¨x¬r©Ê 2.¸Ñ¨M¢¤ÁÂåÀø»Ý¨D (Important urgent unmet medical needs) 3.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥iקï©Î§R°£FDA¨x¬rĵ»y¥i¼W¥[¾¯¶q ¥«³õ: ¤AñQÓi×ô¶È¦b¬ü°ê¤@¦~´N¦³40»õ¬ü¤¸ªº¥«³õ Ävª§¤O: 1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ« 2.¥i§ð¦û¼s¤j¥«³õ¡]NSAID, COX-2 §í¨î¾¯¡BOpioidsÃþ¤îµhÃÄ¥«³õ¡^ 3.¥i¬Ù°£¶D³^¶O¡B±Ð¨|°V½m¶O ¬ãµo¶¥¬q: 1.¤w§¹¦¨§C¾¯¶q¡B°ª¾¯¶qÁ{§É¸ÕÅç 2.¤w¥Ó½ÐUSFDA¼Ï纽Á{§É¸ÕÅç¡B±N¥Ó½Ð¬ð¯}©Ê¼f¬d/§Ö³t³q¹D 3.µL¨x¬r©Ê¤AñQÓi×ô¸Ñ¬r¾¯¦¨¤À¡A¤w¥Ó½Ð¬dÅçµn°O¥Î¤§Á{§É¸ÕÅç ============================================================================= ²£«~04¡GSNP-830/ SNP-840 ¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃĽƤè(ªvÀø¤¤¡B««×¯kµh) ²£«~Àu¶Õ: 1.µL¨x¬r©Ê¤AñQÓi×ôªº½Æ¤è 2.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥iקï©Î§R°£FDA¨x¬rĵ»y¡A¥i¼W¥[¾¯¶q ¥«³õ: ¤AñQÓi×ô³B¤èÃĦb¬ü°ê¤@¦~´N¦³27»õ¬ü¤¸ªº¥«³õ Ävª§¤O: 1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ«½Æ¤è 2.½Æ¤è¤w¥Ñ¬ü°êFDAn¨D°¾¯¶q§C©ó325²@§J¡A±N¼vÅTÀø®Ä 3.¦³¨Ï¥Î±M§Q¡A¥iקï©Î§R°£FDA¨x¬rĵ»y 4.¥i¼W¥[¤AñQÓi×ô¾¯¶q ¡]¥Ñ325mg ¦^´_¦Ü500 mg¬Æ¦Ü§ó°ª¡A·|¸û¦³®Ä¡^¥H¼W¥[Àø®Ä¡A©Î´î¤ÖOpioids¾¯¶q¡A°§C¦¨Å}°Æ§@¥Î 5.¤GªÌ¾Ü¤@±ÂÅv 6.¥i¼W¥[¥«¦û²v ¬ãµo¶¥¬q: 1.SNP-810¨ú±oÃÄÃÒ«á¡A¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê¸ÕÅç SNP-830 ¤£¬O ·s¦¨¤À ªº·sÃÄ¡A©Ò¥H¤£»Ýn¶i¦æ²Ä¤@¡A¤G¤Î¤T´ÁÁ{§É´úÅç µ¥ SNP-810 ®³¨ìÃÄÃÒ«á¡A¥H ·sÀø®Ä½Æ¤è¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê´úÅç ´N¥i¥HÀò±oÃÄÃÒ ============================================================================= ***************************************************************************** SNP-8 ¨t¦C Àø®Ä¤ÀªR¡G 1. ¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005 1. ¤w¸g§¹¦¨¤§¤HÅé¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005 ============================================================================= ***************************************************************************** ¥¼¨Ó¥Ø¼Ð±ÂÅv¥D¤O²£«~¡G 1. ¯×ªÕ¨xÃÄ¡GSNP-610 ©M SNP-630 ¦U¦³ÀuÂI¡A¥Ø¼Ð¬°¥þ²y±ÂÅv 2. ¤îµhÃÄ(OTC): SNP-810, ¥Ø¼Ð¬°¬ü°ê¤Î¥þ²y±ÂÅv 3. ¤îµhÃÄ(³B¤èÃÄ): SNP-830 ¤Î SNP-840, ¦b°Êª«¤W¬Ò¦³¥¿±ªºµ²ªG¡A¥Ø¼Ð¬°¥þ²y±ÂÅv ============================================================================= ***************************************************************************** ¥Ø«e¤½¥q»P°ê»Ú¤j«¬Ãļt¥¿¦b½Í§Þ³N±ÂÅv©M¦X§@p¹º §Ú¬Ý¹L¤½¥q©xºô©M©Ò´£¨Ñªº¸ê®Æ¡Aı±o¤½¥q«Ü¥Î¤ß¦b¸gÀç¡A¦Ó¥B¸ê®Æ¤]«Ü¸Ô²Ó ¹ï¤½¥qµo®i«Ü¦³¦Û«H¡A¥¼¨ÓªÑ»ùȱo´Á«Ý¡A¦³¾÷·|¬O ¤U¤@Ó ¦X¤@ ÄÆªÑ ----------------------------------------------------------------------------- ¥H¤W¸ê®Æ ³£°Ñ¦Ò ªÑªF·|ij¨Æ¿ý.pdf ©M ¤½¥q©xºô (¦³¿³½ìµÛÅwªï¦A²`¤J¬ã¨s»P°Q½×) |
|
·|û¡Gkim10134548 µoªí®É¶¡:2022/6/18 ¤U¤È 02:44:57²Ä 2109 ½g¦^À³
|
½Ð°Ý¦³¤Hª¾¹D¶Ü¡H J±Ð±Âºt»¡ 09_·sÃĬãµo¦¨¥\®×¨Ò_µL¨x¬rTB·sÃÄ ¤w½T©w³Ì«á¸Ñª¼¬O¥¢±Ñ¡]±q¤ÍÀM¥Í§Þ110»P111¦~³ø¤ñ¸ûµo²{¡A¨Ã¥h¹q¸ß°Ý¡^ ¡A¬O§_·|¼vÅT¨ì¤jÃļtÅçÃÒSNP-810¡A¨Ã°§C¦¨¥\ªº¥i¯à©Ê¡A §_«hñ¬ù¤w¤@¦~¥b¤F¡A©ì¶V¤[¶V¥O¤H¤ß¥ÍºÃ¼{ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/18 ¤W¤È 10:58:10²Ä 2108 ½g¦^À³
|
³Ì±`³QÀݥΪºª«½è¬O¹ï¤A酰®ò°ò×ô ------------------------------------------------------------------------------------------------- «C¦~±þ¤H®×ªø´Á¥H¨Ó¤@ª½§e¤W¤ÉÁͶաC®Ú¾ÚÁp¨¹¼Æ¾Ú¡A¦b 10 ¦Ü 24 ·³ªº¤H¸s¤¤¡A2000 ¦~¦Ü 2018 ¦~¶¡¡A¬ü°êªºÁ`Åé¦Û±þ¦º¤`²v¼W¥[¤F 57%¡C¼Æ¾Ú¡C²{¦b¡Aµoªí¦b¡mÁ{§É¬r²z¾Ç¡nÂø»x¤Wªº¤@¶µ·s¬ã¨s¥J²Ó¬ã¨s¤F¦Û±þ¥¼¹Eªº¤@ºØ¯S©w¤èªk¡X¡X¦Û§Ú¤¤¬r¡X¡X¨Ã±o¥X¤F¤@¨Ç¥O¤H¤£¦wªºµ²ªG¡G±q 2015 ¦~¨ì 2020 ¦~¡A³q¹LÄá¤J¦³¬rª«½è©ÎÃĪ«¹L¶q¦Ó¾ÉPªº¦Û±þ¥¼¹E¦b 6 ¦Ü 19 ·³ªº¤H¸s¤¤¼W¥[¤F 26%¡C ¸Ó¬ã¨s¥Ñ¥±¦N¥§¨È¤j¾ÇÂå¾Ç°|ªºÂå¾Ç¬r²z¾Ç®a¸â©g¥±¡Pù´µ³Õ¤h»â¾É¡A°ò©ó°ê®a¬r²z¾Ç¼Æ¾Ú¨t²Îªº¼Æ¾Ú¡A¸Ó¨t²Î¶×Á`¤F¨Ó¦Û¸Ó°ê 55 Ó¦{©M»â¦a¬rª«±±¨î¤¤¤ßªº«H®§¡C®Ú¾Ú±±¨î¤¤¤ßÃö©óºÃ¦ü¦Û±þ¥¼¹Eªº«ü«n¡A±q 2015 ¦~¨ì 2020 ¦~¡A¦³ 514,350 ¦¸¯A¤Î 6 ¨ì 19 ·³¨àµ£ªº¤¤¬r±±¨î¤¤¤ß©I¥s¡A¨ä¤¤¡§¦]¤£·í¨Ï¥Î¹ï¦Û¤v©Î¦Û§Ú¦³®`ªºª«½è¦Ó¼ÉÅS¡¨¯}Ãa©Ê¡¨ªºì¦]¡C 2015 ¦~³ø§i¤F¶W¹L 75,000 °_¦¹Ãþ®×¥ó¡C³oӼƦr¨C¦~³sÄò¤¦~¼Wªø¡A¨ì 2020 ¦~±N¶W¹L 93,500 ¤H¡C¥±¦N¥§¨È¤j¾ÇÂå¾Ç°|Âå¾Ç¬r²z¾Ç¥D¥ô¡B¸Ó½×¤åªº¦XµÛªÌ§J¨½´µ¦«¥±¡PÀNº¸´µ¯S®æ (Christopher Holstege) ¦b¤@¥÷Án©ú¤¤»¡¡A§Ú̦b [the University of Virginia Health System] ªºÁ{§É¹ê½î¤¤pºâ¤F³o¤@ÂI¡CÁn©ú¡C¡§§ÚÌ«D±`Ãö¤ß§Ú̪º¾÷ºc¼Æ¦r¡A¨Ã¨M©w¹ï¥þ°ê¼Æ¦r¶i¦æ¬ã¨s¡A³oÃÒ¹ê¤F³oºØ¼W¥[¤£¶È¬O¤@Ó¦a¤è°ÝÃD¡A¤]¬O¤@Ó°ê®a°ÝÃD¡C®a®x¡¨¡C ¨Ã«D 6 ¦Ü 19 ·³¦~ÄÖ¬qªº¨CÓ³¡¤À³£¨ü¨ì¦P¼ËÄY«ªº¥´À»¡C¦Û§Ú¤¤¬r¨Æ¥óªº³Ì¤j¼W´Tµo¥Í¦b 10 ¦Ü 12 ·³¤§¶¡¡A¦b¤¦~ªº¬ã¨s´Á¶¡¡A³o¤@¼Æ¦röt¤É¤F 109%¡C13-15·³¸sÅé¼Wªø30%¡F6-9·³¨àµ£¦û28%¡F¦Ó±q16·³¨ì19·³¡A³oÓ¤ñ¨Ò¬O18%¡C¤k«Ä¦û¤ñ¸û¤j¡A¦û¯f¨Òªºªñ78%¡C¦b¬ã¨s¤Hû¬ã¨sªº¶W¹L 50 ¸U¨Ò¯f¨Ò¤¤¡A276 ¨Ò¦º¤`©Mªñ 15,000 ¨Ò»P¦M¤Î¥Í©Rªº¯gª¬©Î«ùÄò´Ý¯e¦³Ãö¡C ¦b¤j¦h¼Æ±¡ªp¤U¡A¦~»´¤H¨Ï¥Î®e©ö§ä¨ì©M®e©öÀò±oªºª«½è¡C³Ì±`³QÀݥΪºª«½è¬O¹ï¤A酰®ò°ò×ô¡AµM«á¬O¥¬¬¥ªâ¡AµM«á¬O«D¨å«¬§Üºë¯«¯fÃÄ¡X¡X¨Ò¦pªü¥ß哌Ðü¡X¡X¥¦Ì¶V¨Ó¶V¦h¦a¥Î©óªvÀøºë¯«¯f¡A¤]¥Î©óªvÀø§ó¬y¦æªº§íÆ{¯g¡C ¸ÑÄÀ¥O¤H¤£¦wªºÁͶÕI«áªºì¦]¶W¥X¤F¬ã¨sªº½d³ò¡CµM¦Ó¡A¦b 3 ¤ë¡A¬ü°ê¨à¬ì¾Ç·|¦CÁ|¤F³\¦h¾ÉP«C¤Ö¦~¦Û±þ¥ø¹Ïªº¦]¯À¡A¥]¬A¦bÀò±ot¾á±o°_¥B©ö©óÀò±oªº¤ß²z«O°·ªA°È¤è±ªº®t¶ZÂX¤j¡C¦b®a¤¤¨Ï¥Îºj¤ä©Î¬r«~µ¥¦Û´Ý¤u¨ã¡C ³o¶µ·s¬ã¨sªº§@ªÌ´°«P¤÷¥À©M¬ÝÅ@¤Hª`·N¤é¯qÄY«ªº°ÝÃD¡C»¡¸Ü¡C¡§§Ú̪º¬ã¨s¬Oªí©ú§ÚÌ¥¿¦b¦~»´¸sÅ餤¸g¾ú«e©Ò¥¼¦³ªº¤ß²z°·±d¦M¾÷ªº´X¶µ¬ã¨s¤§¤@¡C§@¬°¤@ÓªÀ·|¡A§ÚÌ¥²¶·¬°¨àµ£ªº¤ß²z°·±d»Ý¨D§ë¤J§ó¦h¸ê·½¡C¡¨ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/18 ¤W¤È 10:31:20²Ä 2107 ½g¦^À³
|
¦p¦¹¥©¦X! ¥l¦^®É¶¡ÂI¦b¬ü°ê¬rª«¤¤¤ßªº¨àµ£¦Û±þ¨Æ¥ó³ø§i«á? 2022.6.16¥Ñ©ó¨àµ£¨¾Å@°ÝÃD¡A¥l¦^¤F¶W¹L 40 ¸U²~«D³B¤èÃÄ www.msn.com/en-us/health/medical/over-400k-bottles-of-otc-medication-recalled-due-to-issues-with-child-proofing/ar-AAYyQPz?ocid=FinanceShimLayer ¶g¥|¡A®ø¶O«~¦w¥þ©eû·|«Å¥¬¥l¦^¶W¹L 400,000 ²~«D³B¤èÃÄ¡Aì¦]¬O¨¾¨àµ£¥]¸Ë¦s¦b°ÝÃD¡A¤£²Å¦X¡m¬rª«¹w¨¾¥]¸Ëªk¡nªºn¨D¡C Aurohealth ¥l¦^¤F¬ù 137,300 ³æ¦ìªºWalgreens µP¹ï¤A酰®ò°ò×ô¡A¥H¤Î¬ù 25,660 ³æ¦ìªºKroger µPÃö¸`ª¢¯kµh¹ï¤A酰®ò°ò×ô¡C ¡§²£«~ªº¥]¸Ë¤£¾A¦X¨àµ£¨Ï¥Î¡A¦pªG¤º®eª«³Q¥®¨à§]¹¡A´N¦³¤¤¬rªº·ÀI¡A¡¨¨C¤@¦¸¥l¦^³£¼g¹D¡C «eÁ`²Î¥§§JªQ©ó 1970 ¦~ñ¸p¤F¡m¬rª«¹w¨¾¥]¸Ëªk¡n¡An¨D±N¬Y¨Çª««~©ñ¤J¨¾¨àµ£¥]¸Ë¤¤¡A¡§¥²¶·³]p©Î»s³y¦¨ 5 ·³¥H¤U¨àµ£«ÜÃø¦b¦X²zªº®É¶¡¤º¥´¶}®É¶¡¡¨¡A¦P®É¤]¡§¤£Ãø¡¨³Q¦¨¦~¤H¥´¶}¡C --------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/16 ¤U¤È 09:56:47²Ä 2099 ½g¦^À³ ¬ü°ê¬rª«¤¤¤ßªº¨àµ£¦Û±þ¨Æ¥ó³ø§i¦b5~6¤ëµn¸ü¦b«Ü¦h´CÅé. FDAµø¦Ó¤£¨£AcetaminophenÄY«¶Ë®`¨ì¬ü°ê¥¼¨Óªº¥D¤H¯Î? |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/6/17 ¤U¤È 08:40:11²Ä 2106 ½g¦^À³
|
§Ú̳o¨Ç¤pªÑªF®ÇÆ[ªÌ²M¡A¤S¦³r¤j½Ñ¦h±M¤å°T®§¨Ñ«ôŪ¡A¬Ý²M·¡¤jÃļt¨Ó¨ÖÁÊ«¥Àu¨q¤½¥q¦³¶W¤j§QÀY¡A¤pªÑªF¤]¼ÖÆ[¨ä¦¨¼Æ¶r²¼¡I¹³ªYÄ£¨xÃÄÀø®Ä¬O§O®a12¿¦n¡A¥Ø«e¥þ¥@¬É²Ä¤@¦W¡A³o¨Ç¤jÃļt¥i¯à¨S¦³¨º»ò²M·¡¡A¦Ó¥B¤jªÑªF¡B¦¶¸³¡BJ¤j̮ڥ»¤£n¾ãÓ½æ¡C¦¶¸³«O¦u»¡n¦¨¬°¿W¨¤Ã~¡AªÑ»ù500¤¸´N¬O¿W¨¤Ã~¡A§Ú»{¬°ªYÄ£·|¦¨¬°¤j¿W¨¤Ã~¡I |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/6/17 ¤U¤È 12:58:36²Ä 2105 ½g¦^À³
|
¤îµh¾¯¤À°Ï±ÂÅv»æ¤£ºâ¤j¡A¹ï¤jÃļtºâ¬OÀ\«eµæ¡F§Ú¦X²z±À¦ô830¥þ²y±ÂÅv©M6¨t¦C¤À§O©M«e¨â¤jÃļtñ±ÂÅv¡C¥Ø«e³Q¨ÖÁʮɶ¡¤w¹L¡Aª^³ò¦n¹³¤]¨S¤F¡C·íµM¡A¤j¼tY¤@¦~«e¨CªÑ500¤¸¨ÖÁʦܤÖÁÈ10¿¡C§Ṳ́pªÑªF¤£°ø¨D¤Ó°ª¡A¥[Á`20»õ¬ü¤¸±ÂÅv¡AªÑ»ù¤@¤d¤¸´N«Ü¦n¤F¡C |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/6/17 ¤W¤È 11:01:44²Ä 2104 ½g¦^À³
|
¦pªG¤jÃļt¦³²´¥ú ¦b¦¹¸ÕÅ綥¬q ª½±µ¨ÖÁÊ Y¶i«×¦b©¹«e¶i »ù®æ·|§ó°ª |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/6/17 ¤W¤È 10:17:47²Ä 2103 ½g¦^À³
|
¦³²´¥ú¤jÃļt²{¦b´Nn¥þ²y±ÂÅvªYÄ£6¨t¦C¨âÃÄ¡A¦]¬°¥¦Àø®Ä¼Æ¾Ú¬O¥þ²y²Ä¤@¦W¡A¶i«×µy§Öªº¤]©ñ±ó©ÎÂର¨ä¥L¥ÎÃÄ¡F¤½¥q»¡¨âÃĤ@¨Ö±ÂÅv¥i¨£¦³¬Û·í¬¢½Í¶i«×¡A¦Ó¥B6¨t¦C¤]½Í¤F¦n´X¦~¤F¡C¨âÃĬù10¢w20»õ¬ü¤¸¡AY¶¯¶¯Ãn¥úªÑ»ù´N·f¤õ½b¤ÉªÅ¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/17 ¤W¤È 08:53:25²Ä 2102 ½g¦^À³
|
¤w¹L2¦~¥b¡A¤]³\¯u¬O6¨t¦C¥ý±ÂÅv!? ·s药¤½¥q¹v¦V¦ó¤è [³Ìªñ协§U¤@®aªC¦{ªº·s药¤½¥q©w°Ó业µ¦²¤, 这®a¬ã发¤p¤À¤l¹v¦V药ªº¤½¥q·Q´Â¦VNASH....] 7.§Ú个¤H«D±`¬Ý¦n³J¥Õ°¸ÑPROTAC¥¥x, ©Î¬OAllosteric modulator§Þ术ªº¤½¥q¬O¥i¥H¦Ò虑¦@¦P开发ªº对¶H; SNP-610/sNP-630:Allosteric modulator --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/9/20 ¤W¤È 10:19:33²Ä 1411 ½g¦^À³ ...发¥¬¤_ 2020-02-06 ·s药¤½¥q¹v¦V¦ó¤è zhuanlan.zhihu.com/p/105323292 ³Ìªñ协§U¤@®aªC¦{ªº·s药¤½¥q©w°Ó业µ¦²¤, 这®a¬ã发¤p¤À¤l¹v¦V药ªº¤½¥q·Q´Â¦VNASH.... µù:¤å³¹¤§©Ò¥H§l¤Þ«¥ª`·Nªº¬O©ñ¦b³Ì³»ºÝªºSNP-630§@¥Î¾÷¨î¹Ï¤ù¡C¤å³¹¶}ÀY[³Ìªñ协§U¤@®aªC¦{ªº·s药¤½¥q©w°Ó业µ¦²¤]»P[¦X¥þ]¦³ÃöÁp??? ------------------------------------------------------------------------------------------- ·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/6/17 ¤W¤È 08:02:57²Ä 2101 ½g¦^À³ ..©Î³\§Ṳ́@ª½¦b´Á«Ýªº8¨t¦C±ÂÅv¡Aµ²ªG¥i¯à¬O6¨t¦C²æ¿o¦Ó¥XÀu¥ýoo¡K¯d«Ý®É¶¡ÃÒ©ú |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/6/17 ¤W¤È 08:02:57²Ä 2101 ½g¦^À³
|
¦U¦ì¤j¤jªº¬Ýªk§Ú³£º¡»{¦Pªº¡A¦b«ä¦Ò«áÂkÃþ´XÓ«ÂI: 1.ÃĬO¦³®Äªº¡A¥B¦b¤@¨Ç¤¤°ª«×¯kµhªº¾AÀ³¯g(¤U©P¤@6/20¦¬®×ªºÂù½¥¤¤««×¯kµh¥i¯à¬OÓ¾÷·|)·|·¥¬°¦³®Ä¥BµL¬r¡A¾A·í®É¾÷¦p¶ø¤j¡B¦V¤j»¡ªº¡A¦³¾A¦Xªº±ÂÅvª÷ÃB 2.¦¶¸³¦~³ø©Ò´£ªº¡A¦U¤jÃļt¬O¦X§@¥ç©Î¬OÄvª§¹ï¤â=>°²¦p¨S¦³»{¥iªº±ÂÅvª÷¡A¨º´N±ÂÅv»P¦Û¦æ¶}µo¨Ã¦æ(¦pJ¤j¯«´£ªº:³oÓ¤½¥q§Ú«Ü³ßÅw¡A¤@¦~ªá¤£¨ì1e¡A°µ¤F¦n¦hÁ{§É¹êÅç¡A§Úı±o«Üsmart)¡A¹êÅç¼Æ¾Ú·U¦h¡A±ÂÅvª÷¥u·|©¹¤W¡A´N¬Ýþ®a·Q¬}Àë¥ý¾÷ 3.¦~³ø³£¬O630±Æ«e±¡AªÖ©w¬O«¤¤¤§«ªº§ëª`;¦~³ø¤¤ªº³o¤G¦~¦X§@«´¬ù(»P¥x¤j¡A¥_Âå¤j¡B©÷¹F¡Kµ¥)³£¬O630;¹w´Á¤ë©³«e¥i¯à·|¦³¶i¤J¤G´Áªº®ø®§¡A³o¤]¬O¥O¤H´Á«Ý 4.©Î³\§Ṳ́@ª½¦b´Á«Ýªº8¨t¦C±ÂÅv¡Aµ²ªG¥i¯à¬O6¨t¦C²æ¿o¦Ó¥XÀu¥ýoo¡K¯d«Ý®É¶¡ÃÒ©ú |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/6/16 ¤U¤È 10:06:33²Ä 2100 ½g¦^À³
|
¶ø¤j Y¦p±z©Ò»¡®³¨ì³B¤èñ®É ¥i¥H¹B¥Î¨ìªº½d³ò®Ç¤j ªÑ»ù¦¤£ª¾öt¨ì¨º¸Ì¤F R¤j´£¹L«Ü¦h¨£¸Ñ¡A´X¥G¥i¥H¨ú¥N²{¦³ªº¦UºØ¤îµhÃÄ¡C ¤£¹L³B¤èñªº¼Ï¶s¸ÕÅçÁÙ¦³±oµ¥ ²{¶¥¬q¬O¸ÕÃĮĪº¶¥¬q¡Bµ²ªG¡A¬O§_¦³¿E½àªº±ÂÅv¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/16 ¤U¤È 09:56:47²Ä 2099 ½g¦^À³
|
¬ü°ê¬rª«¤¤¤ßªº¨àµ£¦Û±þ¨Æ¥ó³ø§i¦b5~6¤ëµn¸ü¦b«Ü¦h´CÅé. FDAµø¦Ó¤£¨£AcetaminophenÄY«¶Ë®`¨ì¬ü°ê¥¼¨Óªº¥D¤H¯Î? www.usnews.com/news/health-news/articles/2022-06-03/intentional-overdoses-rise-among-u-s-kids-teens ...¦b¬ã¨s¤Hû¬ã¨sªº¶W¹L 50 ¸U¨Ò¯f¨Ò¤¤¡A¦³ 276 ¤H¦º¤`¡Aªñ 15,000 ¨Ò¯f¨Ò¯A¤Î¦M¤Î¥Í©Rªº¯gª¬©Îªø´Á´Ý¯e¡C ¬ã¨s¤Hûµo²{¡A©Ò¦³¦~ÄÖ¬qªº«Ä¤lÃhºÃ¦Û±þ©M¥ø¹Ï¦Û±þªº¤H¼Æ³£¦³©Ò¼W¥[¡A¦ý³Ì¤jªºÅܤƬO10 ¦Ü 12 ·³ªº«Ä¤l¡C¯f¨Ò¼W¥[¤F¤@¿¦h¡A±qèè¶W¹L 3,100 ¨Ò¼W¥[¨ì 6,400 ¨Ò¡C -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/24 ¤U¤È 04:26:43²Ä 2014 ½g¦^À³ ¬ü°ê¨àµ£¦Û±þ¨Æ¥ó¼W¥[--->¤z¹w±¹¬I--->µL¨x¬rAPAP. 2022.3.4 ¬ü°ê¬rª«¤¤¤ß³ø§iªº¨àµ£¦Û±þ¨Æ¥ó pubmed.ncbi.nlm.nih.gov/35240919/... |
|
|
·|û¡G¶ø¥ì´µ¯S10031727 µoªí®É¶¡:2022/6/16 ¤U¤È 09:18:43²Ä 2098 ½g¦^À³
|
±ÂÅv½Í§PºCºC¨ÓµL§«¡A½Íªº¦n±ø¥ó¤~¬O«ÂI¡C SNP-810 Ó¤Hı±o«ÂI¤£¦b OTC ¡A¦Ó¬O³B¤èºà¥«³õ¡A¯S§O¬O°ß¤@¯à±À¥X°ª¾¯¶q©Î°ª¾¯¶q½Æ¤èªº²Õ¦X(500~ 1000mg)ªº°t¤è¡C«e´£¬On»¡ªA FDA »{¦PµL¬r¡B¯àªA¥Î°ª¾¯¶q¡A³o¤~¬O«e³~µL«Gªº«OÃÒ¡C SNP-810 ¤£¶Ë¨x¤îµhÃÄ¡A³o¬O¤@ºØ¥ÎÃIJߺDªº¨å½dÂಾ¡A·Ó²z»¡ FDA ·|«Ü·V«ªº³B²z¡A©xºô´£¨ì¥xÆW(©Î°ê»Ú¦P®É)¦¬®×60¦ì°·±d¨ü¸ÕªÌ¡A§¹¦¨48¤H¡A¤£ª¾¹D·|¤£·|¤Ó¤Ö¤F¤@ÂI¡C |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/6/16 ¤U¤È 05:44:59²Ä 2097 ½g¦^À³
|
Ó¤Hı±o ¨S¦³®³¨ì¤£¿ù»ù®æªº±ÂÅv¦X¬ù °ª»ùÃø¯àªí²{¡A¤]¤£·|¦³¡u¾A·í®É¾÷¡v¥X²{¡C ©Ò¥HÁÙ¬O¤îµhÃĤj¼tªº±ÂÅv¦X¬ù¡AªÑ»ù¤£¥X´X¤Ñ¦ÛµM©¹¤WÃk¤É¡I ¦Ü©óÄÀªÑ¡AÁ{®É·|¤w³q¹L²{¼W¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/6/16 ¤U¤È 05:00:10²Ä 2096 ½g¦^À³
|
¥«³õ¦³§Q®É¶¡¸û¶É¦V¤j½L¦n¨Ç¸ÑŪ¡F¦]¬°¤WÂd¤jªÑªFn´£¤@©w¤ñ²v¨Ñ©âÅҥΡA¤§«e¤jªÑªF»{ÁÊ»ù75¤¸¡A¦Ü¤Ö85¤¸¥H¤W¤~¦n¥æ«Ý¡F¤WÂd«eªÑ»ùn100¤¸¥H¤W¡A©Ó¾P»ù¤~¯à©w85¤¸¡CY¦³±ÂÅv½T©w¾ãÓ»ù³£·|©¹¤W©Ô¡C |
|
|
·|û¡GNtumgk10151447 µoªí®É¶¡:2022/6/16 ¤U¤È 04:29:40²Ä 2095 ½g¦^À³
|
TO ¦V¤j ±z»¡ªº¦³±ø¥ó¤WÂdÀ³¸Ó¬O¤£¤Ó¥i¯àªº¡A¤ñ¸û¹³¬O¤½¥q¦bµ¥®É¾÷! |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/6/16 ¤U¤È 01:18:36²Ä 2094 ½g¦^À³
|
N¤j ©Ò¥HÓ¤H±À´ún¡u¨ú±o¤jÃļt±ÂÅv¦X¬ù¡v®É¡A ©¡®É¤~¬O¡u¾A·í®É¾÷¡v¡C ³oªi¬Ì±¡¼vÅT¡uÃĮĸÕÅç¡v®É¶¡¬Æ¹d¡A¨ì©³·|¬O¤°»ò®ÉÔµ²ªG¤~¥X¨Ó¡H ¤£¹LÓ¤H²q´ú¡AÁöµM¾ãÅé¼Æ¾Ú¥Ø¼Ð¤ÀªRÁÙ¥¼§¹¥þ¹F¦¨¡C ¡uÃĮġv¤j¤è¦VÀ³¸Ó¤w²M·¡¤F¡I |
|
|
·|û¡GNtumgk10151447 µoªí®É¶¡:2022/6/16 ¤W¤È 11:50:52²Ä 2093 ½g¦^À³
|
To ¦V«e¦æ¤j «e¨Ç®É¶¡¦³P¹qµo¨¥¤H¸ß°Ý¤WÂd®Éµ{°ÝÃD¡A¦¶¸³»¡·|¿ï¾Ü¥«³õ¦³§Qªº®É¶¡´£¥X¤WÂd¡A¦Ü©ó¬O¤°»ò®É«J¨S¦³©ú»¡¡A¨ì2023¦~3¤ë«e³£¦³¥i¯à¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/16 ¤W¤È 11:19:52²Ä 2092 ½g¦^À³
|
¡m¥ÍÂåªÑ¡n¦¬®×§xÃø ¥ÍµØ¬ì¦b¬ü¹Ù¦ñ²×¤î·s«a«¯gÁ{§É¸ÕÅç 2022¦~6¤ë14¤é ¶g¤G ¤U¤È4:32 ¡i®É³ø-¥x¥_¹q¡j¥ÍµØ¬ì(6492)±µÀòÁ{§É¹Ù¦ñ¬ü°êÂåÀø¾÷ºcBanner Health³qª¾¦]·s«aªÍª¢«¯g±wªÌ¦¬®×§xÃø¡A¤w¨Mij²×¤îSilmitasertibªvÀø·s«aªÍª¢«¯gÁ{§É¸ÕÅç¡A¬ÛÃö¼Æ¾Ú±N¥æ¥Ñ¿W¥ß¼Æ¾ÚºÊ¹î©eû·|¼f¬d¡C¡]½s¿è¡G±i¹ÅÊ¡^ -------------------------------------------------------------------------------------------------- ¦R¼Ñ¨º®a¡A´«·|p®v¤SÀWÁc´«¥D¿ìú³°Ó¡A¥[¤WEUA¤@®×Åý°ª¼h«H¥Î¯}²£¡A¸U¤@¨p¶Ò¤£¦¨¡Aµ²ªG³ô¼{! |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/6/16 ¤W¤È 11:02:59²Ä 2091 ½g¦^À³
|
Ó¤H²q´ú ¤u·~§½¤WÂd¦P·N¨ç¤º®e¬O§_¦³ªþ±a±ø¥ó¡H ¨ú±o¤jÃļtªº±ÂÅv¦X¬ù¡H¤~ã¤WÂd¡I n¤£µM¤½¥q¿ð¿ð¥¼°e¥ó¤WÂd¡H µ¥©ó1¤ë¥÷ªºÁ{®ÉªÑªF·|¥u¬°¤WÂdij®×¥Õ¶}ªº¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/6/16 ¤W¤È 10:31:53²Ä 2090 ½g¦^À³
|
¥H¥[«Tªº¤âªk ¨S¦³¥b¤d¬O¶]¤£¤Fªº ¨rÆN¤âªk ¦Ü¤Ö©Ô¨ì¤j¾ð¤@¼Ë |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/16 ¤W¤È 10:11:42²Ä 2089 ½g¦^À³
|
À³¸Ó¬O¬Ý³Ì¤jªÑªF¨Î®m¦ó®ÉnªíºA? |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/6/16 ¤W¤È 09:42:59²Ä 2088 ½g¦^À³
|
Æp¥Û¥Í§ÞºX¤U ¦X¤@ ÁÞ°ò ªYÄ£ ½×²£«~½uªº¥«³õ³W¼Ò¡AªYÄ£µ´¹ï¬O¦Ê»õ¬ü¤¸ªº¤jÃÄ¡C ¦ý¬O¥Ø«eªºªÑ»ù»ù®t¹F1¦Ê¤¸¡A¦Ó¥BªÑ¥»³Ì¤p¡AÄw½X¶°¤¤¡C ¦ó®ÉªYÄ£¤~¯à³Ó¥X¡H |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/16 ¤W¤È 07:42:26²Ä 2087 ½g¦^À³
|
Veru¥Ó½ÐEUA·Ó°_¤u3->4->5¡A°ê¹©¿W¨B¤Ñ¤U4->5¡C ------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/21 ¤W¤È 08:01:08²Ä 1807 ½g¦^À³ ... ³o¬OEUAªº¬yµ{7¨B¦±! ..Step 3: Pre-EUA Submission A pre-meeting will facilitate a rapid more complete EUA submission. Step 4: Submission of EUA This involves submitting an EUA request to be reviewed by the FDA. Step 5: Approve/Reject EUA After reviewing the EUA application, the FDA issues a formal approval or rejection. ------------------------------------------------------------------------------------------------- |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/16 ¤W¤È 06:57:47²Ä 2086 ½g¦^À³
|
°ê¹©Pȫܺ}«G¶Ü??? NRX »sÃÄ [«ÅºÙ] ¼Æ¾Ú¹F¼Ð (PȹF¼Ð³QFDA§_¨MEUA) ¡A¤½¥qª£§@EUAÃD§÷¡AºG½ßªº§ë¸ê¤H¶°Åé´£§i¤½¥q©ÜÅS¤£¹ê¼Æ¾Ú¡K ZYESAMI ¡K³o¨Ç±wªÌªº¥Í¦s¾÷²vÅãµÛ¼W¥[¡]P=0.006¡^¥|¿¡F·ÀI³Ì°ªªº±wªÌ¡]ÀH¾÷¤À²Õ®É¨Ï¥Î©I§l¾÷ªº±wªÌ¡^ªº¥Í¦s¾÷²v¼W¥[¤F 10 ¿¡]P=0.03¡^¡C 2022.4.22 «e¸ô©ö´µ¦w¨º¦{Á`À˹îªøµo°_½Õ¬dNRX »sÃÄ (2021¦~6¤ëNRX°ª¼h¦V§ë¸ê¤H©ÜÅS¤£¹ê¼Æ¾Ú...) ...KSF ªº½Õ¬d«ÂI¬O NRx ªº©xû©M/©Î¸³¨Æ¬O§_¹H¤Ï¹ï¤½¥qªÑªFªº«H°U³d¥ô©Î¨ä¥L¹H¤Ï¦{©ÎÁp¨¹ªk«ß¡C -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/21 ¤W¤È 07:50:58²Ä 1611 ½g¦^À³ ¸g¹L°ò¨È»P¯E¹©¨Æ¥ó«á¡A§ë¸ê¤H¹ï¥Í§ÞªÑ¯d¤U¤£¦nªº¦L¶H¡A¤£§Æ±æ¾ú¥v¨Æ¥ó«ºt! 1. FDA©Úµ´NRxÃļtZyesami¥Î©óªvÀø¦M«¯f±w¤§EUA 2. 2022.1.20ÃÒ¨é´Û¶B«ß®v¨Æ°È©Ò¥Nªí§ë¸êªÌ«Å¥¬¹ï NRx ¶i¦æ½Õ¬d2021 ¦~ 6 ¤ë¡ANRx «Å¥¬¦V¬ü°êFDA´£¥æ¥Ó½Ð¡An¨DÀò±oZYESAMIªººò«æ¨Ï¥Î±ÂÅvEUA¡A¥HªvÀø±w¦³©I§l°IºÜªº¦M« COVID-19 ±wªÌ. |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/16 ¤W¤È 06:51:51²Ä 2085 ½g¦^À³
|
¼B¸³n¤£±Ð¤@¤U¦p¦ó¸õ¹LPre-EUA·|ijª½±µ¥Ó½ÐEUA? «¥®a¨S¥Ó½Ð«H¥Î¥æ©ö¿Ä¸êú³! ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/19 ¤W¤È 11:56:49²Ä 1804 ½g¦^À³ ¡§³Õ¾Ç¤§¡A¼f°Ý¤§¡A·V«ä¤§¡A©ú¿ë¤§¡A¿w¦æ¤§¡¨ .. °ê¹©¥Í§ÞÁ`¸g²z Ĭ¸g¤Ñ¡G...µM«á¸òFDA´N¬O¥Ó½ÐPre-EUAªº·|ij¡C[¦P·N]¡A¨º§ÚÌ´N·|submit¡A´N¬O¶i¦æ¥Ó½ÐEUAªº°Ê§@¡C¡v °ê¹©¥Í§ÞÁ`¸g²z Ĭ¸g¤Ñ¡G...µM«á¸òFDA´N¬O¥Ó½ÐPre-EUAªº·|ij¡C[¦P·N]¡A¨º§ÚÌ´N·|submit¡A´N¬O¶i¦æ¥Ó½ÐEUAªº°Ê§@¡C¡v °ê¹©¥Í§ÞÁ`¸g²z Ĭ¸g¤Ñ¡G...µM«á¸òFDA´N¬O¥Ó½ÐPre-EUAªº·|ij¡C[¦P·N]¡A¨º§ÚÌ´N·|submit¡A´N¬O¶i¦æ¥Ó½ÐEUAªº°Ê§@¡C¡v |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/16 ¤W¤È 06:36:48²Ä 2084 ½g¦^À³
|
·s³Ð[°ê¹©¦¡]¸Ñª¼¡A¦A¥Í¤@©Û[°ê¹©¦¡]EUA¥Ó½Ð??? FDA¨S¦³¸ò±z¶}pre-EUA meeting¡A»¡¥Õ¸Ü´N¬O±z¨S¦³¥Ó½ÐEUA¸ê®æ!!! ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/12 ¤U¤È 03:10:34²Ä 1898 ½g¦^À³ Veru ªí¥Ü¡A¥Ñ¤_¡§压Ë©Ê¡¨ªº¦³®Ä©Ê¡A该¬ã¨s¦b独¥ß数Õu监测©e员会ªº«Ø议¤U´£«e°±¤î¡C ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/3 ¤W¤È 11:55:26²Ä 1929 ½g¦^À³ °ê¹©Pre-EUA·|ij»»»»µL´Á! VERU¤£¥Î1Ó¤ë±o¨ìFDA¦P·N¦b5/10¶}pre-EUA meeting. |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/14 ¤U¤È 12:26:37²Ä 2083 ½g¦^À³
|
½Þ¤£ªÎªÎ¨ìª¯¥h??? ¤µ¡]14¡^¤é»P¥x·LÅé¦W¦r¬Û¦üªº¤½¥q¥x·LÂå¸õªÅº¦°±¡AºÃ¦ü¬O§ë¸ê¤H»~»{¥x·LÂ嬰¥x·LÅé©ÒP??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/14 ¤W¤È 11:57:11²Ä 2082 ½g¦^À³
|
±q¾P°â»P±ÂÅvª÷¬ÝÃö¸`ª¢(OA)ÃĪ«´N¬O¤jÃÄ! 1.Humira´N¬OªvÀøÃþ·ÀãÃö¸`ª¢(2021¦~¾P°âÃB206.94»õ¬ü¤¸) 2.2006¦~¡A辉·çªá¤F约5亿¬ü¤¸¦¬购Rinat Neuroscience¡A进¦Ó获±o¤FTanezumab¡Cþ÷来¦b2013¦~ÉO辉·ç签订¤F¤@¥÷°ª达 18亿¬ü¤¸ªº协议 3. 2022.6.13¥x·LÅé»PEndo ±ÂÅv6.7»õ¬ü¤¸ 4.SNP-810+ (¤fªAªø®Ä¯Ç¯k¸Ñ)½Æ¤è¤îµhÃÄ»ùÈ? (Âù°¼½¥Ãö¸`¸m´«³N«á¤§¤¤«×¦ÜÄY«¯kµhªvÀø) ¸Ü»¡§Ú¨º¿Ë±´«1°¼«á¡A¦]¼@µh¤£Ä@·N¦A´«¥t1°¼! |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/6/14 ¤W¤È 11:03:43²Ä 2081 ½g¦^À³
|
endo¤]¬O½ä¤F!!!»\µPµ¥¶}¼ú ¥x·LªÑªF¤]¥X¤£¤F¡A¦ý¬O¥x·L¦³ÄY«¤ºÀ`ºÃ¼{!§Ú°O±o¥x·LªºªÑ¥»¦n¹³8e?¤Ï¥¿³£¬O¤jªÑªF¦b·d§A ¦w¦¨¤U¤FÁÙ¬O³Q³¯¸³¦Y¤F¦^¥h ¤£¦R°© ¹ï¤pªÑªF¨Ó»¡ ±¡¦X¥H°É ¤°»ò®ÉÔµ¥¨ìªYÃĨӤ@ªi¡A³o2®a¤j¼tendoªº¥i¯à´N¤p¤F¡CÁÙ¬O«b¥Xµ{«rª÷ ¤@¼Ëªº±ÂÅvª÷¡A¹ï¼Ð¦X¤@ªº¤Ñ»ù +++++++++++++++++++++++ µL©`¥x·LÅé¤U¥«¡A³o«h¤îµhÃĪ«±ÂÅv6.7»õ¬ü¤¸±a¤£°_ªYÄ£¡C 23»õ¬ü¤¸±ÂÅvª÷ªº·s«¬¤îµhÃÄ¡A3¤ë¦b¬ü°êFDA½²î¡A¤W¶g¤S¦b¼Ú¬wEMA½¨®! |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/6/13 ¤U¤È 11:25:14²Ä 2080 ½g¦^À³
|
5¤ë8¤é¾¾¤j¶K¤å¡G111¦~«×¤½¥qÀç¹B¥Ø¼Ð¬O§¹¦¨»PÃļt¦X§@®×±ÂÅv¡A¤½¥qÀç¹B¥Ø¼Ð¤@©w¬O¦¶¸³¼f®Ö¹L¤~¯à¤½¥¬¡C¨ì¤µ¦~©³¾ã¾ã2¦~ÁÙ¤£°÷ªø¶Ü¡H²Ä¤@¡B¤G¦X§@®×¤£¥²©È¤£¦¨¡A¥ý·Q·Q¤jÃļt¤£nªº«áªG³õ´º¬O«ç¼Ë¡H±z´N·|¬Û«HÅK¦¨ªº¡I |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/6/13 ¤U¤È 08:18:30²Ä 2079 ½g¦^À³
|
½²¤j ¦¶¸³¦ó®É»¡¡u¤µ¦~·|±ÂÅv¡v¡H ½T©w¶Ü¡H |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/6/13 ¤U¤È 07:47:57²Ä 2078 ½g¦^À³
|
·PÁÂr¤j¸Ñ»¡¡AÁÂÁ¡C¤O´¹¬O¤U¥««á«Ü¤[¡AªÑ»ù¼u¨ì15¤¸®É¤~»{ÃÑ¥¦¶Rªº¡CªYÄ£¬Ý¨Ó¨S¦³¨ÖÁÊ°ÝÃD¡A¤]¦³ªÑ¤ý¬Û¡A§Ú·|¦º¦ºÂH¦í¥¦´N¬O¤F¡C¦¶¸³説¤µ¦~·|±ÂÅv¡A¬Û«H±ÂÅv®ø®§Ãn¥ú¡Aº¦´T·|«Ü¥i©È¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/13 ¤U¤È 05:23:40²Ä 2077 ½g¦^À³
|
¦w¦¨ÃÄ¡u§Ö°{¤UÂd¡v¤T¤jºÃÂI¦³°÷Äa ...¦¬Áʤèªí¥Ü¡A¤£Ä@·N³Q¦¬ÁʪºªÑªF¤]¥i¥H¿ï¾Ü©M¹Î¶¤Ä~Äò©é¤U¥h¡Fwww.businesstoday.com.tw/article/category/80392/post/201907250022/ --------------------------------------------------------------------------------------------- ¦w¦¨ÃĤ£¬O±j¨î¦¬ÁʤU¥«¡A§ë¸ê¤H¥i½æ¥i¤£½æ! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/13 ¤U¤È 05:08:59²Ä 2076 ½g¦^À³
|
¤U¥«´N2ÓÃþ«¬¡G«D¦ÛÄ@¡]³Q°Ê¡^¤U¥«¡B¦ÛÄ@¡]¥D°Ê¡^¤U¥«¡C «D¦ÛÄ@¤U¥«³q±`µo¥Í¦b¤½¥q°]°È¤£¨Î(«¥®a¦R¼Ñ¨º®a¦³¸ñ¶H)¡C ¥D°Ê¤U¥«¤£¬O¤@Ó±j¨î¦¬Áʪº®×¤l¡A¤pªÑªF´N¥i¥H¿ï¾Ü½æ©Î¤£½æ¡C(±z¤£¬O¦³°Ñ»P¤O´¹¤U¥«?) ---------------------------------------------------------------------------------------------------- ¥xÆW·L¯×Å餵¤é¼È°±¥æ©ö«Å¥¬«¤j°T®§¡A¤U¤È°OªÌ·|«Å¥¬¡A¸³¨Æ·|¨Mij³q¹L»P´Ë§ë¸ê¶i¦æ¦Ê¤À¤§¦ÊªÑÅvÂà´«¡A¨Ã³W¹º¤U¥«¨p¦³¤Æ¡AY¦³¤£·QÂà´«ªº§ë¸ê¤H¡A¤½¥q¤w·Ç³Æ9000¸U¬ü¤¸§@¬°Å«¦^¸êª÷¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/6/13 ¤U¤È 04:41:57²Ä 2075 ½g¦^À³
|
¬Ý¤F¤@¤U¥x·LÅé¥h¦~©|¥¼¦³¬Ü¥Ø³Q¨p¦³¤Æ¤U¥«¡AªÑ»ù±q80¤¸¤pöt20¤¸¨ì100¤¸´²¤á¨C±i¤pÁÈ2¸U¤¸¡A²{¦b6ÂI7»õ¬ü¤¸±ÂÅv¥HªÑ¥»8»õºâ¡AªÑ²¼»ùȤW¤@¤d¤¸¡F°²³]¥h¦~¥x·LÅé´²¤áµo²{¦Û¤v¤½¥q¤£¿ù¡AÁö³Q¨p¦³n¤U¥«¡A¥i¥H¤£n½æ¶Ü¡H½Ð±ÐÀ´ªºª©¤W¤j¤j¡A·PÁ¡I |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/6/13 ¤U¤È 04:27:02²Ä 2074 ½g¦^À³
|
¥i¯à¯unµ¥¨ìÃĮĸÕÅçµ²ªG¥X¨Ó¡A¤~·|¤W¥h§a¡I ¦~³ø¦³¦C·|p®v¡u¤º±±¡v¼f®Ö¶O55¸U¤¸¡C ¤£ª¾¹D¡H¥¼¦ó¨ì²{¦bÁÙ¨S¦³¤½§i¨ú±o¤WÂd¥Î¡u·|p®v¤º±±³ø§i¡v¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/13 ¤U¤È 03:12:28²Ä 2073 ½g¦^À³
|
µL©`¥x·LÅé¤U¥«¡A³o«h¤îµhÃĪ«±ÂÅv6.7»õ¬ü¤¸±a¤£°_ªYÄ£¡C 23»õ¬ü¤¸±ÂÅvª÷ªº·s«¬¤îµhÃÄ¡A3¤ë¦b¬ü°êFDA½²î¡A¤W¶g¤S¦b¼Ú¬wEMA½¨®! ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/9/23 ¤U¤È 01:10:22²Ä 1420 ½g¦^À³ 23»õ¬ü¤¸±ÂÅvª÷ªº·s«¬¤îµhÃÄ¡A3¤ë¦b¬ü°êFDA½²î¡A¤W¶g¤S¦b¼Ú¬wEMA½¨®! ªvÀø°©Ãö¸`ª¢(osteoarthritis)¤SºÙ¬°°h¤Æ©ÊÃö¸`ª¢ªº²Ä1½uÃĪ«:¤AñQÓi×ô»P«DÃþ©T¾J®øª¢¤îµhÃÄ(NSAID). 2006¦~¡A辉·çªá¤F约5亿¬ü¤¸¦¬购Rinat Neuroscience¡A进¦Ó获±o¤FTanezumab¡Cþ÷来¦b2013¦~ÉO辉·ç签订¤F¤@¥÷°ª达18亿¬ü¤¸ªº协议 --------------------------------------------------------------------------------------------- 2021.9.18 ·s«¬¤îµh药¡I辉·ç/þ÷来NGF§í¨î剂tanezumabªv疗°©关节ª¢(OA)¯kµh¡G¦b¬ü国©M欧·ù¾D¹J监ºÞ®À§é! news.bioon.com/article/6791064.html ....tanezumab¬O¤@Ïú·s«¬«Dªü¤ù类¤îµh药¡A归类为¯«经¥Í长¦]¤l¡]NGF¡^§í¨î剂¡Ctanezumab¨ã¦³ÉO¥Ø«e¥i¥Îªºªü¤ù类药ª«¡B«DÍrÊ^类§Üª¢药¡]NSAID¡^©M¨ä¥L镇µh药¤£¦Pªº崭·s§@¥ÎÉó¨î¡C¦b¨´¤µ为¤îªº¬ã¨s¤¤¡Atanezumab还没¦³ªí现¥X¦¨瘾¡B滥¥Î©Î¨Ì赖ªº风险¡C ¥Ø«e¡A¥i¨Ñ选择ªº¤¤««×OAªv疗¤è®×¦}¤£¯à满¨¬©Ò¦³±wªÌªº»Ý¨D¡A许¦h±wªÌ³q过¦hÏúªv疗¤â¬q寻§ä缓¸Ñ¯kµhªº¤èªk¡C¦pªG获§å¡Atanezumab¦³ýͤO¦¨为ªv疗OA¯kµhªºº个NGF§í¨î剂类¤îµh药¡C tanezumab¥Ñ辉·ç¬ã¨î¡Aþ÷来¦b2013¦~ÉO辉·ç签订¤F¤@¥÷°ª达18亿¬ü¤¸ªº协议¡A±À进该药ªº¥þ²y¦@¦P开发©M°Ó业¤Æ¡C2017¦~6¤ë¡A¬ü国FDA±Â¤©tanezumabªv疗°©关节ª¢¡]OA¡^¯kµh©MºC©Ê¤U¸yµh(CLBP)ªº§Ö³t³q¹D资®æ¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/13 ¤U¤È 03:00:02²Ä 2072 ½g¦^À³
|
¬°¦óTLC599©ó¸ÕÅ礤¤¹³\¨Ï¥Îªº±Ï´©ÃĪ«¬°¤AñQÓi×ô(acetaminophen)¡ANSAID¤Î¾~¤ùÃþ¤îµhÃĪ«¬Ò¤£¤¹³\¨Ï¥Î? ì¦]:¨C¤ÑªA¥Î«DÍrÅé§Üª¢ÃÄ/ªü¥q¤ÇªLªvÀøÃö¸`ª¢ªº°·±d±wªÌ¡Aµo²{¡§71% ªº«DÍrÅé§Üª¢ÃļÉÅS¶W¹L 90 ¤Ñªº±wªÌªº¤p¸z¨ü¨ì©úÅã·l¶Ë¡C¡¨ --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/12 ¤W¤È 08:52:00²Ä 1693 ½g¦^À³ ...¨ì2031 ¦~¡A¥þ²y«D³B¤èÂíµhÃÄ¥«³õ¹wp±NÂX¤j1.6 ¿¡A¦ôȱN¹F¨ì 400 »õ¬ü¤¸(¹ï¤A酰®ò°ò×ô¦û45¢H=180»õ¬ü¤¸)¡C ¥Ñ©ó±w¦³Ãö¸`µhµ¥µLªkªv¡ªº°·±d°ÝÃDªº¦Ñ¦~¤H¤f¤£Â_¼W¥[¡A¹ï«D³B¤èÃĹï¤A酰®ò°ò×ô©M«D³B¤èÃĤô·¨»ÄÆQªº»Ý¨D¼W¥[¡C ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/10 ¤U¤È 12:24:22²Ä 1681 ½g¦^À³ ---sites.psu.edu/siowfa13/author/clr5450/ ¡¨ ¤@¶µ¬ã¨s¤ÀªR¤F 43 ¦W¨C¤ÑªA¥Î«DÍrÅé§Üª¢ÃÄ/ªü¥q¤ÇªLªvÀøÃö¸`ª¢ªº°·±d±wªÌ¡Aµo²{¡§71% ªº«DÍrÅé§Üª¢ÃļÉÅS¶W¹L 90 ¤Ñªº±wªÌªº¤p¸z¨ü¨ì©úÅã·l¶Ë¡C¡¨ -------------------------------------------------------------------------------------------- |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/13 ¤U¤È 02:40:52²Ä 2071 ½g¦^À³
|
¦b¦X¤@FB825¥H5.3»õ¬ü¤¸±ÂÅvLEO»sÃÄ¡A쥻»{¬°±µ¤U¨Ó·|¬O¥_·¥¬PADI-PEG20»P¦X¤@ON101½l³y¬ö¿ý¡A ¦³ÂI·N¥~¬O¥ý¥Ñ¥x·LÅéªø®Ä¤îµhÃĪ«TLC599¥´¯}! |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/6/13 ¤U¤È 02:28:53²Ä 2070 ½g¦^À³
|
ªñ´Á¥h¤T®a¤£ºâ¤pªºÃħ½n¶R¦³¬r´¶®³¯k¯Ê³f¶R¤£¨ì¡A¥i·QµL¬r810±N¨Ó·|¦h¤õ¡I¤fªAÃĤS¤ñª`®gnÅý¤H¯à±µ¨ü¡A¥¦³£6»õ¬ü¤¸¤F¡A«¥ªYÄ£8¨t¦C2ÃÄÅK¶W¹L10»õ¬ü¤¸¡AªÑ»ù¥ú8¨t¦C´N¶W¹L2000¤¸¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/13 ¤U¤È 02:24:50²Ä 2069 ½g¦^À³
|
(TLC599ªvµh)Ãö¸`ª¢ÄY«-->½¥Ãö¸`¸m´«³N¡A¬Y¿Ë±´«¹L¡A»¡³N«á«Üµh«Üµh«Üµh!(SNP-810+¤fªAªø®Ä¯Ç¯k¸Ñªvµh) ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/12 ¤W¤È 09:03:09²Ä 1974 ½g¦^À³ ...§Ú¯d·NÃö¤ßªº¬O©³¤U:SNP-810+ (¤fªAªø®Ä¯Ç¯k¸Ñ)ªº½Æ¤è¤îµhÃĸÕÅç¡C ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/25 ¤U¤È 10:28:31²Ä 574 ½g¦^À³ »O¥_ºa¥ÁÁ`Âå°|¤HÅé¸ÕÅç©eû·|(¤@)²Ä 131 ¦¸·|ij¬ö¿ý ¤½§iª© ¶}·|®É¶¡¡G109 ¦~ 11 ¤ë 2 ¤é¤U¤È 2 ®É¥¿ pµe¥D«ù¤H¡G³¯¥¿Â× pµe¦WºÙ¡G·s±j®Ä¤£¦¨Å}¤îµh²Õ¦XÃÄ Sebacoyl Dinalbuphine Ester ¤Î [µL¨x¬r¤AñQÓi×ô]¥Î©óÂù °¼½¥Ãö¸`¸m´«³N«á¤§¤¤«×¦ÜÄY«¯kµhªvÀø |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/13 ¤U¤È 02:07:53²Ä 2068 ½g¦^À³
|
¡u¤AñQÓi×ô¬O¤@Ó°·±d·ÀI¤j©óÁ{§É¯q³Bªº·Å©MÂíµh¾¯¡A¬ü°ê°©¬ìÂå®v¾Ç·|«Øij¨C¤Ñ¤£±o¨Ï¥Î¶W¹L 3000 ²@§J¡A¥HºÉ¶q´î¤Ö¨x·l¶Ëªº·ÀI¡C ------------------------------------------------------------------------------------------------- JP»¡:...²{¦b§ÚÌ¥i¥H¦Y¤@²~(SNP-810¤AñQÓi×ô)®@ ³£¤£·|¦³¨x¬r©Ê³á! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/13 ¤U¤È 02:02:51²Ä 2067 ½g¦^À³
|
TLC599©ó¸ÕÅ礤¤¹³\¨Ï¥Îªº±Ï´©ÃĪ«¬°¤AñQÓi×ô(acetaminophen) ¡u¤AñQÓi×ô¬O¤@Ó°·±d·ÀI¤j©óÁ{§É¯q³Bªº·Å©MÂíµh¾¯¡A¬ü°ê°©¬ìÂå®v¾Ç·|«Øij¨C¤Ñ¤£±o¨Ï¥Î¶W¹L 3000 ²@§J¡A¥HºÉ¶q´î¤Ö¨x·l¶Ëªº·ÀI¡CTLC599²Õ§O¸Ìªº¯f±w©Ò¨Ï¥Îªº¤AñQÓi×ô©úÅ㪺¤Ö©ó¦w¼¢¾¯²Õ§O¡A -------------------------------------------------------------------------------------------- ¡i2022¦~3¤ë7¤é¡jP¤O©ó¸Ñ¨MÂåÀø©|¥¼³Qº¡¨¬¤§»Ý¨D¡A¨Ãºë©ó©`¦ÌÃĪ«¤§¬ãµo»P°Ó«~¤Æ¤§¥xÆW·L¯×Åé¡A¤µ¤é«Å¥¬¨äÃö¸`ª¢ªø®Ä¤îµhÃĪ«TLC599¤G´Á¸ÕÅ礧¸Ô²Ó¼Æ¾Úµ²ªG¤w¥Zµn©ó¬ü°êª¾¦W´Á¥Z¡mÃö¸`ª¢¬ã¨s»PªvÀøArthritis Research & Therapy¡n¡CTLC599¤D¥x·LÅé¿W®a¡uBioSeizer®¡vªø®Ä½wÄÀ°t¤è¤§¦a¶ë¦ÌªQÁC»Ä¶uÃĪ«¡C¸ÕÅçµ²ªGÃÒ¹êTLC599°§C¯kµh«ü¼Æ¥H¤Î¤fªA¤îµhÃĪº¨Ï¥Îªø¹F¤»Ó¤ë¤§¤[¡A¨Ã¹F²Îp¾Ç¤WÅãµÛ·N¸q¡C ¦¹¦h¤¤¤ß¡BÀH¾÷¤À²Õ¡BÂùª¼¡B¦w¼¢¾¯¹ï·Óªº¤G´ÁÁ{§É¸ÕÅç©ó 75 ¦ì½¥Ãö¸`ª¢¯f±w¶i¦æ¡C½¥Ãö¸`³æ¦¸ª`®gTLC599 ©Î¦w¼¢¾¯«á¡A°w¹ïÃĪ«ªºªvÀø¥\®Ä¤Î¦w¥þ©Ê¶i¦æ¬°´Á 24 ¶gªºÆ[¹î¡C¯f¤H®ÄªG³ø§i(PROs)¥]§t°ê»Ú±`¨£ªºWOMACÃö¸`ª¢¶qªí(Western Ontario and McMaster Universities Osteoarthritis Index)ªº¯kµh©M¾÷¯à«ü¼Æ¥H¤ÎVASµøı¼ÒÀÀ¶qªí(Visual Analogue Scale)ªº¯kµh«ü¼Æ¡C ¯f±w©ó¸ÕÅ礤¤¹³\¨Ï¥Îªº±Ï´©ÃĪ«¬°¤AñQÓi×ô(acetaminophen)¡ANSAID¤Î¾~¤ùÃþ¤îµhÃĪ«¬Ò¤£¤¹³\¨Ï¥Î¡C ¸ÕÅçµ²ªGÅã¥Ü¡ATLC599¦b24¶gÆ[¹î´Á¤º¡A©ó¦UºØ¯kµh¤Î¾÷¯à«ü¼Æ¤Wªºªí²{¡A³£¨ã²Îp·N¸qªºÅãµÛÀu©ó¦w¼¢¾¯¡CTLC599±Ï´©ÃĪ«ªº¨Ï¥Î¶q¤]¨ã²Îp·N¸qªºÅãµÛ§C©ó¦w¼¢¾¯¡C ¦¹¬ã¨s¤å³¹ªºº®u§@ªÌ¡A¦P®É¤]¬O³·±ù¤j¾ÇÂå¾Ç°|±Ð±ÂªºDavid HunterÂå®vªí¥Ü¡G¡u¤AñQÓi×ô¬O¤@Ó°·±d·ÀI¤j©óÁ{§É¯q³Bªº·Å©MÂíµh¾¯¡A¬ü°ê°©¬ìÂå®v¾Ç·|«Øij¨C¤Ñ¤£±o¨Ï¥Î¶W¹L 3000 ²@§J¡A¥HºÉ¶q´î¤Ö¨x·l¶Ëªº·ÀI¡CTLC599²Õ§O¸Ìªº¯f±w©Ò¨Ï¥Îªº¤AñQÓi×ô©úÅ㪺¤Ö©ó¦w¼¢¾¯²Õ§O¡A¥NªíTLC599§Y¨Ï¦b¤@Ó±`±`·|¨Ï¥Î¨ì©ö³y¦¨¤WÅ}ªº¾~¤ùÃþ¤fªAÃĪ«ªºÂåÀøÀô¹Ò¸Ì¡A¤]¨ã¦³´î¤Ö¾~¤ùÃþ¤fªAÃĪ«¨Ï¥Îªº¼ç¤O¡C¡v ¦¹½g¦W¬°¡uTLC599 in patients with osteoarthritis of the knee: a phase IIa, randomized, placebo-controlled, dose-finding study¡vªº¬ã¨s¤å³¹¡A¥Zµn©ó¡mÃö¸`ª¢¬ã¨s»PªvÀø¡n¡A¬O¤@Ó¸g°ê»Ú¦P¾«¼f¬d¡A±Mªùµoªí¦³Ãö¦Ù¦×°©Àf¬ã¨s©MªvÀøªºì³Ð¤å³¹¤§¥Zª«¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/13 ¤U¤È 01:45:22²Ä 2066 ½g¦^À³
|
1.2021-07-06 ¥x·LÅé¨p¦³¤Æ 10¤ë¤U¥« 2.2022-06-13 ¥x·LÅ餵(13)¤é«Å¥¬»P°ê»Ú»sÃĤj¼tEndo International plcñq[Ãö¸`ª¢ªø®Ä¤îµhÃĪ«]TLC599°Ó·~¤Æ¦X¬ù¡A¹w´Á±N³z¹L¦¹¦X¬ù¥iÀò±o¨½µ{ª÷°ª¹F6.7»õ¬ü¤¸(¬ù200»õ¥x¹ô)¡A³Ð¥xÆW¥Í§Þ²£·~¾ú¨Óª÷ÃB³ÌÃe¤jªº¦X§@®×¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/13 ¤W¤È 08:54:28²Ä 2065 ½g¦^À³
|
¦]¬°11¤ë¬ü°ê¤¤´Á¿ïÁ|¡A¿ï²¼¦Ü¤W¡A©Ò¥HPHE 7/16¨ì´Á8¦¨·|¦A®i©µ! XX¥Ó½ÐEUAªº¬üÄRÁÀ¨¥¥i¥HÄ~ÄòÄF¡A¤p¤ß³Ì²×µ²§½¬Û·í±~ºG¡C ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/8 ¤U¤È 03:25:28²Ä 1872 ½g¦^À³ 1.¹w´ú¤U¶g4/15¦A©µªø90¤Ñ¨ì7/15¡A«ôµn§Y·|«Å¥¬²×¤îpublic health emergency¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/12 ¤U¤È 03:55:53²Ä 2064 ½g¦^À³
|
1.杨¨q伟团队½×¤å´£¥Xªº¾÷¨î:SNP610(CYP2E1§í¨î-->¤º·½©Ê¥NÁª«ÅãµÛ¼W¥[-->¿E¬¡ PPAR£\-FGF21)¡C 2. 2022 www.ijbs.com/v18p2317.htm PPAR£\¬O¤@ºØ¦b¨xŦ¤¤¤j¶qªí¹Fªº°tÅé¿E¬¡Âà¿ý¦]¤l¡CPPAR£\ ¿E¬¡¾¯¥ý«e¤w³Q³ø¾É¥i¨¾¤î¹ï¤A酰®ò°ò×ô»¤¾Éªº¨x¬r©Ê... ------------------------------------------------------------------------------------------------ ¥Ñ1&2¸ê®Æ¬ã§P¡AªYÄ£SNP-810§@¥Î¾÷¨î¦ü¥G¤£³æ¬O(§í¨îCYP2E1)ªýÂ_¬r©Ê¥NÁª«NAPQI¥Í¦¨¡A§í¨îCYP2E1±q¦Ó¿E¬¡PPAR£\¤]»Ý±´¨s! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/12 ¤U¤È 03:28:49²Ä 2063 ½g¦^À³
|
clinicaltrials.gov/ct2/show/NCT04165772?term=NCT04165772&draw=2&rank=1 (Estimated Primary Completion Date :November 30, 2023 ,¸ÕÅçÁÙ¦b¶i¦æ¤¤) ¬ã¨s¤H员计¦E©Û¶Ò 30 ¦W II/III ´Á dMMR ª½肠Àù±wªÌ¡C ...«e 18 ¦W±wªÌªº¤¤¦ì¦~龄为 54 岁¡A¨ä¤¤¤k©Ê¥e 12 ¦W¡C 14 ¦W±wªÌ±w¦³ T3/4 肿½F¡A°£ 1 ¦W±wªÌ¥~¡A©Ò¦³±wªÌ³£¦³¤@个©Î¦h个¨ü²Ö²O¤Ú结¡C 17 ¦W¥i评¦ô±wªÌ¤¤¦³ 10 ¦W¦³Ïú¨t¬ð变¡A©Ò¦³ 18 ¦W±wªÌ³£¬O BRAF V600E ³¥¥Í«¬¡C ¦b«e 14 ¦W±wªÌ¤¤¡A12 ¦W±wªÌ¦b 6 个¤ëªº随访¤¤¥X现临§É§¹¥þ缓¸Ñ¡A¨ä¤¤ 2 ¦W±wªÌ¦b 3 个¤ë时达¨ì§¹¥þ缓¸Ñªº标ã¡C¨ä§E¥|¦W±wªÌ¥¼达¨ì 6 个¤ëªº随访¡A¦ý¤@¦W±wªÌ¤w达¨ì临§É§¹¥þ缓¸Ñªº标ã¡C (12¦W +2¦W+ 4¦W(¥¼¹F6Ó¤ë,¦ý¦³1¦W¤w§¹¥þ½w¸Ñ---¤j¥i±ÀÂ_¤w©Û¦¬ªº18¦W¬O¥þ³¡§¹¥þ½w¸Ñ) ÁÙ¦³30-18=12¦W«Ý©Û¤¤¡A´§¥X¥þÂS¥´¾÷²v~100%(30¦W¥þ³¡§¹¥þ½w¸Ñ) ----------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/11 ¤W¤È 09:43:31²Ä 2060 ½g¦^À³ 5~10%ª½¸zÀù±wªÌªº¯«ÃÄ¥X²{! (¿ù°t×´_¯Ê³´(MMRd)ªº°ò¦]¬ðÅÜ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/11 ¤W¤È 10:38:32²Ä 2062 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/29 ¤W¤È 10:20:26²Ä 2035 ½g¦^À³ ¥N谢酶(CYP2E1)ÉO®Ö¨üÊ^(PPAR£\)¤§间¦p¦ó协§@调±±¯×ªÕ´Ä¦â¤Æ¤ÎªÎD发¯f鲜见报¹D¡C ..¤å³¹¥Ø«e¦b线发ªí¦b药学权«Â´Á¥ZActa Pharmaceutica Sinica B¤W¡C ----------------------------------------------------------------------------------------------- Acta Pharmaceutica Sinica B15.9: CiteScore 15.9 / Impact Factor:11.614 杨¨q伟团队ªº½×¤å¬O¬Û·í°ª«~½èªº¬ã¨s! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/11 ¤W¤È 09:54:26²Ä 2061 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/27 ¤U¤È 09:34:47²Ä 2028 ½g¦^À³ ªYÄ£ SNP-610»PSNP-820À³¸Ó±´¨sªvÀøªÎD¯g! ------------------------------------------------------------------------------------------------- 2022.6.10 §ÚÌ¥¿¦b¥H¤@ºØ·sªº¤è¦¡¬Ý«ÝªÎD¡X¡X4 ºØÂåÃĪѥi¯à·|¨ü¯q www.investors.com/news/technology/pharmaceutical-stocks-pharma-diabetes-drugs-obesity-treatment/ ³o¬O¤@Ó»ùȼƤQ»õ¬ü¤¸ªº·Qªk¡G´îªÎ¡C¦Ü¤Ö³o¬O¿Õ©M¿Õ¼w( NVO )¡B§¨Ó( LLY )¡B¦w¶i( AMGN ) ©M½÷·ç( PFE ) µ¥»sÃĪѪº§ë¸êªÌ©Ò§Æ±æªº¡C¥ĻƱæ¬Ý¨ì¤½¥q±N¥L̪º¿}§¿¯fÃĪ«¥Î©óªÎDªvÀø¡A¬°§V¤O´îªÎªº±wªÌ±a¨Óªø´Á§Q¯q¡C ¾Ú´X¦ì¥«³õ¬ã¨s¤HûºÙ¡A2027-28 ¦~ªÎDªvÀø¥«³õ¥i¯à¦b 250 »õ¦Ü 270 »õ¬ü¤¸¤§¶¡¡A µM«á [¦b 6 ¤ë 4 ¤é¡A§¨Ó¤½¥q¤½§G¤F tirzepatide¡]MounjaroI«áªº¤À¤l¡^¦bÅ髬ÛÃö¯e¯f¤¤ªº¥O¤H¹ª»Rªº´ú¸Õµ²ªG¡CFDA ¦³±æ¦b 2024 ¦~§åãªvÀøªÎD¯g¡C ¥LÁÙ¹w´ú¡A°²³] Mounjaro ¦bªÎDªvÀø¤è±Àò±o§åã¡A2030 ¦~ªº¾P°âÃB±N¶W¹L 140 »õ¬ü¤¸¡C] |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/11 ¤W¤È 09:43:31²Ä 2060 ½g¦^À³
|
5~10%ª½¸zÀù±wªÌªº¯«ÃÄ¥X²{! (¿ù°t×´_¯Ê³´(MMRd)ªº°ò¦]¬ðÅÜ) 2022.06.06 ¡§§Ú¬Û«H³o¬OÀù¯g¥v¤W²Ä¤@¦¸µo¥Í³oºØ±¡ªp¡A¡¨¦b³o¶µ¤p«¬¹êÅç©ÊÃĪ«¸ÕÅ礤¡A12¦W±wªÌªºÀù¯g³£®ø¥¢¤F! www.sciencealert.com/every-single-patient-in-this-small-experimental-drug-trial-saw-their-cancer-disappear ¦bª½¸zÀùªvÀø¤è±¦ü¥G¬O¤@Ó«D±`¦³§Æ±æªº¬ð¯}¡A¦b¬ü°ê¶i¦æªº¤@¶µ¤p«¬ÃĪ«¸ÕÅçµo²{¡A¦b¹êÅ礤±µ¨üªvÀøªº¨C¦ì±wªÌªºÀù¯g³£¦¨¥\½w¸Ñ¡C ¬ã¨sµ²ªGµoªí¦b¡m·s^®æÄõÂå¾ÇÂø»x¡n¤W¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/6/10 ¤W¤È 11:44:15²Ä 2059 ½g¦^À³
|
ªYÄ£¤Q¦~¿i¨â¤j¼C¡A§Y±Nµo¥X¥ú¨~¡I¥Ñ©ó¤j®a¹ï·sÃĬãµo±N±a¨Ó¦h¤j§Q¼íÁ٫ܯ¥Í¡Aµ¥¨ìµyÃn¥úªÑ»ù¤W¥h´NÃø¤U¤â¡F¹³ªYÄ£³oºØªÑ²¼§ë¸ê¤£¯à¹³¹q¤lªÑ¤@¼Ë¡A±þ¶i±þ¥Xªº¡C¤ßn¼ÖÆ[·Q¡mµ¥¡n´N¦³¿ú¡I§ë¸ê¶V¤[»â¶V¦h³oºØ¤ßºA¡C²{¦b¯à«ù¦³ªYÄ£ªÑ²¼ªº¤H¡A¤£¬O¦æ®a´N¬O¦³°]¹Bªº¤H¡C |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/6/9 ¤U¤È 05:05:41²Ä 2058 ½g¦^À³
|
½Ð°Ý¦³¤j¤j¥h°Ñ¥[ªÑªF·| ¥i§_´£¨Ñ¬ÛÃö¸ê°T¡I |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/6/9 ¤U¤È 01:37:23²Ä 2057 ½g¦^À³
|
¤£°Ê¦p¤s ¬Ý¨Ó¨S®ø®§ gg |
|
|
·|û¡GNtumgk10151447 µoªí®É¶¡:2022/6/8 ¤U¤È 02:54:34²Ä 2056 ½g¦^À³
|
§¹¥þ¤£§Æ±æªYÄ£¤½¥q«æµÛ¦Û¤v½æ810¡A¤@¶¡¤£¨ì40¤Hªº¤½¥qþ¦³¯à¾P°â¤S¬ãµo¡A±ÂÅvµ¹¤jÃļt¡B³q¸ô°Ó¤~¦³¥¼¨Ó¡C ¤ñ¸û·Qª¾¹Dªº¬O¬°¦ó¤½¥q¤WÂdpµe°±º¢¡A¬O¦³¨ä¥L³W¸Ü¶Ü? |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/6/7 ¤U¤È 09:30:05²Ä 2055 ½g¦^À³
|
¦³¨S¦³¤j¼w¥h°Ñ¥[ªÑªF·|®É°Ý¤@¤U¶}½æªº®É¶¡ |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/6/7 ¤U¤È 06:39:27²Ä 2054 ½g¦^À³
|
ªYÄ£Y¯à©e¥N¤u©e½æ¦w®õ®³¯k¡A¥H¤C¦¨§Q¼íºâ¡AÀ禬10»õ¬ü¤¸§C¦ô¡A§Q¼í¤C»õ¬ü¤¸¢w¢w210»õ¥x¹ô¡A¨CªÑÁÈ300¤¸¡A¤£´N¬OªÑ¤ý¡I«Ü¦³´LÄY¡I«Ü»´ÃP¡A¤£¥²Åý¤H¸ÕÅç¤F¥b¤Ñ¡F¥un©ñ¥X·Ánn¦Û»s¦Û½æ¡I¬Û«H°¨¤W·mµÛ±ÂÅv¡I¤£¦An¤£nªº¡F©Z¥ÕÁ¿¹ï¤è¤£n±o°_¶Ü¡H |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/6/7 ¤U¤È 04:02:13²Ä 2053 ½g¦^À³
|
·ÓÁ¿ªYÄ£¦³¬ü°ê¡B»OÆWÃÄÃÒ¡A¥i¥H¥ý»sµL¬r¤îµhÃÄ¢w¦w®õ®³¯k¸Õ½æ¡A§Q¼í¤C¡B¤K¦¨«Ü°ª¡I¤£¥²Åý¤HºÙ¤ç½×¨â¤S¶W¦nÁÈ¡A¾ÇÃĵØÃÄ¡I |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/6/7 ¤U¤È 03:46:39²Ä 2052 ½g¦^À³
|
n¥h¬ü°ê¶R§a §Ú·Q¸òJ¤j¯«¤@¼Ë¡A¦³µL¬r´¶®³¯k¦Y¡K µo«Hµ¹¤½¥q°Ý¦ó®É¯à¦bÃĩжR¨ì¡A¦ý¨S¦^ |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/6/7 ¤U¤È 01:03:15²Ä 2051 ½g¦^À³
|
§Ú·Q¸òJ¤j¯«¤@¼Ë¡A¦³µL¬r´¶®³¯k¦Y¡K µo«Hµ¹¤½¥q°Ý¦ó®É¯à¦bÃĩжR¨ì¡A¦ý¨S¦^ |
|
|
·|û¡GNtumgk10151447 µoªí®É¶¡:2022/6/7 ¤U¤È 12:00:46²Ä 2050 ½g¦^À³
|
¤µ¦~¨S¿ìªk°Ñ¥[¡A¦b³Â·Ð¦³°Ñ¥[ªºª©¤Í´£¨Ñ¸ê°T¡I |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/6/7 ¤W¤È 11:35:13²Ä 2049 ½g¦^À³
|
Ó¤H¬O«Ü·Q°Ñ¥[ªÑªF·|¡A¸ô³~¤Ó»·§@½}¡I ¶}Á{®É·|¬O¦h¾l¡H ¤d±iªÑªF¤H¼Æ»P¶°«O¤£²Å¡H ÃĮĸÕÅç¶i«×¡H «Ü¦h°ÝÃD»Ýnª¾¹D |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/6/7 ¤W¤È 10:25:59²Ä 2048 ½g¦^À³
|
³Ìªñ©e¶R½æ ³£¥u³Ñ¤U3±i ¥H«e³£¬O9±i ½Ð°Ý¦³¤j¤jª¾¹D¬°¤°»ò¶Ü |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2022/6/7 ¤W¤È 10:03:15²Ä 2047 ½g¦^À³
|
¤µ¦~¤p§Ì¤£°Ñ¥[¤F,¬Ì¿³Áñ¬À,¼È®É¸ú¦b®a¸Ì, ¦³½Ð°Ñ¥[ªº¤j¤j¤À¨É¤F,³oÀɪѲ¼¤Ó¿i¤H¤F~ §Æ±æ¤µ¦~¯à¶}ªáµ²ªG~ |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/6/5 ¤U¤È 06:19:09²Ä 2046 ½g¦^À³
|
½Ð°Ý¦³ªO¤Í·|¥hªÑªF·|¶Ü |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/6/5 ¤U¤È 03:45:40²Ä 2045 ½g¦^À³
|
¤U¶g¥|n¶}ªÑªF·|¤F ªÑ»ù¤]nµy¬°ªí²{£¸¤U§a¡I |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/6/5 ¤U¤È 02:52:09²Ä 2044 ½g¦^À³
|
www.sinewpharma.com/news_detail.php?nwno=35 °£¦¹¤§¥~¡AªYÄ£©|¦³¦¬¿ý¦bUSFDA«ü¤Þ¤¤¡A¥H«D«Iŧ©Êªº©w¶q´ú©w³Ñ¾l¨x¥\¯àªº¤èªk¡u¥b¨Å¿}³æÂIªkGSP (galactose single point)¡v¡A¥¿µo®i¬°¶EÂ_ªvÀøNASHªº¥Íª«¼Ð°O(biomarker)¡A¦p¦¹¥i±æ¸Ñ¨M¨ä¥LNASHÃÄn¥Î¨x¬ï¨ë¤~¯à¨Ï¥ÎNASH ÃĨӪvÀøªº§x¹Ò¡CSNP-6¨t¦C²£«~¦]¦³¨}¦nªº¦w¥þ©Ê¤ÎÅãµÛÀø®Ä¡A¤wÀò°ê»Ú¤j¼tÆf¥Ø¡A²`«×°Q½×¨Ã±K¤ÁÁpôµû¦ô°Q½×¤¤¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/3 ¤W¤È 11:42:30²Ä 2043 ½g¦^À³
|
¥Dn§@ªÌ¡G¥ÛªFì(¥xÆW°ê¨¾Âå¾Ç¤¤¤ß¡^ M1430-04-027 - ¥b¨Å¿}³æÂI¸ÕÅç§@¬°¤@ºØ¦w¥þ¡B²³æ¡B°ªÆF±Ó«×ªº«D°sºë©Ê¯×ªÕ¨x±wªÌªº¨x¥\¯à©w¶qµû¦ô¤èªk ¥Øªº¡G«D°sºë©Ê¯×ªÕ¨x¡]NAFLD¡^¬O¥Ø«e³Ì±`¨£ªººC©Ê¨x¯fì¦]¡A¥]¬A¯×ªÕÅÜ©Ê¡B¯×ªÕ©Ê¨xª¢¡BÅÖºû¤Æ©M¨xµw¤Æ¡C°£¤F²×¥½´Á«D°sºë©Ê¯×ªÕ¨x¥~¡Aµû¦ô¨xŦ·l¶Ëªºª÷¼Ð·Ç¬O¨xŦ¬¡ÀË¡C¥Ø«eªº¬ã¨s¦®¦bµû¦ô¤@ºØ¦w¥þ¡B²³æ¡B°ªÆF±Ó«×ªº¨x¥\¯à©w¶q¤èªk--¥b¨Å¿}³æÂI¡]GSP¡^´ú¸Õ¦b«D°sºë©Ê¯×ªÕ¨x±wªÌ¤¤ªºÁ{§É®Ä¥Î¡C ¤èªk¡G¬ã¨s¤F168¦W±w¦³¤£¦Pµ{«×«D°sºë©Ê¯×ªÕ¨xªº«D¿}§¿¯f±wªÌ¡C³q¹L¥b¨Å¿}³æÂI¡]GSP¡^¸ÕÅç´ú©w¨x¥\¯à¡A³o¬O¬ü°êFDA±ÀÂ˪º©w¶q´ú¶q´Ý¾l¨x¥\¯àªºÀË´ú¤èªk¡C 158¦W¡B149¦W©M67¦W¨ü¸ÕªÌªº¯×ªÕ¨xµû¤À¥Ñ¶WÁnÀˬd¡BCT±½´y©Î¨xŦ¬¡ÀË»PIshakÅÖºû¤Æµû¤À½T©w¡A©Ò¦³168¦W¨ü¸ÕªÌªº¦å²M¥Íª«¼Ð»xª«³£¥i¥Î©ó¤ÀªR¡A¥H½T©wGSP´ú¸ÕªºÁ{§É®Ä¥Î¡C µ²ªG¡C¸Ó´ú¸Õ¬O¦w¥þªº¡A¨S¦³¨Ãµo¯g¡C¥ÑGSP´ú©wªº¨xŦ¥\¯à¯à¤O»P¶WÁnÀˬd¡]r = 0.742¡Ap < 0.005¡An=158¡^©Mpºâ¾÷Â_¼h±½´y¡]r = -0.819¡Ap < 0.005¡An=149¡^´ú©wªº¯×ªÕµû¤ÀÅã¥Ü¥X¨}¦nªº¬ÛÃö©Ê¡C«nªº¬O¡A·íGSP»P°ò©ó¬¡À˵²ªGªºIshakÅÖºû¤Æµû¤À¬ÛÃö®É¡AÅã¥Ü¥X«D±`ºò±Kªº¬ÛÃö©Ê©M³Ì¤pªº«Å|¡]r = 0.922¡Ap < 0.0001¡An=67¡^¡C»P¦å²M¥Íª«¼Ð»xª«¡]¥]¬A¦å²M¥Í¤Æ«ü¼Ð¡B¦å¿}©M¦å¯×ª¬ªp¡^¤]¦³¬ÛÃö©Ê¡A¦ý¥¦Ìªº¬ÛÃö©Ê¸û®z¡A¦Ó¥B¦b±w¦³¤£¦P¨x¯fªº¨ü¸ÕªÌ¤§¶¡ªºµ²ªG¤]¦³©úÅã«Å|¡C µ²½×¡C GSP´ú¸Õ¬O¤@ºØ¦w¥þ¡B²³æ©M°ª«×±Ó·Pªº¨x¥\¯à©w¶q´ú¸Õ¡A»P«D°sºë©Ê¯×ªÕ¨x¨ü¸ÕªÌªº¨x·l¶Ëµ{«×¦³«Ü¦nªº¬ÛÃö©Ê¡C¸Ó´ú¸Õ¦³¥i¯à¦b«D°sºë©Ê¯×ªÕ¨xªºÁ{§ÉºÞ²z¤¤¨ú¥N¨xŦ¬¡ÀË¡A¨Ã´£¥X¤F¤@ºØ¼ç¦bªº·sªºÁ{§ÉºÞ²zºâªk¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/3 ¤W¤È 07:58:51²Ä 2042 ½g¦^À³
|
¦X§@¶}µo! GSP §@¬°¯×ªÕ¨x (GSP) ±wªÌ´Ý¾l¨x¥\¯àªº·s«ü¼Ð (210¤H¤w§¹¦¨) clinicaltrials.gov/ct2/show/NCT04546022?term=NCT04546022&draw=2&rank=1 Tung Yuan Shih(ªYÄ£¥ÛªFì¨ó²z) ¸Ô²Ó»¡©ú¡G...¬ã¨s¤Hû¦®¦bµû¦ô¨Ï¥Î¬ü°ê FDA ±ÀÂ˪º¥b¨Å¿}³æÂI (GSP) ´ú¸Õ©w¶q´ú¶q NAFLD ±wªÌ¨x¥\¯àªºÁ{§É®Ä¥Î¡C ------------------------------------------------------------------------------------------------- ·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/5/8 ¤U¤È 06:04:12²Ä 1945 ½g¦^À³ (¥|) «D«I¤J¦¡ªº³Ñ¾l¨x¥\¯àÀËÅç¸Õ¾¯¤Î¤èªk(GSP)¡G ¥¼¨Ó¤]³W¹º¦X§@¶}µo GSP¡A¥H¨ó§UÁ{§É¶Eªv¯×ªÕ¨xª¢....²{¤w¦³¦b±Ä¼Ë²{³õ§Q¥Î¥iÄ⦡ªº¤ÀªR»ö¾¹¤Î®M²Õ§Ö³t±o¨ìÀË´úµ² ªG(point-of-care)¡A¤w³q¹L¤W¥«¡A¥¿»P¥»¤½¥q³W¹º¦X§@¤¤.... |
|
|
·|û¡G¶ø¥ì´µ¯S10031727 µoªí®É¶¡:2022/6/2 ¤U¤È 10:50:15²Ä 2041 ½g¦^À³
|
GSP ¨S¦³§ÞÂ൹ªYÄ£¡A¥u¬O®³³oÓªk¤è¨Ó°µÁ{§É¤Wªº Biomarker. ¬Ù¥h©Î´î¤Ö°µ biopsy ªº°Ê§@¡C |
|
|
·|û¡GNtumgk10151447 µoªí®É¶¡:2022/6/2 ¤U¤È 08:21:19²Ä 2040 ½g¦^À³
|
½Ð±Ð¦U¦ì¤j¤jgsp ¬O¤w¸g§ÞÂ൹ªYÄ£¤F¶Ü¡H¡ã¦L¶H¦³ÂI¼Ò½k |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/2 ¤U¤È 05:57:54²Ä 2039 ½g¦^À³
|
GSP§ð§J¤jÅ]¤ýÃö¥d¡A´N¬ONASH¦nÀ¸µn³õ! J³Õ:GSP±N¨Ó°µ½T¶E¤]¦nÁ{§É¸ÕÅç¤]¦n ¬O¤@Ó«D±`«nªº¤u¨ã ¥un³Q»{¥i¤F biopsy´N¤£¬O°ÝÃD¤F ¬OGSP¤F ¨º®ÉÔ§ÚÌ´N ¤@¤U¸Ñ¶}¤@ӫܤjªºbottleneck Åý¤H®a¥h©¹«e¨«.... ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/8 ¤U¤È 09:28:41²Ä 1948 ½g¦^À³ ¨xŦ¬ï¨ë¬¡²Õ´À˹ï¶}µoNASHÃĪ«ªºÃļt¨Ó»¡¬O¤jÅ]¤ýÃö¥d! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/2 ¤U¤È 05:33:38²Ä 2038 ½g¦^À³
|
·|û¡G¶ø¥ì´µ¯S10031727 µoªí®É¶¡:2022/6/2 ¤U¤È 04:49:13²Ä 2037 ½g¦^À³ ¥_Âå¤j¡B¤¤¬ã°|¡B°ê¨¾Âå²£¾ÇÄâ¤â¬ãµo ¨x¥\¯à§Ö³t´ú¶q¨t²ÎµnÅv«Â´Á¥Z --------------------------------------------------------------------------------------------------- ¥i¥HťťJ³Õ¸Ñ»¡GSP www.facebook.com/watch/?v=298211662214622 17_Q&A_NASH Á{§ÉÀu¶Õ³]p 1¤À50¬í°_ J³Õ: ²{¦bPhase2b¦³3Ótrial...¬O2b¦ý¬O¨S¦³°µBiopsy ©Ò¥H²{¦b¦³¾÷·|¤F....¦Ó¥B§Ú¥[¤W§ÚªºGSP ²{¦bGSP¤w°e¥hµoªí .ì¨Ó23¤ÀªºÂø»x±µ¦¬¤F Åý§ÚÌ°µrevise §ÚÌ®³¦^¨Órevise»¡ §ÚÌrevise¤[¤@ÂI §ÚÌ¥ý¤£µ¹±z...... |
|
|
·|û¡G¶ø¥ì´µ¯S10031727 µoªí®É¶¡:2022/6/2 ¤U¤È 04:49:13²Ä 2037 ½g¦^À³
|
¥_Âå¤j¡B¤¤¬ã°|¡B°ê¨¾Âå²£¾ÇÄâ¤â¬ãµo ¨x¥\¯à§Ö³t´ú¶q¨t²ÎµnÅv«Â´Á¥Z ¤µ(2)¤é¡A¥Ñ»O¥_Âå¾Ç¤j¾Ç¡B¤¤¥¡¬ã¨s°|¡B°ê¨¾Âå¾Ç°|¡A¥[¤W°ê»Ú¤½¥qAvalon HepaPOC Limited¡B¶®¦U¥Í§Þ¦@¦P²Õ¦¨ªº²£¾Ç¬ã¨s¹Î¶¤¡A¦@¦Pµoªí¡u¥b¨Å¿}³æÂI§Ö³t´ú¶q¨t²Î(GSP)¡v¡AÀˬdªÌ¥u»Ýª`®g©Î¶¼¥Î¥b¨Å¿}«á60¤ÀÄÁ¡A¤â«ü¨ú1ÂI¦å²G¡A§Y¥i¦b75¬í¤º´úª¾¨x¥\¯à¡A¥B¤ñ°_¶Ç²ÎªºSGPT©ÎALTÀˬd¡A§ó¯à¤Ï¬M¹ê»Ú¤Wªº¨x¥\¯à¡A¦Ó«D¶È¤ÏÀ³¨x²ÓM¯}Ãa¦h¤Ö¡C ¦¹¸ó³æ¦ì¬ãµo¹Î¶¤¡A¬O¥Ñ»O¥_Âå¾Ç¤j¾ÇÃľǨtÁ¿®y±Ð±ÂJ¥®®E»â¾É¬ãµo¡A¤£¶È¤w¨ú±o½ÃºÖ³¡Åé¥~¶EÂ_ÂåÀø¾¹§÷³\¥iÃÒ¡AÁÙÀò±o½ÃºÖ³¡·Ç«h¡B¥H¤Î¬ü°ê¹«~ÃĪ«ºÞ²z§½(FDA)ªº·Ç«h±ÀÂË¡A¨Ã¦b¤µ¦~5¤ëÀò¥Zµn¦bÅv«Â¥ÍÂå¤ÀªR´Á¥Z¡mAnalytical and Bioanalytical Chemistry¡n¡C news.gbimonthly.com/tw/article/show.php?num=50047&range=news&fbclid=IwAR0RtbiGDrnz3Pf1Fw0AbCJnKi5VmVRShKW0wlCaok53zqGtKO0cCDolKpA |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/5/29 ¤U¤È 01:01:18²Ä 2036 ½g¦^À³
|
¤p´¹´¹§Ú¤]¦³¥[¤J ¦ý·sÃijo¤£¤Ó¤@¼Ë¡A¦Ü¤Ö§Ų́S¦³©T©wªº¸s¤F¸Ñ¤â¤Wªº¹Ø½X¡A¦Ó¥B¤Oª÷§Ú¬O¤£¬Û«H¤¯¡C¦ý·sÃÄ·Pı¤W¤ñ¸ûÃ!!!¤£¹Lr¤j¦³·NÄ@¡A§Ú¬O¥i¥HºÉ·L³Õ¤§¤O r¤j¬O§ÚÌ´²¤á»â¯è¡A¹ï¤½¥q¤]¦³¬Û·í¦nªº·§°á¡F§Ú¬O·Pı¤j®a¨Ó¤ä«ù¥L¿ï¸³ºÊÃþ¾°È¡A¹ï¤½¥q¤@©w¬O§ó°í±j¡I¹³·í¦~¤O´¹´²¤á±À¥XªL¸³¤@¼Ë¡A§Ú¦³¤ä«ù¨ì¡A¤½¥q¤]¶¶§Q¤WÂd¡A¤j®a³£ÁȨì¿ú¡C·íµMn¦³¤H·|°µ³o¨Ç¨Æ¤Î·í¨Æ¤H¦P·N¡C§Æ±æ¤½¥q¦³§ó¦h±M·~¡B¿Ñ²¤ªº¤H¡A¤@©w¬O¦n¨Æ¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/29 ¤W¤È 10:20:26²Ä 2035 ½g¦^À³
|
¥N谢酶(CYP2E1)ÉO®Ö¨üÊ^(PPAR£\)¤§间¦p¦ó协§@调±±¯×ªÕ´Ä¦â¤Æ¤ÎªÎD发¯f鲜见报¹D¡C 杨¨q伟团队ªº½×¤å´N¬O2022.5¤ë³o½gwww.sciencedirect.com/science/article/pii/S2211383522000545 ---------------------------------------------------------------------------------------------------- research.bjmu.edu.cn/kydt/a1560bda7220457a8546ebd67d4df288.htm 杨¨q伟团队¦b¥N谢酶¥Í²z©Ê¥\¯à¬ã¨s¤è±¨ú±o进®i 发¥¬¤é´Á¡G2022-04-01 CYP2E1酶¬O细M¦â¯ÀP450酶¶W®a±Ú®Ö¤ßÊ^¨t¦¨员¡A¬O¤HÊ^«nªº药ª«¥N谢酶¤§¤@¡C¨ä¥Dn¤À¥¬¤_¨x脏¤¤¡A¯àû{¶Ê¤Æ¥N谢¦hÏú内·½©Ê©M¥~·½©Ê¤p¤À¤l¤Æ¦Xª«¡C¦¹¥~¡ACYP2E1酶还¨ã¦³ÆΪxªº¥Í²z¬¡©Ê¡A¥i调±±¿}§¿¯f¡B¯×ªÕ¨x©M©MÀù¯gµ¥¦hÏú¯e¯fªº发¥Í过µ{¡C¥N谢©Ê®Ö¨üÊ^PPAR£\¬O¿}¯×¥N谢ªº关键®Ö转录¦]¤l¡A¨x脏PPAR£\¿E¬¡¥i显µÛ«P进¨x脏¦¨纤维细M¥Í长¦]¤lFGF21ªí达¦}¤Àªc进¤J¦å²G´`环¡A¦ÓFGF21¬O调节¥Õ¦â¯×ªÕ组织´Ä¦â¤Æ¤Î产热°ò¦]ªí达ªº关键Ê^内¿E¯À¡CµM¦Ó¡A¥N谢酶ÉO®Ö¨üÊ^¤§间¦p¦ó协§@调±±¯×ªÕ´Ä¦â¤Æ¤ÎªÎD发¯f鲜见报¹D¡C 为¦¹¡A¦Û2017¦~°_药学°|¤ÑµM药ª«¤Î¥é¥Í药ª«国®a«点实验«Ç杨¨q伟±Ð±Â团队©M¬ü国国¥ß卫¥Í¬ã¨s°|国¥ßÀù¯g¬ã¨s©ÒFrank J. Gonzalez ±Ð±Â¦X§@¡A³q过ªö¥Î¦hÏú转°ò¦]¤p¹«¥H¤Î¥N谢组学¡B转录组学µ¥¬ã¨s¤èªk¡A发现¤FCYP2E1¥N谢酶³q过ÉO®Ö¨üÊ^PPAR£\¦@¥Î©³ª«¦Ó协§@调±±ªÎDªº§@¥ÎÉó¨î¡C¬ã¨s发现¡AºV°£¤p¹«Cyp2e1°ò¦]¯àû{显µÛ§ïµ½°ª¯×饮¹诱导ªº¤p¹«ªÎD¤Î¿}¯×¥N谢¯¿乱¡A¼W¥[®ñ¤Æ©I§l¥N谢²v¡C转录组学¬ã¨s´¦¥Ü¡A¤p¹«Cyp2e1°ò¦]ºV°£¥i显µÛ¤W调PPAR£\«H号³q¸ô¤U´å¦hÏú¹v°ò¦]ªº转录ªí达¡A¨ä¤¤¥]¬AFGF21¡C¬ã¨s进¤@¨B证实¡ACyp2e1°ò¦]ºV°£¤p¹«¦å²MFGF21ªº¤ô¥显µÛ¤É°ª¡A¥B¥Ö¤U¥Õ¦â¯×ªÕ¬Û关产热°ò¦]Ucp1µ¥ªºªí达显µÛ¼W°ª¡C¦³½ìªº¬O¡ACYP2E1¯SÉݩʧí¨î剂¤A°ò¤G²¸¥N®ò°ò¥Ò»Ä钠¡]DDC¡^¥i¥H¼ÒúQ¤p¹«Cyp2e1°ò¦]ºV°£¦Ó发挥类¦üªºú£ªÎ§@¥Î¡A¿E¬¡¨x脏PPAR£\-FGF21«H号³q¸ô¡A¦}¥[üL¥Õ¦â¯×ªÕ´Ä¦â¤Æ¡F¦ÓDDCªºú£ªÎ§@¥Î¦b¨x脏¯SÉÝ©ÊPPAR£\ºV°£¤p¹«¤¤®ø¥¢¡A´£¥Ü¤FCYP2E1¥\¯à¯Ê¥¢¨Ì赖对PPAR£\«H号ªº¿E¬¡¦Ó发挥ú£ªÎ§@¥Î¡C¥»¬ã¨s运¥Î¥N谢组学¤ÀªR¡BÊ^¥~¥N谢¡B¤À¤l对±µ¡Bªí±µ¥Öäl¦@®¶¤Î双荧¥ú¯À酶报§i°ò¦]§Þ术进¤@¨B´¦¥Ü¤F ¤G¤Q¤GºÒ¤»²m»Ä (DHA)¡Bªá¥Í¥|²m»Ä (AA)©M亚ªo»Ä (LCA) ¥H¤Î·»¦åÁC¯×酰胆þé22:4 (LysoPC22:4)为CYP2E1¤ÎPPAR£\ªº双«©³ª«¡A¯à³QCYP2E1¥N谢酶ª½±µ¥N谢¡A¦}¥i¥R当PPAR£\¿E动剂¡F¨ä¤¤LysoPC22:4为¥»¬ã¨sº¦¸¤Æ学¦X¦¨¦}³Q证实为¤@Ïú¥þ·sªºCYP2E1酶©³ª«¤ÎPPAR£\¿E动剂¡C 该¬ã¨s为¬ã¨s¥N谢酶ÉO®Ö¨üÊ^¤§间¥æ¤¬§@¥Î开©Ý¤F¤@条·s颖ªº¬ã¨s«ä¸ô¡C该¤å³¹¥Ø«e¦b线发ªí¦b药学权«Â´Á¥ZActa Pharmaceutica Sinica B¤W¡C张¤Íªi讲师©M³Õ¤h¦Z颜´@´@为该论¤å²Ä¤@§@ªÌ¡C¬ã¨s¤u§@±o¨ì¤F国®a¦ÛµM¬ì学°òª÷¡]81891011¡^©M¬ü国国¥ß卫¥Í¬ã¨s°|国¥ßÀù¯g¬ã¨s©Ò内³¡¬ã¨s项¥Øªº¤ä«ù¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/5/29 ¤W¤È 09:25:35²Ä 2034 ½g¦^À³
|
r¤j¬O§ÚÌ´²¤á»â¯è¡A¹ï¤½¥q¤]¦³¬Û·í¦nªº·§°á¡F§Ú¬O·Pı¤j®a¨Ó¤ä«ù¥L¿ï¸³ºÊÃþ¾°È¡A¹ï¤½¥q¤@©w¬O§ó°í±j¡I¹³·í¦~¤O´¹´²¤á±À¥XªL¸³¤@¼Ë¡A§Ú¦³¤ä«ù¨ì¡A¤½¥q¤]¶¶§Q¤WÂd¡A¤j®a³£ÁȨì¿ú¡C·íµMn¦³¤H·|°µ³o¨Ç¨Æ¤Î·í¨Æ¤H¦P·N¡C§Æ±æ¤½¥q¦³§ó¦h±M·~¡B¿Ñ²¤ªº¤H¡A¤@©w¬O¦n¨Æ¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/28 ¤U¤È 06:36:15²Ä 2033 ½g¦^À³
|
ªYÄ£SNP-610(DGAT1 + CYP2E1)¦bNASH¸ÕÅçµ²ªGÀu©óElafibranor(4.8»õ¬ü¤¸±ÂÅvPBC¸ÕÅç)»POcaliva(¥Ø«e°ß¤GªºPBCªvÀøÃĪ«¡A¦ý¬O°Æ§@¥Î¨x¬r©Ê¤Ó¤j) SNP-820(CYP2E1§í¨î)ÅçÃÒ³q¸ô¾÷¨î:CYP2E1§í¨î-->¤º·½©Ê¥NÁª«ÅãµÛ¼W¥[-->¿E¬¡PPAR£\ Äݹê¡A °£¤F¬OAPAP¤¤¬r¸Ñ¬r¾¯¡A¦A·s¼WPBC¾AÀ³¯g¡A«h»ùÈ°ª©ó4.8»õ¬ü¤¸!!! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/28 ¤U¤È 06:14:44²Ä 2032 ½g¦^À³
|
¹v¦V§í¨î CYP2E1 ¥i¯à¹ê²{ì¦ì¨x²ÓM¤¤ªº PPAR £\¿E¬¡!!! 1.2021¦~ñ4.8»õ¬ü¤¸±ÂÅvElafibranorªvÀøìµo©ÊÁx¥Ä©ÊÁxºÞª¢(PBC)¸ÕÅç 2.¥Ø«e¡AUDCA©MOCA¬O¶È¦³ªº¨âºØÀò±oFDA§åã¥Î©óªvÀøÁx¥Ä²J¿n¯gªºÃĪ«¡A¥¦Ì³£¬Oªk¥§¾JX¨üÅé¡]FXR¡^ªº°tÅé¡C ----------------------------------------------------------------------------------- 2017.8.30 Nature½×¤å:PPAR£\¬¡¤Æ¥i¨¾¤îÁx¥Ä²J¿n©Ê¨x·l¶Ë www.nature.com/articles/s41598-017-10524-6 1993 ¦~ªº¤@¶µ¬ã¨sµo²{¡APPAR£\ ¿E°Ê¾¯¹ïÁx¥Ä²J¿n±wªÌ¦³¯q PPAR£\ ¿E¬¡¥i¯à³q¹L½Õ¸`£] -FAO °ò¦]¡]¥]¬A Cpt1b¡BCpt2 ©M Mcad¡^¨Ó§ïµ½Áx¥Ä²J¿n©Ê¨x·l¶Ë¡C¨xŦ¤¤ PPAR£\ ¬¡¤Æªº¦³¯q§@¥Î³Ì²×·|¾ÉPª¢¯g²ÓM¦]¤lªº´î¤Ö¡A³o¥i¥H¥~±À¨ì¨ä¥LÁx¥Ä²J¿n±¡ªp¡]¨Ò¦pÃĪ«©Î Bsep §í¨î»¤¾Éªº¡^¡C³o¨Çµo²{¤ä«ù³o¼ËªºÆ[ÂI¡A§Y PPAR£\ ¿E°Ê¾¯¥i³q¹L¤W½Õ£] -FAO ¥Î§@Áx¥Ä²J¿n©Ê¨x·l¶ËªºªvÀø´À¥N«~¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/28 ¤U¤È 05:22:04²Ä 2031 ½g¦^À³
|
ªYÄ£¥²nÅçÃÒ³o½g½×¤å´£¥Xªº¾÷¨î:SNP610(CYP2E1§í¨î-->¤º·½©Ê¥NÁª«ÅãµÛ¼W¥[-->¿E¬¡ PPAR£\-FGF21)¡C 2022.5¤ë www.sciencedirect.com/science/article/pii/S2211383522000545 ¥Ñ©ó CYP2E1 ¥Dn¦b¥Dnµo¥Í¥NÁªº¨x²ÓM¤¤ªí¹F¡A¹v¦V§í¨î CYP2E1 ¥i¯à¹ê²{ì¦ì¨x²ÓM¤¤ªº PPAR £\¿E¬¡¡A³o¥i¥HÁ× §KÁ{§É¤¤°¸º¸µo¥Íªº«D²Õ´¯S²§©Ê PPAR £\¿E¬¡ªº°Æ§@¥Î--->SNP-610Àø®Ä¦w¥þÀu©óElafibranor (PPAR£\/£_¿E动剂) --->SNP-610Àø®Ä¦w¥þÀu©óElafibranor (PPAR£\/£_¿E动剂) 2021¦~ñ4.8»õ¬ü¤¸±ÂÅvElafibranorªvÀøìµo©ÊÁx¥Ä©ÊÁxºÞª¢(PBC)¸ÕÅç 2021¦~ñ4.8»õ¬ü¤¸±ÂÅvElafibranorªvÀøìµo©ÊÁx¥Ä©ÊÁxºÞª¢(PBC)¸ÕÅç |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/5/28 ¤U¤È 12:22:43²Ä 2030 ½g¦^À³
|
ªYÄ£¦³»Ã¯À°ò¦]½Õ±±¤G¥¥x¡A¤S¦³¤@¬yÃĪ«¬ãµo¯à¤O¡A¯à¦b¦w¥þ¤UÅýªý¤îªÎ¦×§Î¦¨¡A¬O°·±d³Ì¤j³Ì¦n¤èªk¡A¥¦ÄÝ«O¾iµ¥¯ÅÃĨS¦³ÃĪ«ÃþÄYÂÔ¡A¥i¥H¦W¬°¹B°Ê¤Y¡A´N¬O¹B°Ê¥i¥H¥Î¦Yªº¡A¬O²{¥N¤H³Ì´Á«ÝªºÃÄ¡CY¯à¬ãµo¦¨¥\¡A¥þ¤HÃþ¤j¥b³£·|¦³¿³½ì¡I¨ºªÑªF¼Æ¿ú¤£¤î¼Æ¨ì»ÄÁÙ·|³Â¡IÅõ¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/28 ¤W¤È 12:23:43²Ä 2029 ½g¦^À³
|
2003.12.30 ¤@½g¾Ç³N¬ã¨s¥ÎÁ{§É¸ÕÅç (16¦WªÎD¨ü¸ÕªÌ¶}G´î«¤â³N VS 16¦WÅé«¥¿±`ªº¹ï·Ó²Õ) ±w¦³«D°sºë©Ê¯×ªÕ¨xªº¯fºAªÎDªÌ¦b´îªÎ«e«áªºCYP2E1¬¡©Ê aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1053/jhep.2003.50342 ...Á`¤§¡A¦b¯fºAªÎD¨ü¸ÕªÌ¤¤¡A¨xŦ CYP2E1 ¬¡©Ê¤W½Õ¡C³N«e¯×ªÕÅܩʵ{«×»PCYP2E1¬¡©Ê¤§¶¡¥H¤Î³N«áªÎDµ{«×»PCYP2E1¬¡©Ê¤§¶¡¦s¦b¥¿¬ÛÃö¡A³oªí©úCYP2E1ªº»¤¾É»P¯fºAªÎD¾ÉPªº¨xż¯fÅܦ³Ãö©Î¥Ñ¨ä¤Þ°_¡C ----------------------------------------------------------------------------------------------- ³oÓ¤HÅé¸ÕÅçµ²ªG¡Aµ¹ªYÄ£ªºNASH (CYP2E1§í¨î)Á{§É¸ÕÅç¤j¥[¤À¡C «Øij§âªÎD¥[¤JªvÀø¾AÀ³¯g! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/27 ¤U¤È 09:34:47²Ä 2028 ½g¦^À³
|
ªYÄ£ SNP-610»PSNP-820À³¸Ó±´¨sªvÀøªÎD¯g! ¿Õ©M¿Õ¼w»¼¥æ¤F¤@±iÀu¥ý¼f¬d¾ÌÃÒ¡]PRV ,»ùÈ>1»õ¬ü¤¸¡^¨Ó¥[³t´îªÎÃÄNDA¼f¬d(FDA§Ö³t¦b4Ӥ뤺§åã¤W¥«) Àu¥ý¼f¬d¾ÌÃÒ¨S¦³¯d«ÝNASH NDA¼f¬d®É¦A¨Ï¥Î¡Aªí¥Ü´îªÎÃÄ°Ó¾÷¤]«Ü¤j¡C ------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/27 ¤W¤È 11:40:09²Ä 2022 ½g¦^À³ SNP-610n¤£¶}Ó´îªÎÁ{§É¸ÕÅç? ----------------------------------------------------------------------------------------- 2021.6.4 ´î«·sÃÄÅQ¥D¨Ó¤F news.gbimonthly.com/tw/article/show.php?num=39613 FDA§åã¿Õ©M¿Õ¼wSemaglutide(wegovy)´îªÎÃĤW¥«....68¶g¸ÕÅç®É¶¡¡A1/3ªº±wªÌÅé«´î»´¶W¹L20% (§Ú·Q¶R¨Ó¦Y¦Y¬Ý) Semaglutide¬O·s¤@¥NªºGLP-1¿E°Ê¾¯¡A¹ï©óNASHªvÀøÁ{§É¤¤! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/27 ¤U¤È 09:19:38²Ä 2027 ½g¦^À³
|
§Æ±æ¨ã¦³¦h«§@¥Î¾÷Âà(DGAT1»PCYP2E1§í¨î)ªºSNP-6·sÃÄ¡A¶¶§Q¦bP2a®³¨ì¬ð¯}©ÊÀøªk»P§Ö³t³q¹D¸ê®æ!!! ---------------------------------------------------------------------------------------------------- 2022.5.26 www.pfizer.com/news/press-release/press-release-detail/pfizer-granted-fda-fast-track-designation (FDA) ¤w±Â¤©½÷·ç¥Î©óªvÀøNASHªº¬ã¨s©ÊÁp¦XÀøªkªº§Ö³t³q¹D¸ê®æ ervogastat¡]PF-06865571¡ADGAT2§í¨î¾¯¡^©Mclesacostat¡]PF-05221304¡AACC§í¨î¾¯¡^¡C §Ö³t³q¹D¬O¤@Ó¦®¦b«P¶i¶}µo©M¥[§Ö¼f¬d¦®¦bªvÀø©Î¹w¨¾ÄY«¯e¯f¨Ã¸Ñ¨M¥¼º¡¨¬ªºÂåÀø»Ý¨Dªº·sÃÄ©M¬Ì]ªº¹Lµ{¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/27 ¤U¤È 01:09:17²Ä 2026 ½g¦^À³
|
SNP-6(CYP2E1§í»s¾¯)¥«³õº¨£·sÃĦP®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x 1. 2021.7.30 www.ncbi.nlm.nih.gov/pmc/articles/PMC8348366/ ¨xÅÖºû¤Æªº¥Dnì¦]¬O¡G¤þ«¬(C¨x)¨xª¢·P¬V (33%)¡B°sºë (30%) ©M NASH (23%) ALD(°sºë)¬O¼Ú¬w³Ì±`¨£ªº¨x¯f¡A¨C¦~¾ÉP¬ù 500,000 ¤H¦º¤` ..[CYP2E1 §í»s¾¯¤w³QÃÒ©ú¹ïALD(°sºë)ªºµo®i¦³®Ä] 2.§ó¥¿:FDA :Alcoholic liver disease °sºë©Ê¨x¯fÁ{§É¦³187®×(¥ÎASH¤~¬O1¥ó) clinicaltrials.gov/ct2/results?cond=&term=Alcoholic+liver+disease&cntry=&state=&city=&dist= ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/8 ¤U¤È 01:03:58²Ä 1941 ½g¦^À³ §Ú¤§«e»´µø¤FSNP-630ªº[°sºë©Ê]¨xª¢¥«³õ!!! ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/7 ¤U¤È 11:04:17²Ä 1660 ½g¦^À³ µn¿ý¦b®×ªºASHÁ{§É©tªù¿W¥«´N1¥ó 1¥ó 1¥ó(ÁÙºM®ø¨S°õ¦æ)---³oªí¥ÜASHÀ³¸Ó¨S¥«³õ§a¡A¤£¸ÑªYÄ£·F¹À±´°Q??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/27 ¤U¤È 12:18:28²Ä 2025 ½g¦^À³
|
µ²½× ¦b¥»¬ã¨s¤¤....³o¨Çµo²{±N CYP2E1-PPAR £\¶b©w¸q¬°ªÎDªvÀøªº·sªvÀø¹vÂI¡C ------------------------------------------------------------------------------------ SNP-610¬O CYP2E1§í¨î¡A¤£±´¨sªÎDªvÀø¤Ó¥i±¤¤F!!! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/27 ¤U¤È 12:12:56²Ä 2024 ½g¦^À³
|
2022.5¤ë www.sciencedirect.com/science/article/pii/S2211383522000545 ..FDA §å㪺¥Î©óªvÀø°sºë¤¤¬rªºÃĪ«Âù²¸±[ [¨ã¦³±j¤jªº§ÜªÎD§@¥Î]¡A¦Ó³o¨Ã«D³q¹L¨ä¹ïîDzæ²B酶2(ALDH2)ªº§í»s§@¥Î¨Ó¹ê²{ªº¡C¦bµ²ºc¤W¡AÂù²¸±[¥i¥H¥NÁ¦¨ DDC¡ACYP2E1 §í»s¾¯¡A¦]¦¹¥i¥H¦X²z¦a±ÀÂ_Âù²¸±[ªº§@¥Î¥i¯à¬O³q¹L¨ä¥NÁª« DDC ¤¶¾Éªº CYP2E1 §í¨î¡C ---------------------------------------------------------------------------------------------- ªvÀø°sºë¤¤¬rªºÃĪ«Âù²¸±[ [¨ã¦³±j¤jªº§ÜªÎD§@¥Î]-->§@¥Î¥i¯à¬O³q¹L¨ä¥NÁª« DDC ¤¶¾Éªº CYP2E1 §í¨î¡C SNP-610°£¤F°µ[°sºë©Ê]¯×ªÕ¨xª¢¡A¤]¸Ó±´¨s¤@¤U´îªÎ®ÄªG??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/27 ¤W¤È 11:48:56²Ä 2023 ½g¦^À³
|
SNP-610ªvÀø[12¶g ]---®É¶¡¤£¨¬¥HÆ[¹îÅé«ÅܤÆ??? Semaglutide(wegovy)68¶g¸ÕÅç®É¶¡ ---------------------------------------------------------------------------------------- û¡GROGER588910148151 µoªí®É¶¡:2022/5/27 ¤W¤È 11:40:09²Ä 2022 ½g¦^À³ SNP-610n¤£¶}Ó´îªÎÁ{§É¸ÕÅç? ----------------------------------------------------------------------------------------- 2021.6.4 ´î«·sÃÄÅQ¥D¨Ó¤F news.gbimonthly.com/tw/article/show.php?num=39613 FDA§åã¿Õ©M¿Õ¼wSemaglutide(wegovy)´îªÎÃĤW¥«....68¶g¸ÕÅç®É¶¡¡A1/3ªº±wªÌÅé«´î»´¶W¹L20% (§Ú·Q¶R¨Ó¦Y¦Y¬Ý) ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/8/20 ¤U¤È 01:49:07²Ä 299 ½g¦^À³ ª`·N¹Ïªí®É¶¡¶b:SNP-610¬OªvÀø [12¶g ] AST¡BALTÅãµÛ¤U° / Ocaliva ¬O18Ó¤ë¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/27 ¤W¤È 11:40:09²Ä 2022 ½g¦^À³
|
SNP-610n¤£¶}Ó´îªÎÁ{§É¸ÕÅç? ----------------------------------------------------------------------------------------- 2021.6.4 ´î«·sÃÄÅQ¥D¨Ó¤F news.gbimonthly.com/tw/article/show.php?num=39613 FDA§åã¿Õ©M¿Õ¼wSemaglutide(wegovy)´îªÎÃĤW¥«....68¶g¸ÕÅç®É¶¡¡A1/3ªº±wªÌÅé«´î»´¶W¹L20% (§Ú·Q¶R¨Ó¦Y¦Y¬Ý) Semaglutide¬O·s¤@¥NªºGLP-1¿E°Ê¾¯¡A¹ï©óNASHªvÀøÁ{§É¤¤! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/27 ¤W¤È 11:15:56²Ä 2021 ½g¦^À³
|
©³¤U1&2ªº½×¤å½T»{CYP2E1 ¯Ê¥F·|¿E¬¡¥Õ¦â¯×ªÕ[½ÅÅÜ]¡C(½ÅÅÜ:¥Õ¦â¯×ªÕ-->½Å¦â¯×ªÕ) J³Õ¦b13_Q&A_Ãø±oJÒ\_01´îªÎÃÄ---µªÂÐÒ\¿ôõ:SNP-6¨S¦³´îªÎ®ÄªG??? ------------------------------------------------------------------------------------------------ 1. 2022.5¤ë www.sciencedirect.com/science/article/pii/S2211383522000545 CYP2E1 ©MPPAR£\ ©³ª«©M¿E°Ê¾¯¤§¶¡ªº¦êÂZ½Õ¸`¯×ªÕ½ÅÅÜ©MªÎD.... ³Ìªñªº¬ã¨s¶°¤¤¦b½Õ¸`«DŸ§Ý²£¼ö¥HªvÀøªÎD¯g...½Õ¸`²£¼ö[¯×ªÕ½ÅÅÜ]¡C³o¶µ¬ã¨sªº¤@ÓÅå¤Hµo²{¬O CYP2E1 ¯Ê¥F·|¿E ¬¡¥Õ¦â¯×ªÕ[½ÅÅÜ]¡A¦ñÀHµÛ®Ö¤ß·Å«×©M¯à¶q®ø¯Óªº¼W¥[ 2.2020.10.28 Nature³o½g:www.nature.com/articles/s41586-020-2856-x ...µo²{¤@Ó»P²£¼ö¦³Ãöªº°ò¦] Aldh1a1¡A¸Ó°ò¦]»P Cyp2e1 Ãö«Yºò±K¡CAldh1a1 »P Cyp2e1 ¬V¦âµ²ªG¦b¦UºØ¯×ªÕ²Õ´ ¤¤§e²{¥X§¹¬üªº«¦X¡A¶i¤@¨B¦LÃÒ¤F¥¦ÌªºÃö«Y¨Ã¤£¤@¯ë¡C ¼Æ¾Úªí©úAldh1a1 / Cyp2e1 +²ÓMªí¹F¤@ºØ®Ç¤Àªc¦]¤l¡A¥¦§í¨î´Ä¦â¯×ªÕ²ÓMªº²£¼ö¥\¯à¡C 3.´îªÎ·s¤èªk¡I±N¯×ªÕ¡u½ÅÅÜ¡v¥i¼W¿U¯×®Ä²v ¥Õ¦â¯×ªÕ²Õ´¡A¦¨¤HÅ餺´X¥G³£¬O³oÃþ«¬ªº¯×ªÕ¡A¥Dn¬O°µ¬°Àx¦s¥H¨Ñ«áÄò¨Ï¥Î¡C ½Å¦â¯×ªÕ²Õ´¡A¯à³z¹L®ñ¤Æ¹Lµ{¡A±N©Ò§tªº¯à¶q¥H¼ö¯àÄÀ©ñ¡A¥H©è¿m´H§Nªº¤Ñ®ð¡A³q±`¥u¥X²{¦bÀ¦¨à¨¤W¡AÀHµÛ¦~ÄÖ¼Wªø ·|³vº¥®ø¥¢¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/26 ¤W¤È 06:53:17²Ä 2020 ½g¦^À³
|
www.facebook.com/watch/?v=3194947797458964 5¤À6¬í:Àø®Ä¤ñ¸û¹Ï(ª`·N¹Ïªí®É¶¡¶b): ªYÄ£ /SNP-610¬O(3Ó¤ë) VS. Genfit /Elafibranor(12Ó¤ë) VS. Intercept/Ocaliva(18Ó¤ë) 1. SNP-610 ÃĮį«³t§ó¦w¥þ! 2. Genfit /Elafibranor :4.8»õ¬ü¤¸±ÂÅvªvÀøìµo©ÊÁx¥Ä©ÊÁxºÞª¢(PBC)¸ÕÅç (¤w²×¤îNASHÁ{§É) 3. Intercept/Ocaliva: FDA¦b2016.5.27§åãOcaliva¤W¥«ªvÀøìµo©ÊÁx¥Ä©ÊÁxºÞª¢(PBC)¡C ¤µ¦~¬ONASHÃÄÃÒ§å㪺²× §½¤§¾Ô! ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/8/20 ¤U¤È 02:01:59²Ä 300 ½g¦^À³ ªYÄ£SNP-610(3Ó¤ë)ALT¥§¡°§C30U/L VS Genfit Elafibranor(12Ó¤ë)ALT¥§¡°§C10U/L ·íSNP-610ªvÀø¶g´Á12~18Ó¤ë«áµ²ªG...? ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/8/20 ¤U¤È 01:49:07²Ä 299 ½g¦^À³ ª`·N¹Ïªí®É¶¡¶b:SNP-610¬OªvÀø [12¶g ] AST¡BALTÅãµÛ¤U° / Ocaliva ¬O18Ó¤ë¡C ©Ò¥H.... ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2020/8/19 ¤U¤È 10:44:40²Ä 298 ½g¦^À³ Ocaliva (Intercept)¬ONASHÃĪ«»â¥ý¸s¤¤²Ä1¤ä¥B¬O°ß¤@¤ä±o¨ìFDA[¬ð¯}©ÊÀøªk]¸ê®æªº¡C SNP-610¯uÀu©óOcaliva?! FDA¨S²z¥Ñ¤£µ¹SNP-610/SNP-630[¬ð¯}©ÊÀøªk]¸ê®æ§a! ¤£¹L¤½¶}ªº¼Æ¾Ú¤Ö©Ò¥H...? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/25 ¤U¤È 11:31:56²Ä 2019 ½g¦^À³
|
SNP-610Àu©óElafibranor (PPAR£\/£_¿E动剂-Genfit) Genfit¤½¥q¦b2020¦~终¤îElafibranor NASH项¥Ø news.bioon.com/article/6759334.html Genfit»PIpsen¦b2021¦~ñ4.8»õ¬ü¤¸±ÂÅvElafibranorªvÀøìµo©ÊÁx¥Ä©ÊÁxºÞª¢(PBC)¸ÕÅç ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151µoªí®É¶¡¡G2020/7/3¤W¤È08:05:38²Ä35½g¦^Î` - The decreases in several clinical parameters from baseline to the end of treatment were greater in SNP-610-12-week treatment than Ocaliva, Cenicriviroc, Elafibranor, MGL3196 or Selonsertib treatment in literature, especially in ALT. |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/25 ¤U¤È 11:04:16²Ä 2018 ½g¦^À³
|
CYP2E1 ¯Ê¥F·|¿E¬¡¨xŦ¹L®ñ¤Æª«酶Åé¼W´Þª«¿E¬¡¨üÅé£\ (PPAR£\ )¹v°ò¦]ªºªí¹F¡A¥]¬A¦¨ÅÖºû²ÓM¥Íªø¦]¤l (FGF) 21¡A³o¨Ç°ò¦]¦b±q¨xŦÄÀ©ñ«á¡A·|¼W±j¯×ªÕ½ÅÅÜ©M¯à¶q®ø¯Ó¡A±q¦Ó´î¤ÖªÎD¡C -------------------------------------------------------------------------------------------------- §ì´X¤äªvÀøNASHªºCYP2E1-PPAR£\-FGF21ÃĪ«§@¬ö¿ý 1.CYP2E1/DGAT1-SNP610/630 ªYÄ£ 2.FGF21 Stimulants: a. BIO89-100 - 89bio b. Efruxifermin (EFX) - Akero Therapeutics c. Pegbelfermin - Bristol Myers Squibb/Ambrx Inc 3.PPAR£\ a.Seladelpar-CymaBay Therapeutics b.Lipaglyn-Zydus Discovery DMCC c.Lanifibranor-Inventiva Pharma d.Icosabutate-NorthSea Therapeutics, BASF |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/25 ¤U¤È 10:46:10²Ä 2017 ½g¦^À³
|
2020¦~¦L«×®ÖãSaroglitazarªvÀø NASH¡A©ó¬ü°ê§¹¦¨Phase II¡C Saroglitazar ¤fªAPPAR-£\/£^ Âù«¿E°Ê¾¯. ------------------------------------------------------------------------------------------------- CYP2E1§í¨î-->4ºØ¤Æ¦Xª«LysoPC 22:4/DHA/AA/LCA ÅãµÛ¼W¥[-->¿E¬¡ PPAR£\-FGF21¡C ¥Ñ©ó CYP2E1 ¥Dn¦b¥Dnµo¥Í¥NÁªº¨x²ÓM¤¤ªí¹F¡A¹v¦V§í¨î CYP2E1 ¥i¯à¹ê²{ì¦ì¨x²ÓM¤¤ªº PPAR £\¿E¬¡¡A³o¥i¥HÁקKÁ{§É¤¤°¸º¸µo¥Íªº«D²Õ´¯S²§©Ê PPAR £\¿E¬¡ªº°Æ§@¥Î SNP-610/630§ó¨ãÀø®Ä»P§C°Æ§@¥Î??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/25 ¤U¤È 10:11:14²Ä 2016 ½g¦^À³
|
¤À¤l¹vÂICYP2E1 ¬Ofirst-in-class!!! ¤@ª½W«ä³o¬q-[SNP-610¸gÀø®ÄÃÒ¹ê¡A¨ä¤G´Á¸ÕÅçµ²ªGÀu©ó¤wµoªí¨Ã¶i¤J¤T´Á¤§¦U°ê NASH Ô¿ïÃĪ«]ªº½t¥Ñ¡C ª½¨ì³o½g·s½×¤å¥X²{-2022.5¤ë ttps://www.sciencedirect.com/science/article/pii/S2211383522000545 ...·í CYP2E1 ¥¢¬¡®É¡A¤º·½©Ê PPAR £\¿E°Ê¾¯¥i¯à·|¼W¥[... ...¦³½ìªº¬O¡A¥þ²y¥NÁ²վǿz¿ïµo²{ CYP2E1 ªº¥\¯à³à¥¢¾ÉP¨xŦ¤¤ LysoPC 22:4 ©M¤TºØ PUFA¡BDHA¡BAA ©M LCA ÅãµÛ¼W¥[¡A³o¬O PPAR £\°ªªí¹Fªº¦P¤@²Õ´¡A¥i¥H½Õ¸`¨xŦ FGF21 ÄÀ©ñ¤@¦¸¬¡©Ê¡C³o¨Ç¥Íª«¼Ð»xª«³Q¶i¤@¨BÅçÃÒ¥i§@¬° CYP2E1 酶©³ª«©Mª½±µ PPAR £\¿E°Ê¾¯¡C¤@¥¹ CYP2E1 ³Q§í¨î¡A¨xŦ¤¶¾Éªº CYP2E1 ¤º·½©Ê¥NÁª«¡]¥]¬A LysoPC 22:4¡BDHA¡BAA ©M LCA¡^ªº¥NÁ´N·|´î®z¡A±q¦Ó¨Ï³o¨Ç¤Æ¦Xª«¦b¨x²ÓM¤¤¼W¥[¡AµM«á§@¬°ª½±µ PPAR £\¿E°Ê¾¯»¤¾Éì¦ì¨x²ÓM¬¡¤Æ. ¥Ñ©ó CYP2E1 ¥Dn¦b¥Dnµo¥Í¥NÁªº¨x²ÓM¤¤ªí¹F¡A¹v¦V§í¨î CYP2E1 ¥i¯à¹ê²{ì¦ì¨x²ÓM¤¤ªº PPAR £\¿E¬¡¡A³o¥i¥HÁקKÁ{§É¤¤°¸º¸µo¥Íªº«D²Õ´¯S²§©Ê PPAR £\¿E¬¡ªº°Æ§@¥Î ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/27 ¤U¤È 04:10:48²Ä 1753 ½g¦^À³ CYP2E1? 2017-05-24ªYÄ£«Å¥¬¨ä¦b NASH ¤è±ªº«¤j¬ð¯} www.microbio.com.tw/news_detail.php?nwno=251 SNP-610¨ã¦³¦hºØ§@¥Î¾÷¨î(CYP2E1 + DGAT1)...¤À¤l¹vÂICYP2E1 ¬Ofirst-in-class¡A¤£¦P©ó¥@¬É¤W©Ò¦³¨ä¥L¦b¬ãÃĪ«¡C -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151µoªí®É¶¡¡G2020/7/3¤W¤È08:05:38²Ä35½g¦^Î` 108/07/24 Bio-Asia¨È¬w¥Í§Þ¤j®iÁ|¿ì¤§¤½¥q®i±æ»¡©ú·| mops.twse.com.tw/nas/STR/663420190724M001.pdf Phase II study: - The decreases in several clinical parameters from baseline to the end of treatment were greater in SNP-610-12-week treatment than Ocaliva, Cenicriviroc, Elafibranor, MGL3196 or Selonsertib treatment in literature, especially in ALT. |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/24 ¤U¤È 04:41:14²Ä 2015 ½g¦^À³
|
www.vdh.virginia.gov/content/uploads/sites/110/2022/04/Youth_SelfHarm_Suicide_Report.pdf ¬ü°êºû¦{ 9-18·³¨àµ£ ±q 2016 ¦~¨ì 2020 ¦~¡A¤j¦h¼Æ«DP©R©Ê¦Û¶Ë¦í°|¬O¥Ñ©óÃĪ«¤¤¬r¡]93%¡^¡A¨ä¦¸¬O5%¥Ñ©ó³Î¶Ë¡A4%¥Ñ©ó«DÃĪ« ¤¤¬r¡A¥]¬A°sºë¡]¹Ï 7¡^.....¦b¨º¨Ç¦]ÃĪ«¾ÉPªº¦Û´Ý¦í°|¤¤ 2016-2020 ¦~¤¤¬r¡]n=2,178¡^¡A³Ì±`¥ÎªºÃĪ«¬O4-®ò°òf×ôl¥Íª«¡A¤SºÙ¹ï¤A酰®ò°ò×ô¡]28%¡^ ------------------------------------------------------------------------------------------------- 9-18·³¨àµ£ APAP¤¤¬r 2178*28%=610¤H¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/24 ¤U¤È 04:26:43²Ä 2014 ½g¦^À³
|
¬ü°ê¨àµ£¦Û±þ¨Æ¥ó¼W¥[--->¤z¹w±¹¬I--->µL¨x¬rAPAP. ¥¬¬¥ªâ¹L¶q¤]«Ü±`¨£¡A¦ýÄY«ªº¬r©Ê§@¥Î¨Ã¤£±`¨£¡AªvÀø«ü«n¤]«Ü²³æ(¤ñAPAP¹L¶q¤¤¬r¦nÂåªv¦h¤F)¡C -------------------------------------------------------------------------------------------- 2022.3.4 ¬ü°ê¬rª«¤¤¤ß³ø§iªº¨àµ£¦Û±þ¨Æ¥ó pubmed.ncbi.nlm.nih.gov/35240919/ µ²ªG¡G ¤ÀªR¤F 514,350 ¦WºÃ¦ü¦Û±þªº¨àµ£¡A¨ä¤¤ 10 ¦Ü 12 ·³¨àµ£ªººÃ¦ü¦Û±þ²v¼W´T³Ì¤j¡]109.3%¡Ap = 0.002¡^¡C13 ¦Ü 15 ·³¡]30.3%¡Ap < 0.001¡^©M 16 ¦Ü 19 ·³¡]18.1%¡Ap< 0.05)¡C³Ì±`¥Îªºª«½è¬O¥¬¬¥ªâ©M¹ï¤A酰®ò°ò×ô¡A¨ä¤¤¹ï¤A酰®ò°ò×ôªº¼ÉÅS²v¼W´T³Ì¤j¡C°Q½×¡G¸Ó¼Æ¾Úªí©ú¦Û§Ú¤¤¬r¯f¨Ò¦³©Ò¼W¥[¡A³oªí©ú¨à¬ì¤ß²z°·±d¦M¾÷¥¿¦b´c¤Æ¨Ã©µ¦ù¨ì¦~»´¤H¸s¡C¨à¬ì¤H¸s§ó®e©öÀò±o«D³B¤èÃÄ¡A³o¥i¯à¸ÑÄÀ¤F¦b¨à¬ìºÃ¦ü¦Û±þ±wªÌ¤¤¨Ï¥Î³o¨ÇÃĪ«ªº¥i¯à©Ê¡C µ²½×¡GÀ³¦Ò¼{¦b³o¨Ç¦~»´¸sÅ餤±Ò°Ê¾A·íªº¤ß²z°·±d¿z¬d©M¤z¹w±¹¬I¡A¥H¨¾¤î¦Û§Ú¤¤¬r¯f¨Ò©M¬ÛÃöµo¯f²v©M¦º¤`²v¶i¤@¨B¤W¤É¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/24 ¤U¤È 03:37:19²Ä 2013 ½g¦^À³
|
·¸Ãº¬O¦Y¤U¤pªÑªF©ñ±ó»{Áʪº³¡¦ì¡C(ú´Ú´Á®É¨S¤°®t»ù) ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/9/25 ¤U¤È 02:24:54²Ä 1428 ½g¦^À³ ¼W¸ê16000±i¡A¤pªÑªF¤j¬ù»{ÁÊ1781±i(16000-14219)¡C¦h¦h¤j«á¨Ó¦³¸Éú¦¨¥\¶Ü? ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/7/6 ¤U¤È 02:25:48²Ä 1289 ½g¦^À³ ¯S©w¤H¿ãÅD¤£¿ãÅD? 7/26«á¨£¯u¾å! ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/7/3 ¤U¤È 12:02:11²Ä 1268 ½g¦^À³ 2021¦~«×¼W¸êpµe ¦U¦ìªÑªF¡B§ë¸ê¤H¡G¤j®a¦n¡I ...¥Ñ©ó¥»¤½¥q¬ãµo¹Î¶¤¦b·sÃĶ}µo¡BÁ{§É¸gÅçÂ×´I¤§Àu¶Õ¤U¡A³°Äò¦b±M§Q¡B§Þ³N¡B¬ãµo¦¨ªG¤Î°ê»Ú¦X§@«´¬ùµ¥¼h±§¡Àò±o·¥¬°Â׺Ӥ§¬ãµo¦¨ªG¡A¥Ø«e¦V¤½¥q¥D°Êªí¹F¦³·NÄ@ªø´Á§ë¸ê¤§¯S©w¤H¬Û·í¿ãÅD¡A±©ìªÑªF¾Ö¦³ªk©wÀu¥ý»{ªÑÅv¡A¨C¥aªÑ¥i»{ÁÊ273.803ªÑ....ÁٽЪѪF̼f·Vµû¦ô¡B´x´¤§ë¸ê¥ý¾÷¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/5/24 ¤U¤È 02:15:38²Ä 2012 ½g¦^À³
|
4eª½¦b¿³Âd¶R¡A³o¤£ª¾nöt¥h¨º ~~~~~~~~~~~~~~~ ¼W¸ê»{ªÑ¦hú¥|»õ¡A¨S·N¥~À³¸Ó¤]¬O´I¨¹¶°¹Î |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/23 ¤W¤È 09:37:02²Ä 2011 ½g¦^À³
|
APAPÁöµM¦W¥s¤îµh¾¯¡A¦ý¬O¬G·N¤j¶qªA¥Î¡A¨Åé¤Ï¦Ó¬O¼@µh§é¿i¥B¬Oªø´Á©Ê¡A¬O³Ì¤£©ú´¼ªº¿ï¾Ü! ¥xÆW2003~2012¡A3235¦WAPAP¤¤¬r--> ¦~§¡¬ùµo¥Í323¥ó¤¤¬r¡C(«C¤Ö¦~¤×¬Æ) -------------------------------------------------------------------------------------------- 2018 ©_¬üÂå°| sjtrem.biomedcentral.com/articles/10.1186/s13049-017-0468-8 ¥xÆW¤@¶µ°ò©ó¥þ°ê¤H¤fªº¶¤¦C¬ã¨s¡A¬°´Á10¦~ªº¸ò踪½Õ¬d¹ï¤A酰®ò°ò×ô¤¤¬rªºªø´Á¦º¤`²v ¤èªk:§Ú̳q¹L¦b 2003 ¦~¦Ü 2012 ¦~¶¡¦b¥þ°ê¤¤¬r¼Æ¾Ú®w©MÁa¦V°·±d«OÀI¼Æ¾Ú®w2000¤¤¡A½T©w¥xÆW 3235 ¦W APAP ¤¤¬rªº°Ñ»PªÌ... µ²ªG:241 ¦W APAP ¤¤¬r°Ñ»PªÌ¡]7.5%¡^©M 94 ¦W¹ï·Ó²Õ¡]1.0%¡^¦bÀH³X´Á¶¡¦º¤`...APAP¤¤¬r°Ñ»PªÌªº¥þ¦]¦º¤`·ÀI§ó°ª ¤×¨ä¬O¦b20·³¤Î¥H¤U... µ²½×:APAP ¤¤¬r»Pªø´Á¦º¤`²v¼W¥[¦³Ãö¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/5/21 ¤U¤È 07:34:44²Ä 2010 ½g¦^À³
|
¬Ý¨ì®³´¶®³¯kÁý¦Ñ¹«¦º¤`¹êÅç«á¡AÃļtº¡Áy¨§ªá¡I¡mªYÄ£¤@©w¤£¬O¬G·Nªº¡n´¶®³¯k¯«ÃĪ±¤£¤U¥h¤F¡I¨S¦³¤Æ¼Ä¬°¤Í¤£¦æ¡AÃø©Ç²Ä¤@ӽͦX§@¡C§Ú²{¦bn¤jÁn»¡¡G¡i³o±ÂÅv®×ÅK¦¨¤F¡I¡j¤j®aµ¥¦n®ø®§§a¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/21 ¤W¤È 10:32:50²Ä 2009 ½g¦^À³
|
¤p©ó¦w¥þ¾¯¶q4g/¤é¡A¤´·|µo¥Í¤¤¬r! ¤p©ó¦w¥þ¾¯¶q4g/¤é¡A¤´·|µo¥Í¤¤¬r! ¤p©ó¦w¥þ¾¯¶q4g/¤é¡A¤´·|µo¥Í¤¤¬r! §ó¥¿:¦Û±þ¶É¦Vªº±wªÌ¬G·N¹L¶qªA¥Îªº¤¤¦ì¼Æ¾¯¶q20g (500mg *40Áû)¡A ¤£¤p¤ß·N¥~ªA¥Î¹L¶qªÌ¬O12g(500mg*24Áû). ¦³¦Û±þ¶É¦Vªº±wªÌÄá¤Jªº¹ï¤A酰®ò°ò×ô´X¥G¬O·N¥~¹L¶q²Õ±wªÌªº¨â¿¡]¤¤¦ì¼Æ:20g VS. 12 §J¡FP = 0.009¡^ www.nejm.org/doi/full/10.1056/nejm199710163371602 ...The suicidal patients had ingested almost twice as much acetaminophen as those in the accidental-overdose group (median, 20 vs. 12 g; P = 0.009). ¦³5¦W±wªÌ¡]·N¥~¹L¶q²Õ 3 ¦W¡A¦Û±þ²Õ 2 ¦W¡^¦b 24 ¤p®É¤º©úÅãÄá¤J 4 §J©Î§ó¤Öªº¹ï¤A酰®ò°ò×ô¡AÆ[¹î¨ì©úÅ㪺¬r©Ê§@¥Î¡A¥i¯à»P¸T¹¡B¹L¶q¶¼°s¦³Ãö... ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/20 ¤U¤È 09:15:05²Ä 2008 ½g¦^À³ ¥H«áªA¥ÎAPAP¦Û±þÃø¤F! (SNP-810¦Y1²~200ÁûÁÙ¤£·|¤¤¬r) §Ú¬Ý¹L¤@½gªA¥Î´¶®³¯k¦Û±þªº¸ê®Æ¡A¦Û±þªÌ¬G·N¹L¶qªA¥Îªº¤¤¦ì¼Æ¾¯¶q¦n¹³¦b25g(50Áû)¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/20 ¤U¤È 09:15:05²Ä 2008 ½g¦^À³
|
¥H«áªA¥ÎAPAP¦Û±þÃø¤F! (SNP-810¦Y1²~200ÁûÁÙ¤£·|¤¤¬r) §Ú¬Ý¹L¤@½gªA¥Î´¶®³¯k¦Û±þªº¸ê®Æ¡A¦Û±þªÌ¬G·N¹L¶qªA¥Îªº¤¤¦ì¼Æ¾¯¶q¦n¹³¦b25g(50Áû)¡C ¦¨¤H³æ¦¸Äá¤J¹ï¤A酰®ò°ò×ôªº³Ì¤p¬r©Ê¾¯¶q¬° 7.5 ¦Ü 10 g¡F¦¨¤H«æ©ÊÄá¤J >150 mg/kg ©Î 12 g ¹ï¤A酰®ò°ò×ô³Q»{¬°¬O¦³¬r¾¯¶q¡A¨Ã¨ã¦³«Ü°ªªº¨x·l¶Ë·ÀI¡C 1 ¦Ü 6 ·³ªº°·±d¨àµ£¤¤¡A³æ¦¸Äá¤J¹ï¤A酰®ò°ò×ôªº³Ì¤p¬r©Ê¾¯¶q¬° 150 mg/kg¡A«æ©ÊÄá¤J≥250 mg/kg ¹ï¤A酰®ò°ò×ô¤Þ°_ªº¨x¬r©Ê¨ã¦³ÅãµÛ·ÀI¡C -------------------------------------------------------------------------------------------------- 2019.6.12 health.ettoday.net/news/1465329 17·³¤k²r§]¡u110Áû´¶®³¯k¡v¸¡µh±¾«æ¶E¡@ÂåÅå¡G14Áû´N¤¤¬r¤F (14Áû*500mg=7g) |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/5/20 ¤U¤È 08:51:40²Ä 2007 ½g¦^À³
|
¦~³øªÑªF«ùªÑ ¤d±i¦³15¤H¡A¦@40052±i¡A¦û58%¡C 10¤jªÑªF¡A¦@33430±i¡C ¤d±i³o2Ó¤ë¦@´î½X1%¡A§âªÑ»ù©¹¤U¥´¡C ¶°«O¤½¥q«ùªÑ ¤d±iÁÙ¬O12¤H¡A«ùªÑ4¸U1¤d¦h±i¡C ¨ì©³¬O½Ö¿ù¡H |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/20 ¤U¤È 08:44:53²Ä 2006 ½g¦^À³
|
¬Ý¨Ó[¦Y¤@²~=100g]¤]¤£·|¤¤¬r¬O¯u¦a! ¨Ì¨C¤é«Øij¶q4g*20¿=80g ¦~³ø74¶:¥»¤½¥q©Ò¶}µo¤§µL¨x¬r¤îµh·sÃÄ¡AªA¥Î¥i¹F¦w¥þ¾¯¶qªº [20¿] ¤´¤£·|¤¤¬r¡A¥¼¨Ó¬Æ¦Ü¦³¥i¯à¥i¥H§¹¥þ¨ú¥N²{¦³ªº¤AñQÓi×ô¤îµhÃÄ¡A¬G¥Ø«e¥«³õ¤Wªº¦U¤jÃļt¥i¯à¬O¥»¤½¥q¼ç¦b¦X§@¹Ù¦ñ§í©Î¬OÄvª§ªÌ¡C ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/9 ¤U¤È 10:28:55²Ä 1958 ½g¦^À³ 08_·sÃĬãµo¦¨¥\®×¨Ò_·s¦¨¤À(ªø®Ä¤î¼@µh¤£¦¨Å}) J¤j¯«¦b19:00¬í°_»¡:..²{¦b§ÚÌ¥i¥H[¦Y¤@²~]®@ ³£¤£·|¦³¨x¬r©Ê³á ¨ì³oºØ¦a¨B¤F ·íµM ³oÁÙ»Ýn¤@¬q®É¶¡¤~·|¤W¥« |
|
|
·|û¡G¾¾¹À©OÎN¹À«¡10150521 µoªí®É¶¡:2022/5/20 ¤U¤È 06:22:14²Ä 2005 ½g¦^À³
|
¨L¥°¶v¬O´I¨¹´xÂd¡A¼W¸ê»{ªÑ¦hú¥|»õ¡A¨S·N¥~À³¸Ó¤]¬O´I¨¹¶°¹Î |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/5/20 ¤U¤È 06:18:17²Ä 2004 ½g¦^À³
|
¼öÄËÄ˪ºªÑªF·|¦~³ø¥X¨Ó¤F¡A·s¤jªÑªF¥X²{ ¥H°¨¤º§Q§ë¸ê¦³¤½¥q¡A¥Nªí¤H:½²©Ó¾§ ôù¦è¹ê·~ªÑ¥÷¦³¤½¥q¥Nªí¤H:¨L¥°¶v |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/5/20 ¤W¤È 11:29:09²Ä 2003 ½g¦^À³
|
´²¤áªí¹F¼¥¼©¼ÖÆ[¥¼¨Ó½}¤F¡F¤@¤Á¤j¤H»¡¤Fºâ¡A«e´ºÁö¬ü¦n¤]¤£®e©ö¹ê¦ô»ù¦ì¡FY¬O¥~°ê¨ÖÁʬü¤¸pºâ¤]¤@©w·|Åý¤j®a¯º¼H¼H¡I¨ÖÁÊ·Qªk¬O¯¸¦b¥~°ê¤jÃļt¨¤«×¦³§Q¬Ý¡F¤½¥q¤jªÑªF¸³¨Æ¤@ÂI¤]¬Ý¤£¥X·Q³Q¨ÖÁʪº·Qªk¡CÁ`»¡¤@¥y¸Ü¡Aªø´Á«ù¦³ªÑ²¼¡A·|ÁÈ¿úªº¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/5/20 ¤W¤È 10:47:06²Ä 2002 ½g¦^À³
|
³Q¤¤¤Ñ¿ö¤F §C¦ô ¤ß¤¤ªºµh¤S³Q´£°_ ¤Ö¤F¦Ü¤Ö¤dw ¨S«H¥Îªº¸ôxx(´N¬O©U§£)¡A«ÂI¤£¬O·¸»ù ¬O¥ý¨Ö¤F ¦A´«¦X¤@ ©ú©ú´N¦b½Í±ÂÅv/³o¤£¬O¤º½u ¤°»ò¬O¤º½u ´N·|¥h§ä¯E¹©ªº³Â·Ð ¨S¿úªº¤pªÑªF ÁÙn³Q¶Êµ| ¨S¤°»ò¤£¦P·N¦X¨Ö¡A´N¬O¥~°ê¥Xªº°÷¤£°÷ »¡Ó¤§«e¸gÅç ¬ü¤è¥X20¬ü¦¬ ¥x¹ô600 §A½æ¤£½æ ¯º¤F §Ú·í¤Uºâ¨ì¤â»Ä ÁÙµ¥Ó3`5¦~ ¤]½ü¤£¨ì§A¦P¤£¦P·N ¤jªÑªFn±j«Á§A ¹J¨ì¤Õ©ú§A¥u¯àúú ¬ë¨ì20¬ü §A´N¯º¯º +++++++++++++++++ ³Q°ê¥~Ãļt¨ÖÁʧÞÂàok¡A³Q°ê¤ºÃÄ¥ø·¸»ùÓ2-30%¦¬Áʤ£¦æ!! ²ö§Ñ¬u²±!! |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/5/19 ¤U¤È 02:06:51²Ä 2001 ½g¦^À³
|
¹wp 2029 ¦~¥þ²y«D°sºë©Ê¯×ªÕ©Ê¨xª¢ (NASH) ÃĪ«¥«³õ³W¼Ò±N¹F¨ì 843.4 »õ¬ü¤¸¡A¦b 2022-2031 ¦~´Á¶¡¥H 39.13% ªº½Æ¦X¦~¼Wªø²v¼Wªø www.marketwatch.com/press-release/non-alcoholic-steatohepatitis-nash-drugs-market-size-2022-2031-to-reach-at-cagr-of-3913-2022-05-17?mod=search_headline |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/5/19 ¤U¤È 01:48:59²Ä 2000 ½g¦^À³
|
§Ú¯uªºn¾K¤F¡I¥H³Ì¥O¤H¹Ú·Qªº°¯×ªÕ¨x¤T¦Ê»õ¬ü¤¸¡A810¤@¦Ê»õ¬ü¤¸¡Ap¥|¦Ê»õ¬ü¤¸¡A¤@¦¨¤À¼íª÷40»õ¬ü¤¸¡A1200»õ¤¸¥x¹ô¡A¨CªÑÁÈ1700¤¸¡A¥»¯q¤ñ20´N¦n¡A¤W¬Ý34000¤¸¡C¥ú¸Õºâ´N¥O¤H§Ö¼Ö¡I¥´¤@§é3000¤¸ªÑ»ù´N¬OªÑ¤ý¤F¡C¦³¿úµ{¡I |
|
|
·|û¡GNtumgk10151447 µoªí®É¶¡:2022/5/19 ¤U¤È 01:23:40²Ä 1999 ½g¦^À³
|
³Q°ê¥~Ãļt¨ÖÁʧÞÂàok¡A³Q°ê¤ºÃÄ¥ø·¸»ùÓ2-30%¦¬Áʤ£¦æ!! ²ö§Ñ¬u²±!! |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/5/19 ¤U¤È 01:04:27²Ä 1998 ½g¦^À³
|
½²¤j àªÕ¨xªº¥«³õ¬O±Ð±Â¦ôªº ¥L¦³«½Æ»¡ª÷ÃB ¶W¹L3¦Ê»õ¬ü¤¸ ¦pªG¦³¤j¼tÄ@·N°ª»ù¨ÖÁÊ ¦óÀ|¤£¬O¬ü¨Æ¡I ¦pªG³£°µ¨ì3´Á®É¡A»ù½X·|§ó°ª¡C ¦ý¬O¡A¬Û¹ï®É¶¡¦¨¥»·|§ó°ª¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/5/19 ¤U¤È 12:37:44²Ä 1997 ½g¦^À³
|
¦Ñ¹«¹êÅç¸ê°T¹ï810§ó¥[±À±R¡I¦V«e¤j°¯×ªÕ¨xÃĤG¦Ê»õ¬ü¤¸±À¦ô¡A§ó¬OÅåÆv³s³s¡I±q¦U¦ì¤j¤jªñ¤é´£¨Ñ¸ê°T¡A·P¿E¡I¤ß¤¤·Pı«¥ªYÄ£±N¨Ó·|Åý§Ú̼ƿú¼Æ¨ì»Ä¡I°í©w¤Ï¹ï³Q¨ÖÁÊ¡I |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/5/19 ¤W¤È 10:18:40²Ä 1996 ½g¦^À³
|
§t¤A²mÓi×ô¤îµhÃĥثe¥«³õ³W¼Ò´N¶W¹L¦Ê»õ¬ü¤¸ ¥[¤WàªÕ¨xÃĪº¹w¦ô°ª¹F3¦Ê»õ¬ü¤¸ °ê»Ú¤jÃļt®³´X¤Q»õ¬ü¤¸¨ÖÁʪYÄ£ ¥u¯à»¡¬O®³¥X¹sÀY¦Ó¤w ¥H¤W¬OÓ¤H¬Ýªk ¶È¨Ñ°Ñ¦Ò |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/5/19 ¤W¤È 09:42:41²Ä 1995 ½g¦^À³
|
Ó¤Hı±o ¹ï°ê»Ú¤jÃļt¨Ó»¡ ªYÄ£ªÑ¥»«D±`¤p ¤£¶Ë¨x¤ÎàªÕ¨xªºÃĪ«¶}µo ¤w¸g¦³¬Ý¨ì®ÄªG¤Î¦¨ÁZ ¥B¦¹2ºØÃÄ¥«³õ³£«D±`¤j ¥Ø«e¤]ÁÙ¨S¦³¥ô¦ó¤@ºØÃĪ«¤W¥« ¨ú±o±ÂÅv¬Û¹ïÀ³§Q¯q¤Ï¦Ó¤£§¹¾ã ª½±µ¨ÖÁʳ̦Eºâ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/19 ¤W¤È 09:36:59²Ä 1994 ½g¦^À³
|
Q:½Ð°ÝSNP-810²{¦b¬ãµoªº¶i«×¦p¦ó? A:SNP-810¬°µL¨x¬r©Ê¤îµh¡u·sÀø®Ä·sÃÄ¡v....¬ü°êFDA»{¬°¡A»ÝnGLP¹êÅç«Ç¨ÓÃÒ©ú¨ä°Êª«Àø®Ä(µL¨x¬r©Ê)... -------------------------------------------------------------------------------------------------- www.facebook.com/watch/?v=3194947797458964 ³o±i¤j¹«P¦º¾¯¶q¹ÏªíÀ³¸Ó´N¬O¥ÑGLP¹êÅç«Ç§¹¦¨ªº¸ÕÅç? P2000(mg/kg)´¶®³¯k:6°¦¤j¹«¦b1~6¤p®É¤º¦º¥ú / (S2000(SNP-810)6°¦¤j¹«¦Ü14¤Ñ¥þ¬¡µÛ. ... P8000(mg/kg)´¶®³¯k:6°¦¤j¹«¦b1¤p®É¤º¥þ¦º /(S8000(SNP-810)1°¦¤j¹«¦b4¤p®É¦º¥h¡A5°¦¤j¹«¨ì14¤Ñ¬¡µÛ. J³Õ»¡¦A°µ¤@¦¸¹êÅç(S8000(SNP-810)6°¦¨ì14¤Ñ¥þ¬¡µÛ. |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/19 ¤W¤È 08:34:05²Ä 1993 ½g¦^À³
|
§Ú»¡[°ê»Ú¤j¼t¨ÖÁʪYÄ£¬°¤W¡AÅý¤pªÑªF¤@¦¸¤J³U¡C] ¥i¬O¤j¤ûJ³Õ:±zn´N¶Rcompound ±z·Q¶R[¤½¥q] §Ṳ́£½æ±z! -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/13 ¤U¤È 08:50:10²Ä 1784 ½g¦^À³ ---°ê»Ú¤j¼t¨ÖÁʪYÄ£¬°¤W¡AÅý¤pªÑªF¤@¦¸¤J³U¡C ---------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/10 ¤U¤È 01:35:06²Ä 1961 ½g¦^À³ ±q³o2¥yÃöÁä¦r:[«e10¦W°ê»Ú¤jÃļt]»P[§Ú¿Ë¦Û¨ì¤Fheadquarter¥h]¡AÀ³¸Ó¬O«üªYÄ£µL»~!!! 05_·sÃĶ}µo_¿ïÃD 13.10~14:30¬í: .....³o¬O¨Æ¹ê®@ [«e10¦W°ê»Ú¤jÃļt] ........§Úɨ䤤¤@®a [§Ú¿Ë¦Û¨ì¤Fheadquarter¥h] ½Í¨ì³Ì«á ¥L»¡±z̯ण¯à ³o®a.§Ú´N¶R±z̪ºªÑ²¼°Ú.§ë¸ê±z̪ºªÑ²¼°Ú...§Ú»¡ ¥xÆWªºªÑ²¼¤Ó«K©y..¹ï¤£°_ ¤£¦æ ±zn´N¶Rcompound ±z·Q¶R[¤½¥q] §Ṳ́£½æ±z....½Í¨ì³o¼Ë£²... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/19 ¤W¤È 08:24:44²Ä 1992 ½g¦^À³
|
SNP-610ªº2Ó¤G´ÁÁ{§É: 1.Àø®Ä±´¯Á¸ÕÅç(¤w§¹¦¨) SNP-610 [¶}©ñ¦¡]Á{§É¤G´Á¬ã¨s¤wÀò±oÅãµÛ¤HÅéÀø®ÄÃÒ¾Ú¡C¾Ú109¦~7¤ë´Á¤¤¤ÀªRµ²ªG¡A35¦ì NASH¯f¤H¡A¥]§t17¦ì°ª¾¯¶q ²Õ©M18¦ì¤¤¾¯¶q²Õ¡A¸g12¶gªvÀø«á¡A¥DnÀø®Ä«ü¼Ð¨xŦ¾¢Ói»Ä¤þ଻ÄÂà®ò°ò»Ã¯À(ALT)¦b°ª¾¯¶q²ÕÅãµÛ°§C¹F -29.5¡Ó33.0 U/L, p=0.002¡A¤¤¾¯¶q²ÕÅãµÛ°§C¹F -18.9¡Ó27.3 U/L, p=0.009¡C 2.¬dÅçµn°O¥ÎÁ{§É¸ÕÅç 2022.3.9¤½¥q¦³§ó·sFDAÁ{§É¶iµ{:2022.12.1 ~2023.12.30:SNP-610ªvÀø«D°sºë©Ê¯×ªÕ©Ê¨xª¢±wªÌÀø®Ä©M¦w¥þ©ÊªºÀH ¾÷¡B[Âùª¼]¡B¦w¼¢¾¯¹ï·Ó¬ã¨s(80¤H) clinicaltrials.gov/ct2/show/NCT03468556?term=SNP-610&draw=2&rank=1 ¥Dnµ²ªG´ú¶q¡G ¤þ®ò»Ä®ò°òÂಾ酶 [®É¶¡®Ø¬[¡G12 ¶g]: ¦å²M¤þ®ò»Ä®ò°òÂಾ酶 (ALT/GPT) ¬Û¹ï©ó°ò½uªºµ´¹ïÅÜ¤Æ ¦¸nµ²ªG´ú¶q¡G MRI ¨xŦ FF [®É¶¡½d³ò¡G12 ¶g] ¨xŦ¯×ªÕ§t¶q¬Û¹ï©ó°ò½uªºµ´¹ïÅÜ¤Æ MRI ¨xŦ FF [®É¶¡½d³ò¡G12 ¶g]¨xŦ¯×ªÕ§t¶q¬Û¹ï©ó°ò½uªºÅÜ¤Æ ... ... |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/5/18 ¤U¤È 07:28:24²Ä 1991 ½g¦^À³
|
µL©Ò¿×¡A¤Ï¥¿¬n°ê¤H¦³¿ú¡A¬Ý¥X¦h¤Ö¡A12eÁâ¤]¦n¡C¥_·¥³£n¤W¤F¡C ²ö«D¬O¤£¤WÂd¤F¡A³Qªü°Â°Ú¾ã¸JºÝ¨«...? ¤p§ÌJ¨¥¶Ã»y¦U¦ì¤j¤j»~»{¯u 1.2021.11.10 ½÷·ç¯{ 12.4»õ¬ü¤¸¶R°¾ÀYµhÃĪ«Rimegepant(°ß¤@¤ä¤fªACGRP药ª«) www.taiwanlab.com.tw/news/show.asp?id=24440 |
|
|
·|û¡GNtumgk10151447 µoªí®É¶¡:2022/5/18 ¤U¤È 02:06:44²Ä 1990 ½g¦^À³
|
¤£ª¾¹D¬°¦ó¨ú±o®Öã¨ç«á¿ð¿ð¨S¦³¶i®i¡A¤½¥q¨ì©³¦bµ¥¤°»ò... ²ö«D¬O¤£¤WÂd¤F¡A³Qªü°Â°Ú¾ã¸JºÝ¨«...? ¤p§ÌJ¨¥¶Ã»y¦U¦ì¤j¤j»~»{¯u |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/5/17 ¤U¤È 12:02:02²Ä 1989 ½g¦^À³
|
·Ç!!!!!!!! ªYÄ£´N¹³¡u³Âò¡v£¸¼Ë³n¡I ½L¤F¥b¦~¡A¤S§Ö¶^¨ì¥h¦~9¤ëªº²{¼W»ù75¤¸¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/5/16 ¤U¤È 02:05:08²Ä 1988 ½g¦^À³
|
§Ú³s0.1»õ³£¨S¦³¡A¤£´±²q4eªº·Qªk |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/5/16 ¤U¤È 12:22:31²Ä 1987 ½g¦^À³
|
¬OnÅý²{¼W75¤¸¨S¦³¶R¨ì©Ò°h¦^ªº4»õ¤¸ ³£¦³¾÷·|¤W¨®¶Ü¡H |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/5/16 ¤W¤È 11:59:28²Ä 1986 ½g¦^À³
|
Âà¤J¤j¾ð ¥s¦n¤£¥s®y ·|ª£¤~¬O¤ý¹D ¤£n©M¶¶n¤@¼ËªºªÑ»ù´Ngg |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/5/16 ¤W¤È 11:51:54²Ä 1985 ½g¦^À³
|
ªYÄ£´N¹³¡u³Âò¡v£¸¼Ë³n¡I ½L¤F¥b¦~¡A¤S§Ö¶^¨ì¥h¦~9¤ëªº²{¼W»ù75¤¸¡C |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/5/16 ¤W¤È 06:40:15²Ä 1984 ½g¦^À³
|
½Ð°Ý¤j®a¦³ª`·N¨ì¤½¥q¥h¦~©³¦³¥Ó½Ð2ӰӼСA¤À§O¬OCEPLENITOL©MCORDYCEPLEN |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/14 ¤U¤È 01:38:49²Ä 1983 ½g¦^À³
|
TGA±N¹ï¯«ÃÄ´¶®³¯k¥X«¤â?! 2022.5.12 ¿D¤j§Q¨ÈªºÃÄ«~ºÊºÞ¾÷ºc(TGA)¥¿¦b¦Ò¼{¨î¨Ï¥Î¥@¬É¤W³Ì±`¥Îªº¤îµhÃÄ¡C ...³ø§i±N¦b 7 ¤ë«e§¹¦¨³ø§i ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/6/27 ¤U¤È 10:04:52²Ä 1252 ½g¦^À³ ±N¨C¤é¾¯¶q¥Ñ4g°¦¨3§J¡A¹ïÃļtªº¾P°â¶q¼vÅT´N¬O¥´¤F75§é! ¥t¥~¡A¿D¬w/¯Ã¦èÄõªººÊºÞ¾÷ºc¦³·N¹ï¥]¸Ë®e¶q¨î¡A¹ïÃļtªº¾P°â¶q¼vÅT¤]¬Û·í¤j¡C©Ò¥HSNP-810ªº[¥i¼W¥[¾¯¶q]¡A¤]ªí¥ÜÃļtªº¾P°â¶q¥i¥HÅܤj! --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/6/19 ¤U¤È 01:13:39²Ä 1215 ½g¦^À³ ...¤µ¦~5¤ëTylenol¦b¿D¬w¤W¬[¶}½æ¡A³Ì«Ü¤j¦]¯À´N¬OGSKªº´¶®³¯k¨ÑÀ³µu¯Ê |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2022/5/13 ¤U¤È 01:19:41²Ä 1982 ½g¦^À³
|
ªñ´ÁªYÄ£®ø®§±§ó²M·¡¤]¥¿¦V¡F¦³¤@¦ì¥Í§Þ»â°ì³Õ¤h»¡ªYÄ£¦³¨âÓ¥¥x¡A³o¥¥x¬O¬ã¨s³õ°ì¡A»ùÈ«Ü°ª¡IªÑ²¼©ñÓ¤¦~¡A¨â¤j¨t²ÎÃĦ¨ªG®i²{¡B±ÂÅv¡AµP±±È§¹«á¡A¨º®ÉªÑ»ù¤~¬O¯u¥¿¤ÏÀ³ªYÄ£»ùÈ¡Cµu®É¶¡ªÑ»ù¤£¦p¹w´Á¡A¤j®a¤£¥²®ð¾k¡A±N¨Ó·|¶¥±è¦¡¤@¶¥¤ñ¤@¶¥°ª¡C |
|
|
·|û¡G¶ø¥ì´µ¯S10031727 µoªí®É¶¡:2022/5/12 ¤U¤È 05:58:06²Ä 1981 ½g¦^À³
|
¼v¤ù¤º®e¦³´£¨ì TB ªºªvÀø§xÃøÂI¤Î¥Ø«eÁ{§É¤W¤£¶Ë¨xªºªvÀø¤è¦¡¡C³oӮפl¥xÆW¦¬®× 556 ¤H¡A¦]¬°¦¬®×³t«×¤£§Ö¡AÁ{§É®É¶¡¤~·|³o»ò¤[¡A¦ý·ÓJ±Ð±Âªº»¡©ú¡A±q¥Ø«eªº¼Æ¾Ú¤w¯à©úÅã¬Ý¥X¸¨®t¡A¬Û«H¦¨¥\ªº¾÷²v·¥°ª¡C ¾ãÓºtÁ¿ªº¼v¤ù¡AÁöµM¨S¦³´£¨ì¤½¥q¦WºÙ¡A¦ý§ÚÓ¤Hı±o´X¥G´N¬O¦bÀ°ªYÄ£¦æ¾P°Ú! J±Ð±Â¦b°ê»Ú¤W¨É¦³¦WÁn¡A°µ·sÃĪºÅÞ¿è²M´·¡A¤S«á±¤j¤O«ü¾É¡BÀ°¦£ªYÄ£¡A¬Û«HªYÄ£¤é«á¤j¦³¥i¬°¡C ¼v¤ù¤¤´£¤Î¡A610/630 «D°sºë¯×ªÕ©Ê¨xª¢¤Î°sºë¯×ªÕ©Ê¨xª¢³£¬O¾A¥Îªº¡A³o¬O¤@¤j«GÂI¥B GSP Y¯à¸ò FDA °Q½×¥X¦bÁ{§ÉÀ³¥Îªº¼Ò¦¡¡A¦¬®×ªº³t«×À³¸Ó·|§Ö¤W¬Æ¦h¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/12 ¤U¤È 12:39:00²Ä 1980 ½g¦^À³
|
辉·ç»¨掷116亿¬ü¤¸¡A¤@©w¤£¬O¦]为¥h¦~赚¤Ó¦h¡A¦Ó¬O¦]为BiohavenÚ̦³独¨ì¤§处¡A°£¤F产«~ºÞ线¥~¡A¬Û«H¨ä独¯Sªº°¾头µh药ª«¬ã发¥¥x¤]¬OɲȩҦb¡C ¦b¥Ø«e资¥»¥«场热«×¤U°ªº±¡úG¤U¡A拥¦³®tÉݤƪº¤½¥q¤~¯à§ó¦nªº¦s¬¡¤U来¡A¥¥x§Þ术«¬¥ø业会¦b¨ä¤¤¦³þӫܦhªºÉ¬势¡C 从¤Ñºt&赛诺µá¡A©M铂&ªü´µ§Q±d¡A¦Ê奥赛图&Àq§J¡A¨ì现¦bªºBiohaven&辉·ç¡A¥i¥H¬Ý¨ì¡A§Þ术¥¥xªºÉ²È¥¿¦bºCºC¥Y显¡C 这对¤_¤@¨ÇP¤O¤_开发§Þ术¥¥xªº¥ø业¡A©Î许¬O§ó¤jªº¿E励¡C -------------------------------------------------------------------------------------------------- ªYÄ£ªº¥Dn§Þ³N¥¥x¬O¨Ï¥Î¦w¥þªº½Æ¦Xª«¨Ó½Õ±±¨xŦ»Ã¯À¤Î°ò¦]¡A¦¹ºØ§Þ³N¥iÀ³¥Î©ó¥i¯à¾ÉP¨x¬r©Ê¤§ÃĪ«¥H¤Î¨xŦ¯e¯f(¦p¯×ªÕ¨x)¤§ªvÀø¡C µL¨x¬r§Þ³N¥¥x¦ó®Éµo¥úµo¼ö°Ú? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/12 ¤U¤È 12:34:05²Ä 1979 ½g¦^À³
|
½÷·ç±q·s«aÃĪ«Áȱo¬Öº¡²Úº¡¡A°®¯Üª½±µ¦Y±¼! 2022.5.11 ½÷·ç¥H116»õ¬ü¤¸²{ª÷¦¬ÁÊ°¾ÀYµhÃÄ°ÓBiohaven(°¾ÀYµhÃĪ« Rimegepant) news.cnyes.com/news/id/4870079 ªvÀø«æ©Ê°¾ÀYµh¤@½uÃĪ«¤AñQ®ò×ô¡]acetaminophen¡^. ----------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/28 ¤U¤È 10:14:42²Ä 1756 ½g¦^À³ SNP-810±ÂÅv«á¦A°µ´XÓ°¾ÀYµhÁ{§É¹êÅç¡A°£¤F»´¯g¡A©Î³\¤¤«¯g¤]¯à¦¨¬°¤@½uÃĪ«! 1.2021.11.10 ½÷·ç¯{ 12.4»õ¬ü¤¸¶R°¾ÀYµhÃĪ«Rimegepant(°ß¤@¤ä¤fªACGRP药ª«) www.taiwanlab.com.tw/news/show.asp?id=24440 |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/5/12 ¤W¤È 10:44:35²Ä 1978 ½g¦^À³
|
±Ð±Â©Ò»¡ªº¡u¶Ë¨x¡v¦¨¥÷¬O¤°»ò ¨Ã§ä¨ì¥i¥H¥NÁ¦¨¡u¤£¶Ë¨x¡vªº²Õ¦X ¸g°Êª«¡B¤HÅé¸ÕÅç«á¡AÃÒ©ú¥\®Ä ¦p¦ó¨ú±o¬ü°êOTC¤Î¥xÆWÃÄÃÒ ³s³e¤U¨Ó¡A«üªº´N¬O810¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/12 ¤W¤È 10:13:54²Ä 1977 ½g¦^À³
|
2022.5.11 FDA¦P·N¤£»ÝnÃB¥~ªº¥\®Ä¬ã¨s©Î¦w¥þ¼Æ¾Ú¨Ó¤ä«ù EUA ªº½Ð¨D-Verup¹º¦b 2022 ¦~²Ä¤G©u«×´£¥æ EUA ½Ð¨D finance.yahoo.com/news/fda-states-veru-submit-request-103000648.html ------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/11 ¤W¤È 06:25:36²Ä 1967 ½g¦^À³ ¥Ó½ÐFDA pre-EUA meeting¡AFDA¦P·N»P§_±oªá¦h¤[? ¥un6Ó¤u§@¤Ñ!!! Veru contacted on MAY 2 about FDA willing to meet on EUA and granted meeting MAY 10, TODAY, only 6 (SIX) BUSINESS DAYS AFTER! ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/3 ¤W¤È 11:55:26²Ä 1929 ½g¦^À³ °ê¹©Pre-EUA·|ij»»»»µL´Á! VERU¤£¥Î1Ó¤ë±o¨ìFDA¦P·N¦b5/10¶}pre-EUA meeting. |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/12 ¤W¤È 09:28:12²Ä 1976 ½g¦^À³
|
¶ø¥ì´µ¯S¤j¬O·~¤º¤H¤h? ¦³ªÅ½Ð¤W¨Ó¦h²á²á¡A§Ú¯à»´ÃP¦h¤F¡C HUEXC030 = HUYPS-2(mannitol¥ÌÅS¾J)´NSNP-810ªº½á§Î¾¯¦¨¤À¤§¤@ -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/28 ¤W¤È 10:56:48²Ä 617 ½g¦^À³ ±q(§Üµ²®ÖÃĪ«+HUEXC030 )-¸Ñ¨M§Üµ²®ÖÃĪ«¨x¬r©Ê »P (APAP+SNP-820)=SNP-810-¸Ñ¨M§ÜAPAP¨x¬r©Ê¡A ¦P²z½×·íµM¯àl¥Í¸Ñ¨M¨ä¥LÃĪ«ªº¨x¬r©Ê! ALF«æ©Ê¨x¥\¯à°IºÜ: 1¤äAPAPÃĪ«(46%) VS 1,036¤äÃĪ«(11%)---³Ì¤j°¦ªº·íµM¬OÀu¥ý¸Ñ¨M¡A©Ò¿×¡u®¾¤}·í®¾±j¡A¥Î½b·í¥Îªø¡C®g¤H¥ý®g°¨¡A¾à¸é¥ý¾à¤ý¡C¡v ------------------------------------------------------------------------------------------ ³o¬OªYÄ£¥ÛªF¤¸¸g²zªº³Õ¤h½×¤å (¹Á¸Õ¸Ñ¨M§Üµ²®ÖÃĪ«ªº¨x¬r©Ê) ndltd.ncl.edu.tw/cgi-bin/gs32/gsweb.cgi?o=dnclcdr&s=id=%22101NDMC0105024%22.&searchmode=basic ...§Q¥Î¤H¨x»P¹«¨x·L²ÉÅé¿z¿ïCYP2E1§í¨î¾¯¡A¬D¿ï§í¨î²v¥i¹F60-88%ªºHUEXC030 (mannitol¥ÌÅS¾J)¶i¦æ¤p¹«ÃÄ®ÄÃİʸÕÅç.... §Üµ²®ÖÃĪ«³y¦¨¨x¬r©Ê¤§°Êª«¼Ò¦¡¡A¨Ã¦¨¥\¦Û111ºØ±`¥Î¤¤¿z¿ï¤F¦hºØCYP2E1¤Îamidase§í¨î¾¯¡A¥Ñ²ÓM¡B°Êª«©MÁ{§É ------------------------------------------------------------------------------------------------ -·|û¡GROGER588910148151 µoªí®É¶¡:2021/7/18 ¤W¤È 09:59:28²Ä 1331 ½g¦^À³ SNP-810n¥þ±¨ú¥N¥«³õ¤W«Ü«K©y¦ý¦³¨x¬r©ÊªºAPAP¡A¤W¥««á°â»ù¤]¬OÃöÁä¡C ¥ÌÅS¾J©M¤T´â½©¿}§¹¥þ²Å¦X:[¬ü°êFDA®Öã]¡B[±`¥Î¥B¦w¥þ]¡B[«K©yt¾á±o°_]¡B[¤HÅé¥i¹¥Î¦w¥þ¤Æ¦Xª«] ¥xÆWSafeTynadol ¦w®õ®³¯kªº¥é³æ¤¤½á§Î¾¯¦¨¤À file:///C:/Users/USER/Downloads/1.6.1+%E4%BB%BF%E5%96%AE-110-07-16.pdf ...HUYPS-2(Mannitol)¡BHUYPS-4(Sucralose)... |
|
|
·|û¡G¶ø¥ì´µ¯S10031727 µoªí®É¶¡:2022/5/12 ¤W¤È 09:04:29²Ä 1975 ½g¦^À³
|
¼v¤ù¤¤J±Ð±Â´£¨ìªºÁ{§É¤T´Áªñ§ÀÁn¡A¬O«üªÍµ²®Ö TB ¥ÎÃÄ¡A³o¬O¤ÍÀM¥Í§Þ¦b°µªºÁ{§É¡A¤£¬OªYÄ£¡C¦ý¨ä¤¤ªº HUEXC030 ¦¨¥÷¡A¥i¯à¸ò 810 / 610 / 630 ¦³¤@ÂIÃö«Y¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/12 ¤W¤È 09:03:09²Ä 1974 ½g¦^À³
|
¨S²Ó¨s¤¤°êÁ{§É¸ÕÅç(ª`®gªø®Ä¯Ç¯k¸Ñ)¡A¤£¦n»¡¡C¦ý±qÀÙ¥Á¥i«H±N³z¹L«·s³]pÁ{§É¸ÕÅç¡AÄ~Äò¤¤°êªºÁ{§É¶}µo¡C ±ÀÂ_¬O°_©lªºÁ{§É¸ÕÅç³]p¤£¬¢·í¡A¤wºØ¤U«¤j°ÝÃD¡A¸ÕÅçª`©wµLªk¦³®Ä¡C §Ú¯d·NÃö¤ßªº¬O©³¤U:SNP-810+ (¤fªAªø®Ä¯Ç¯k¸Ñ)ªº½Æ¤è¤îµhÃĸÕÅç¡C ------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/13 ¤U¤È 09:35:49²Ä 784 ½g¦^À³ ²Ä 3 ²ÕAAP 1000 mg+¯Ç¯k¸Ñ 20 mg??? [«·s§Q¥Î]SNP-810 1000mg+¯Ç¯k¸Ñ20mgªº(½Æ¤è)¤îµhÃÄ¡An¥´¯}2014¦~FDA¤½§i°Ç¥O°±¤î»s³yAcetaminophen§t¶q¶W¹L325 mgªº [½Æ¤è] ¤îµhÃĸT¥O??? -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/25 ¤U¤È 10:28:31²Ä 574 ½g¦^À³ »O¥_ºa¥ÁÁ`Âå°|¤HÅé¸ÕÅç©eû·|(¤@)²Ä 131 ¦¸·|ij¬ö¿ý ¤½§iª© ¶}·|®É¶¡¡G109 ¦~ 11 ¤ë 2 ¤é¤U¤È 2 ®É¥¿ pµe¥D«ù¤H¡G³¯¥¿Â× pµe¦WºÙ¡G·s±j®Ä¤£¦¨Å}¤îµh²Õ¦XÃÄ Sebacoyl Dinalbuphine Ester ¤Î [µL¨x¬r¤AñQÓi×ô]¥Î©óÂù °¼½¥Ãö¸`¸m´«³N«á¤§¤¤«×¦ÜÄY«¯kµhªvÀø |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/5/12 ¤W¤È 08:39:28²Ä 1973 ½g¦^À³
|
R¤j ²³øªº2¤p®É26¤À-31¤À ³£¦b½Í¡u¶Ë¨x¡v¡A¨Ã¤£¬O¤îµh¡C ³o¬q®É¶¡ªº¤º®e±z¥i¥H¦AÅ¥¤@¦¸¡A§Ú¤]¤£ª¾¹D±Ð±Â«ü¨ººØÃÄ¡H ¦pªG¬O3´Á¡H¬O§_¬O¼Ï¶s¡H |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/5/12 ¤W¤È 08:13:12²Ä 1972 ½g¦^À³
|
¥xÆW®õ°ê·s¥[¬Á³£¤W¥«¡A´N¤¤°ê¨S¹L¡A¬Oµû¦ô«ü¼Ð³]p¤£¦P¶Ü?? ===================== 1.08 ==>20¤À ¬Ý¬ÝPÈ---³o¬O¶¶ÃĪø®Ä¤îµh°w¾¯LT1001(¯Ç¯k¸Ñ)¼Æ¾Ú==>À³¸Ó¨S¿ù =====================b.¸ÕÅçpµe¨ü¸ÕªÌ¤H¼Æ¡G120¤H¡]¹ê»Ú¦¬®×¤H¼Æ: 124¤H¡^ c.¥Dnµû¦ô«ü¼Ð¡G¸ÕÅçµ²ªGÅã¥Ü³N«á48¤p®É¤º¶Ü°Ø·í¶q¦b±µ¨üLT1001ªø®Äª`®g²G²Õ¬°21.76¡A¦b±µ¨ü¦w¼¢¾¯ªº¹ï·Ó²Õ¬°18.36¡A¥¼¹F¨ì²Îp¤WÅãµÛ®t²§(p=0.86)¡C d.¦¸nÀø®Ä«ü¼Ð¡G 1.³N«á48¤p®É¤º¯kµhµ{«×µøı¼ÒÀÀµû¤À¦±½u¤U±¿n¡A¦b±µ¨üLT1001ªø®Äª`®g²G²Õ¬°1164.56¡A¦w¼¢¾¯¹ï·Ó²Õ¬°1124.25¡A¥¼¹F¨ì²Îp¤WÅãµÛ®t²§(p=0.76)¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/12 ¤W¤È 06:55:16²Ä 1971 ½g¦^À³
|
1.08 ==>20¤À ¬Ý¬ÝPÈ---³o¬O¶¶ÃĪø®Ä¤îµh°w¾¯LT1001(¯Ç¯k¸Ñ)¼Æ¾Ú 2.¤j®aÀ³¸Ó¦³¬Ý¨ìJ±Ð±Â´£¤w§Ö±µªñ3´Á¸Ñª¼(§Ú¨SÅ¥¨ì³o¬q¸Ü!)--- ªYÄ£ÁÙ¨S¶i¤J¤T´ÁÁ{§É¡A¦p¦ó±µªñ3´Á¸Ñª¼? ±q®É§Ç¤W§Ú²qJ´£ªº¬OLT1001: 2022.2.25¶¶ÃÄLT1001ªø®Ä¤îµh°w¾¯©ó¤¤°ê¤T´ÁÁ{§É¸Ñª¼¤ÀªRµ²ªG¡G¥Dnµû¦ô«ü¼Ð¥¼¹F²Îp¤WÅãµÛ®t²§ www.moneydj.com/kmdj/news/newsviewer.aspx?a=5753e28c-53cf-4517-b95d-ca74d807e4dc ...LT1001©ó¤¤°ê¦a°Ï¤§¶}µo¤Î°Ó·~¤ÆÅv§Q±ÂÅv¤©¦¿¦èÀÙ¥Á¥i«H¡A¥Ñ¨ät³d¦b¤¤°ê¤W¥««e¥²n¤§Á{§É¸ÕÅç.. ÀÙ¥Á¥i«H±N¤ÀªR¥¼¹F¼Ðì¦]¡A¥Ø¼Ð³z¹L«·s³]pÁ{§É¸ÕÅç¡AÄ~Äò¤¤°êªºÁ{§É¶}µo¡C [ÀÙ¥Á¥i«H±N¤ÀªR¥¼¹F¼Ðì¦]¡A¥Ø¼Ð³z¹L«·s³]pÁ{§É¸ÕÅç¡AÄ~Äò¤¤°êªºÁ{§É¶}µo¡C] |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/5/11 ¤U¤È 07:03:47²Ä 1970 ½g¦^À³
|
Ó¤H¥HªÑªF·|ij¨Æ¿ýµ¥¤å¥ó±À¦ô קï«Ü¦h³W©w¡A¥i¯àn²Å¦X¡u¤º±±¡vªºªk¥O³W©w¡C ¤j®aÀ³¸Ó¦³¬Ý¨ìJ±Ð±Â´£¤w§Ö±µªñ3´Á¸Ñª¼¡H ®É¶¡¤w¦A¹L¥b¦~¤F¡AÁÙ¬O¨S¦³®ø®§¡H |
|
|
·|û¡G¾¾¹À©OÎN¹À«¡10150521 µoªí®É¶¡:2022/5/11 ¤U¤È 06:54:41²Ä 1969 ½g¦^À³
|
To ¤p¨k¤H¤j 3/15¤½§i¥»¤½¥q¨ú±o¸gÀÙ³¡¤u·~§½¥X¨ã¤§¡u«YÄݬì§Þ¨Æ·~¥B¨ã¥« ³õ©Ê¡v¤§·N¨£®Ñ¡C 6.¦]À³±¹¬I:¥»¤½¥q±N¨Ì³W¹º®Éµ{´£¥XªÑ²¼¤WÂd¤§¥Ó½Ð§@·~¡C ²ö«D¤SÅܧópµe¡A§ï¬°¥Ó½Ð¤W¥«¡A©Ò¥HÁÙ¨S´£¥X¤º±±¼f¬d? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/11 ¤U¤È 04:06:57²Ä 1968 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/9 ¤U¤È 10:41:53²Ä 1959 ½g¦^À³ 10_·sÃĬãµo¦¨¥\®×¨Ò_GSP¨x¥\¯à©w¶qªk 1:18 avalon hepaPOC ¤z¯à¿}---GSP¦X§@¼t??? --------------------------------------------------------------------------------------------- 2018.6.29 ATHENEX THERAPEUTICS LIMITED»PAVALON HEPAPOC LIMITED ñ±ÂÅv¬ù ¹w¥I¶O¥Î¡Cñ¸p¥»¨óij«á¡AAthenex À³¥ß§Y¦V Avalon ¤ä¥I 500,000 ¬ü¤¸¡C 5.2¨½µ{¸O¥I´Ú¡C (a) Athenex ±N¦bµo¥Í¥H¤U¨Æ¥ó®É¡]¦pªG¦³¡^¦V Avalon ¤ä¥I¥H¤Uª÷ÃB¡G (i) ¦b Avalon ¦¬¨ì¦b¥xÆW¾P°â°Ó«~¥H¨Ñ²{³õ¨Ï¥Î©Ò»Ýªº©Ò¦³ºÊºÞ§åã«á¤T¤Q (30) ¤Ñ¤º¤ä¥I *** ¬ü¤¸¡F (ii) ¦b Avalon ¦¬¨ì¦b¬ü°ê¾P°â³fª«¥H¨Ñ²{³õ¨Ï¥Î©Ò»Ýªº©Ò¦³ºÊºÞ§åã«á¤T¤Q (30) ¤Ñ¤º¤ä¥I *** ¬ü¤¸¡F (iii) ¦b Avalon ¦¬¨ì¦b¼Ú·ù¾P°â³fª«¥H¨Ñ²{³õ¨Ï¥Î©Ò»Ýªº©Ò¦³ºÊºÞ§åã«á¤T¤Q (30) ¤Ñ¤º¬ü¤¸***¡F (iv) ¦b Avalon ¦¬¨ì¦b¤¤µØ¤H¥Á¦@©M°ê¡]¬°²M·¡°_¨£¤£¥]¬A»´ä¡B¥xÆW©M¿Dªù¡^¥Î©ó¦b³õ¦a; (v) ¦b Athenex ¦b¬ü°êº¦¸°Ó·~¾P°â³\¥iªA°È«á¤T¤Q (30) ¤Ñ¤º¤ä¥I *** ¬ü¤¸¡F©M (vi) ¦b Athenex ¦b¼Ú·ùº¦¸°Ó·~¾P°â³\¥iªA°È«á¤T¤Q (30) ¤Ñ¤º¤ä¥I *** ¬ü¤¸¡F©M ©Ò¥H¬O¥ÑATHENEX THERAPEUTICSt³d¥þ²y¦æ¾P! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/11 ¤W¤È 06:25:36²Ä 1967 ½g¦^À³
|
¥Ó½ÐFDA pre-EUA meeting¡AFDA¦P·N»P§_±oªá¦h¤[? ¥un6Ó¤u§@¤Ñ!!! Veru contacted on MAY 2 about FDA willing to meet on EUA and granted meeting MAY 10, TODAY, only 6 (SIX) BUSINESS DAYS AFTER! ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/3 ¤W¤È 11:55:26²Ä 1929 ½g¦^À³ °ê¹©Pre-EUA·|ij»»»»µL´Á! VERU¤£¥Î1Ó¤ë±o¨ìFDA¦P·N¦b5/10¶}pre-EUA meeting. ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/12 ¤W¤È 07:44:08²Ä 1896 ½g¦^À³ ..±q¸Ñª¼¼Æ¾Ú¥ÎÃIJջP¹ï·Ó²Õ¨S¦³®t²§¡A§Ú±ÀÂ_°ê¹©¨S¦³Pre-eua meeting! |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/5/10 ¤U¤È 08:55:13²Ä 1966 ½g¦^À³
|
ªYÄ£¹ê¦¬¸ê¥»ÃB¬O6e9,Ãø¹D¬O«áªÌ¡H ------------------------- ¡´À³¥Ó³ø^¤åª© ¡¹¡uªÑªF·|ij¨Æ¤â¥U¤Î·|ij¸É¥R ¸ê®Æ¡v ¡¹¡uªÑªF·|¦~³ø¡v ¡¹¡u¦~«×°]°È³ø§i¡v ¡´¡u110¦~©³¹ê¦¬¸ê¥»ÃB¹F20»õ¤¸¥H¤W¡v ©Î ¡u110¦~¥l¶}ªÑªF±`·|®ÉªÑªF¦Wï¥~(³°)¸ê«ùªÑ¤ñ²v¦Xp¹F 30%¥H¤W¡v |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/5/10 ¤U¤È 08:45:11²Ä 1965 ½g¦^À³
|
¦Û©ú¡]108¡^¦~«×°_¡A²Å¦X¤@©w±ø¥ó¤§¤W¥«¤½¥qÀ³¥Ó³ø^¤åª©ªÑªF·|ij¨Æ¤â¥U¡B¦~³ø¤Î¦~«×°]°È³ø§i µo¥¬®É¶¡¡G¥Á°ê107¦~08¤ë29¤é (ÃÒ¥æ©Ò·s»D½Z) ¬°°t¦X¥DºÞ¾÷Ãö·sª©¤½¥qªv²zÂŹϬFµ¦¡AÃÒ¥æ©Ò¤w·s¼W³W©w¡A¦Û©ú¡]108¡^¦~«×°_²Å¦X¤@©w±ø¥ó¤§¤W¥«¤½¥qÀ³¥Ó³ø^¤åª©ªÑªF·|ij¨Æ¤â¥U¤Î·|ij¸É¥R¸ê®Æ¡BªÑªF·|¦~³ø¤Î¦~«×°]°È³ø§i¡C ÃÒ¥æ©Òªí¥Ü¡A¬°´£ª@¸ê°T´¦ÅS«~½è¤Î³Ð³y°ê»Ú¤Æ¤§§ë¸êÀô¹Ò¡A¤Z¹ê¦¬¸ê¥»ÃB¹F·s¥x¹ô¤@¦Ê»õ¤¸©Î¥~¸ê«ùªÑ¤ñ²v¹F¦Ê¤À¤§¤T¤Q¥H¤W¤§¤W¥«¤½¥q¡A§¡À³©ó¦¸¤@·|p¦~«×¤º¥Ó³ø^¤åª©ªÑªF·|ij¨Æ¤â¥U¤Î·|ij¸É¥R¸ê®Æ¡BªÑªF·|¦~³ø¤Î¦~«×°]°È³ø§i¡C¥H¾ä¦~¨î¤§¤W¥«¤½¥q¬°¨Ò¡A107¦~12¤ë31¤é¤§¹ê¦¬¸ê¥»ÃB¹F·s¥x¹ô¤@¦Ê»õ¤¸©Î107¦~¥l¶}ªÑªF±`·|¤§ªÑªF¦Wï°O¸ü¤§¥~¸ê«ùªÑ¤ñ²v¹F¦Ê¤À¤§¤T¤Q¥H¤WªÌ¡AÀ³©ó108¦~¥l¶}ªÑªF±`·|«e¡A¥Ó³ø«ez¸ê°T¤§^¤åª©¹q¤lÀÉ¡FYªÑªFÁ{®É·|©ó108¦~«×´Á¶¡¥l¶}ªÌ¡A¥çÀ³¤ñ·Ó¿ì²z¡C ÃÒ¥æ©Ò¥tªí¥Ü¡A¸g²ÎpºI¦Ü107¦~6¤ë¤î¡A¥~¸ê«ù¦³§Ú°ê¤W¥«¤½¥q¤§ªÑ¥÷¥«È¤wªñ¥|¦¨¡A±©¤W¥«¤½¥q´¦ÅS^¤å°]°È·~°È¸ê°T¤´¥¼´¶¹M¡]106¦~«×¥Ó³ø^¤åª©Ä³¨Æ¤â¥Up¦³267®a¡B^¤åª©ªÑªF·|¦~³øp¦³193®a¡^¡AÃÒ¥æ©Ò·~¤w×¥¿¡u¹ï¦³»ùÃÒ¨é¤W¥«¤½¥q¤Î¹Ò¥~«ü¼ÆªÑ²¼«¬°òª÷¤W¥«¤§¹Ò¥~°òª÷¾÷ºc¸ê°T¥Ó³ø§@·~¿ìªk¡v¬ÛÃö³W©w¡A½Ð²Å¦X±ø¥ó¤§¤W¥«¤½¥q¤Î¦¦]À³¡A¥H´£ª@¸ê°T´¦ÅS«~½è¤Î±j¤Æ§ë¸ê¤HÃö«Y¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/5/10 ¤U¤È 08:28:05²Ä 1964 ½g¦^À³
|
©_©Ç¤F §Ú³£¨S¦¬¨ì³qª¾ ^¤å¬Oµ¹n±ÂÅvªº¦Ñ¥~¬Ýªº¶Ü?©ú¤Ñ¨Óº²Â_¤U |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/5/10 ¤U¤È 04:45:28²Ä 1963 ½g¦^À³
|
½Ð±Ð¤j®a¡A§Úª`·N¨ì¤@¥ó¨Æ¤£ª¾ì¦]¥i¯à¬°¦ó: ¶}©l¥X²{^¤åª©ªº¶}·|³qª¾¤Îij¨Æ¤â¥U¡A¬O§_¬°¤WÂd»Ýn? |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/5/10 ¤U¤È 02:54:15²Ä 1962 ½g¦^À³
|
08 ==>20¤À ¬Ý¬ÝPÈ «¢«¢ ªÑ»ù§Ö¶W¹L¨SPȪº§r Åܤdª÷ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/10 ¤U¤È 01:35:06²Ä 1961 ½g¦^À³
|
±q³o2¥yÃöÁä¦r:[«e10¦W°ê»Ú¤jÃļt]»P[§Ú¿Ë¦Û¨ì¤Fheadquarter¥h]¡AÀ³¸Ó¬O«üªYÄ£µL»~!!! 05_·sÃĶ}µo_¿ïÃD 13.10~14:30¬í: .....³o¬O¨Æ¹ê®@ [«e10¦W°ê»Ú¤jÃļt] ........§Úɨ䤤¤@®a [§Ú¿Ë¦Û¨ì¤Fheadquarter¥h] ½Í¨ì³Ì«á ¥L»¡±z̯ण¯à ³o®a.§Ú´N¶R±z̪ºªÑ²¼°Ú.§ë¸ê±z̪ºªÑ²¼°Ú...§Ú»¡ ¥xÆWªºªÑ²¼¤Ó«K©y..¹ï¤£°_ ¤£¦æ ±zn´N¶Rcompound ±z·Q¶R[¤½¥q] §Ṳ́£½æ±z....½Í¨ì³o¼Ë£²... --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/9 ¤U¤È 09:21:39²Ä 1957 ½g¦^À³ J¤j¯«¬OªYÄ£ªºSAB¡A«ö²z·|¥X®u¤U¦Cªº¦X§@¬¢½Í¡A©Ò¥H±z·Q¶R[¤½¥q]¡A©Ò¿×ªº[¤½¥q]8¦¨´N¬OªYÄ£¡C --------------------------------------------------------------------------------------------- ·|û¡G«ä¦Ò¤¤10147262 µoªí®É¶¡:2020/7/23 ¤U¤È 09:36:18²Ä 195 ½g¦^À³ 2019/04 »P¸ó°ê«e¤¦W¤§»sÃĤ½¥q¡A¬ãµo¹Î¶¤¦@¤E¦ì¤£¦P³æ¦ì°ÆÁ`µô¤Î¨Mµ¦¤H¤h¡A¦b¬ü°êÁ`³¡³sÄò¤K¤p®É¡A 2019/04 »P¸ó°ê«e¤Q¦W»sÃĤ½¥q¬ãµo¹Î¶¤¡A¦b¬ü°êÁ`³¡¡A¬¢½Íªø¹F¥|¤p®É¦³Ãö¤îµhÃÄSNP-810¦X§@¨Æ©y¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/5/10 ¤W¤È 11:49:25²Ä 1960 ½g¦^À³
|
¹Ú«Ü¬ü ¥i±¤ªÑ»ù¤£¶R±b |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/9 ¤U¤È 10:41:53²Ä 1959 ½g¦^À³
|
10_·sÃĬãµo¦¨¥\®×¨Ò_GSP¨x¥\¯à©w¶qªk 1:18 avalon hepaPOC ¤z¯à¿}---GSP¦X§@¼t??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/9 ¤U¤È 10:28:55²Ä 1958 ½g¦^À³
|
08_·sÃĬãµo¦¨¥\®×¨Ò_·s¦¨¤À(ªø®Ä¤î¼@µh¤£¦¨Å}) J¤j¯«¦b19:00¬í°_»¡:..¦ý¬O§Ú¦Û¤v³£¦b¦Y°Ú §Ú¤£¦Y¨ºÓ¦³¨x¬r©Êªºpanadol ´N¬O´¶®³¯k §Ú¤]¤£¦Y¦³¨x¬r©Êªºtylenol ²{¦b§ÚÌ¥i¥H[¦Y¤@²~]®@ ³£¤£·|¦³¨x¬r©Ê³á ¨ì³oºØ¦a¨B¤F ·íµM ³oÁÙ»Ýn¤@¬q®É¶¡¤~·|¤W¥« ¦ý¬O... ----------------------------------------------------------------------------------------------------- J¤j¯«²{¦b¥u¦YªYÄ£ªºSAFETYNADOL¡A[¦Y¤@²~=100g]¨S¤¤¬r³o»ò¸Ø±i??? dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=b956d527-7ea7-e084-e053-2a95a90a866d&type=display 500mg *200Áû/²~=100g |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/9 ¤U¤È 09:21:39²Ä 1957 ½g¦^À³
|
J¤j¯«¬OªYÄ£ªºSAB¡A«ö²z·|¥X®u¤U¦Cªº¦X§@¬¢½Í¡A©Ò¥H±z·Q¶R[¤½¥q]¡A©Ò¿×ªº[¤½¥q]8¦¨´N¬OªYÄ£¡C --------------------------------------------------------------------------------------------- ·|û¡G«ä¦Ò¤¤10147262 µoªí®É¶¡:2020/7/23 ¤U¤È 09:36:18²Ä 195 ½g¦^À³ 2019/02 »P¸ó°ê«e¤Q¦W»sÃĤ½¥qñ¸p¦³Äv·~¸T¤î¤§«O±K¨ó©w¡A°Ó°QSNP-810¦X§@¨Æ©y¡C 2019/04 »P¸ó°ê«e¤¦W¤§»sÃĤ½¥q¡A¬ãµo¹Î¶¤¦@¤E¦ì¤£¦P³æ¦ì°ÆÁ`µô¤Î¨Mµ¦¤H¤h¡A¦b¬ü°êÁ`³¡³sÄò¤K¤p®É¡A 2019/04 »P¸ó°ê«e¤Q¦W»sÃĤ½¥q¬ãµo¹Î¶¤¡A¦b¬ü°êÁ`³¡¡A¬¢½Íªø¹F¥|¤p®É¦³Ãö¤îµhÃÄSNP-810¦X§@¨Æ©y¡C 2019/07 »P¸ó°ê«e¤Q¦W»sÃĬü°ê¤½¥q¹Î¶¤Á|¦æ²Ä¤G¦¸¹q¸Ü·|ij¡A²`¤J°Q½×¥þ²yº¨ÒµL¨x¬r¤îµhSNP-810¤§¬ì§Þ¡B¬ãµo¶i«×¤Î¦X§@¨Æ©y¡C 2019/12 »P¸ó°ê«e¤Q¦W»sÃĤ½¥q¬ü°ê¡B¼Ú¬w¡B·ç¤h¤§°Ó·~µo®i¡B¬ãµo³¡¤Î±M§Q«ß®v¡AÄ~«e¤T¦¸§¹¦¨¬ì§Þ¤Î¬ãµo¶i«×«á¡A²Ä¥|¦¸Á|¦æ¦¸¹q¸Ü·|ij¬¢½ÍSNP-810¦X§@¡B±ÂÅv¡B°Ó·~µo®i¨Æ©y¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/9 ¤U¤È 08:52:57²Ä 1956 ½g¦^À³
|
05_·sÃĶ}µo_¿ïÃD J¤j¯«¦b14:15¬í°_:...½Í¨ì³Ì«á ¥L»¡±z̯ण¯à ³o®a.§Ú´N¶R±z̪ºªÑ²¼°Ú.§ë¸ê±z̪ºªÑ²¼°Ú...§Ú»¡ ¥xÆWªºªÑ²¼¤Ó«K©y..¹ï¤£°_ ¤£¦æ ±zn´N¶Rcompound ±z·Q¶R[¤½¥q] §Ṳ́£½æ±z....½Í¨ì³o¼Ë£²... ±z·Q¶R[¤½¥q]ªº[¤½¥q]¤£¾å±o¬O¤£¬OªYÄ£??? ªYÄ£³oºØ¤p¤½¥q¡A¤jÃļt¬O¥Î¦¬ÁÊÂX¤j²£«~½uÅý¦Û¤vÅܧó¤j¡A¦Ó¤£¬O¤JªÑ¡C --------------------------------------------------------------------------------------------------- ·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/5/9 ¤U¤È 05:41:54²Ä 1951 ½g¦^À³ §ä¨ì¤@ÓLinkingPros³X½ÍJ¤j¯«ªº¤½¶}¼v¤ù»P¤j®a¤À¨É: www.facebook.com/watch/108155710567674/1041370163073318 ------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/24 ¤U¤È 11:37:52²Ä 1835 ½g¦^À³ ªYÄ£³oºØ¤p¤½¥q¡A¤jÃļt¬O¥Î¦¬ÁÊÂX¤j²£«~½uÅý¦Û¤vÅܧó¤j¡A¦Ó¤£¬O¤JªÑ¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/5/9 ¤U¤È 08:49:36²Ä 1955 ½g¦^À³
|
°¨¤W§ó·s?? ¤½¥q¬ãµo¤Hûªº¬ãµo¸gÅç¦Xp306/¤H¦~¡AªYÄ£®Ö¤ß§Þ³N¨Ó¦Û¥]§t¬ì§Þ³¡µ¥¬ã¨s¾÷ºc±MÄݱÂÅv¡A¤½¥q¬ãµo¹Î¶¤«h¥ÑÀò±o¡u¬ü°ê°ê®aµo©ú®a¾Ç°|¡v°|¤h³Ì°ªºaÅA¡B²{¾»O¥_Âå¾Ç¤j¾ÇÁ¿®y¡B¤¤¬ã°|«È®yÁ¿®y±Ð±ÂªºJ¥®®E³Õ¤h«ü¾É¤U¡A¦Û¦æ«Ø¸m¥H¡u¨xŦ¥NÁȕÀ¬¡©Ê¡v¤Î¡u°ò¦]½Õ±±¡v¤G§Þ³N¥¥x¡A¶}µo¥X¤»¶µ®Ö¤ß²£«~¡C¥»¤½¥q±Mª`¥H¤HÅé¥NÁȕÀ¬¡©Ê½Õ±±µ¥¬ÛÃö±M§Q§Þ³N¡C |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/5/9 ¤U¤È 08:36:42²Ä 1954 ½g¦^À³
|
R¤j ¤w°µ200¤H¡H¬O¯uªº¶Ü¡H °µ¥X¨Óªºµ²ªG·Ç½T¶Ü¡H |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/9 ¤U¤È 07:43:27²Ä 1953 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/8 ¤U¤È 09:28:41²Ä 1948 ½g¦^À³ ¨xŦ¬ï¨ë¬¡²Õ´À˹ï¶}µoNASHÃĪ«ªºÃļt¨Ó»¡¬O¤jÅ]¤ýÃö¥d! -------------------------------------------------------------------------------------------- «D«I¤J¦¡ªº³Ñ¾l¨x¥\¯àÀËÅç¸Õ¾¯¤Î¤èªk(GSP-)---¥Ø«e¤w°µ§¹200Ó¯f¤H..... Æg°Õ!!! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/9 ¤U¤È 07:01:02²Ä 1952 ½g¦^À³
|
¤p¨k¤H¤jµ¹±z«öÆg°Õ!!! |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/5/9 ¤U¤È 05:41:54²Ä 1951 ½g¦^À³
|
©ÓR¤j©Ò»¡ªº¤j¯«¡A§ä¨ì¤@ÓLinkingPros³X½ÍJ¤j¯«ªº¤½¶}¼v¤ù»P¤j®a¤À¨É: www.facebook.com/watch/108155710567674/1041370163073318 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/9 ¤U¤È 12:56:37²Ä 1950 ½g¦^À³
|
108¦~«×¡u½ÃºÖ³¡¡P¸gÀÙ³¡ ÃĪ«¬ì§Þ¬ã¨sµo®i¼ú¡v±o¼ú¦W³æ ¥Ó½Ð¤H:J¥®®E ¼ú¶µ:»É½è¼ú ²£«~¦WºÙ:§Ö³tºë·Ç´ú¶q(Point-of-Care, POC)¨x¥\¯à¤§·s¥b¨Å¿}ÀË´ú¨t²Î Point-of-Care Determination System for Quantitative Liver Function Test ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/8 ¤U¤È 09:23:14²Ä 1947 ½g¦^À³ (¥|) «D«I¤J¦¡ªº³Ñ¾l¨x¥\¯àÀËÅç¸Õ¾¯¤Î¤èªk(GSP-)³o¬O¤j¤û¾ÇªÌJ¥®®E³Õ¤hªºµo©ú |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/8 ¤U¤È 09:48:18²Ä 1949 ½g¦^À³
|
2019.4.12 ¡m2019¼Ú¬w¨xŦ¦~·|¡nNASH¤j¼tGileadµoªí«D«I¤J©Ê¶EÂ_¨ú¥N¶Ç²Î¤Á¤ù www.genetinfo.com/investment/featured/item/25302.html ----------------------------------------------------------------------------------------------- §Ú°O±oFDA©|¥¼®ÖãGileadªº«D«I¤J©Ê¶EÂ_ªk! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/8 ¤U¤È 09:28:41²Ä 1948 ½g¦^À³
|
¨xŦ¬ï¨ë¬¡²Õ´À˹ï¶}µoNASHÃĪ«ªºÃļt¨Ó»¡¬O¤jÅ]¤ýÃö¥d! ¥Ø«eÁ{§É¶EÂ_¤W¡A¨ã[«I¤J©Ê]¥B [ªá¶O°ª]ªº¨xŦ¬ï¨ë¬¡²Õ´Àˬd¬°FDA°ß¤@®Ö㪺ÀËÅç¤èªk¡A¤]¬Oµû»ù·sÃĸÕÅ禳®Ä©Êªº¡§ª÷¼Ð·Ç¡¨¡C ¦³¨Ç±wªÌ¤£Ä@·N¶i¦æ¤Á¤ùÀˬd¡A©Ò¥HNASHÃĪ«Á{§É¤£¦n©Û¦¬±wªÌ¡C ¦]¦¹ÃļtÄv¬Û§ë¤J¶}µo[«D«I¤J]©Ê¥Íª«¶Ç·P¾¹¨ÓºÊ´ú©M°lÂÜNASH¡A§Æ±æ¯àÀò±oFDA®Ö㬰NASHÀø®ÄÀËÅç¼Ð·Ç!!! 2020.11.17(¬ü°ê¨x¯f¬ã¨s¨ó·|¦~·|) Glympse Bio¶}µoNASH«D«I¤J¦¡¶EÂ_13ºØ¥Íª«¼Ð°O¥i±æ¨ú¥N¬ï¨ëÀˬdnews.gbimonthly.com/tw/article/show.php?num=34577 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/8 ¤U¤È 09:23:14²Ä 1947 ½g¦^À³
|
(¥|) «D«I¤J¦¡ªº³Ñ¾l¨x¥\¯àÀËÅç¸Õ¾¯¤Î¤èªk(GSP-)³o¬O¤j¤û¾ÇªÌJ¥®®E³Õ¤hªºµo©ú ªYÄ£©|¦³¦¬¿ý¦bUSFDA«ü¤Þ¤¤¡A¥H«D«Iŧ©Êªº©w¶q´ú©w³Ñ¾l¨x¥\¯àªº¤èªk¡u¥b¨Å¿}³æÂIªkGSP (galactose single point)¡v¡A¥¿µo®i¬°¶EÂ_ªvÀøNASHªº¥Íª«¼Ð°O(biomarker)¡A¦p¦¹¥i±æ¸Ñ¨M¨ä¥LNASHÃÄn¥Î¨x¬ï¨ë¤~¯à¨Ï¥ÎNASH ÃĨӪvÀøªº§x¹Ò¡CSNP-6¨t¦C²£«~¦]¦³¨}¦nªº¦w¥þ©Ê¤ÎÅãµÛÀø®Ä¡A¤wÀò°ê»Ú¤j¼tÆf¥Ø¡A²`«×°Q½×¨Ã±K¤ÁÁpôµû¦ô°Q½×¤¤¡C ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/7/11 ¤W¤È 06:03:29²Ä 112 ½g¦^À³ ...ªYÄ£SNP6/SNP8--J¥®®E³Õ¤h(2016¦~Àò¿ï¬°¬ü°êÃľǬì¾Ç®a¾Ç·|°|¤h¤Îµo©ú®a³Ì°ªºaÅA¤§¬ü°ê°ê®aµo©ú®a¾Ç°|Âù°|¤h) www.microbio.com.tw/tw/news_detail.php?nwno=264 J¥®®E³Õ¤hµo©úªº¥b¨Å¿}³æÂIªk¤w³Q¦¬¿ý¦bUSFDA«ü¤Þ¤¤...¥¿µo®i¬°¶EÂ_ªvÀøNASHªº¥Íª«¼Ð°O(biomarker)¡A¦p¦¹¥i±æ¸Ñ¨M¨ä¥LNASHÃÄn¥Î¨x¬ï¨ë¤~¯à¨Ï¥ÎNASH ÃĨӪvÀøªº§x¹Ò¡C 1.www.sinewpharma.com/news_detail.php?nwno=35 2.www.cna.com.tw/news/ahel/201911130336.aspx |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/5/8 ¤U¤È 06:19:08²Ä 1946 ½g¦^À³
|
¦V¤j¡A¥t¥~µo²{ ¨Î®mªºªL¡¯·ìݶ겻¥Í§Þ¸³¨Æ ¶ê²»¦n¹³¤S¬O¯E¹©ªº¤l¤½¥q |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/5/8 ¤U¤È 06:04:12²Ä 1945 ½g¦^À³
|
Page19,³o¬q¤]ÆZ¦³½ìªº¡G¤£¾å±o¬O¤£¬O¸ò110/12¤ëñ¬ùªº¦³Ãö (¥|) «D«I¤J¦¡ªº³Ñ¾l¨x¥\¯àÀËÅç¸Õ¾¯¤Î¤èªk(GSP)¡G ¥¼¨Ó¤]³W¹º¦X§@¶}µo GSP¡A¥H¨ó§UÁ{§É¶Eªv¯×ªÕ¨xª¢¡C³Ñ¾l¨x¥\ ¯àÀËÅç¸Õ¾¯¤Î¤èªk(GSP)¤w©ó 2003 ¦~¯Ç¤J¬ü°ê FDA ¶EÂ_«ü¤Þ¤Î±Ð¬ì ®Ñ¡A²{¤w¦³¦b±Ä¼Ë²{³õ§Q¥Î¥iÄ⦡ªº¤ÀªR»ö¾¹¤Î®M²Õ§Ö³t±o¨ìÀË´úµ² ªG(point-of-care)¡A¤w³q¹L¤W¥«¡A¥¿»P¥»¤½¥q³W¹º¦X§@¤¤¡C¯×ªÕ¨xª¢¨t ¦C·sÃÄ¡A¥¼¨Ó±N¦¹²£«~ÂX®i¨ì¡u°sºë©Ê¯×ªÕ¨xª¢¡v¤Î¡u¯×ªÕ¨x¡v¡A¦p ¦¹¥«³õ¦û¦³®É¶¡¥i©µªø¡A©Ôªø¾P°â¾Ô½u |
|
|
·|û¡G¾¾¹À©OÎN¹À«¡10150521 µoªí®É¶¡:2022/5/8 ¤U¤È 04:59:09²Ä 1944 ½g¦^À³
|
111¦~«×Àç¹Bp¹º (¤T)»P°ê»Ú¤j«¬Ãļt¬¢½Í§Þ³N±ÂÅv¤§¦X§@pµe ¤½¥q¦³©ú½T¼g¤W¡A§Æ±æ¯à¦pÄ@ |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/5/8 ¤U¤È 04:33:22²Ä 1943 ½g¦^À³
|
¤p¨k¤H¤j Ó¤H¤]ı±o¸ê®Æ«Ü©_©Ç¡H Áp¹©»P¨Î¯C³£¤£¬O¸³¨Æ¡A«o¦C¡u¸³¨Æ±Æ°£Äv·~¡v¡C Áp¹©ªº¥Nªí¤H¡G°¨XµY¬O§_¬°´I¨¹ªº¤H°¨¡H ±©¤@«GÂI¡A75¤¸²{¼W¦³¶WÃB·Q»{5¤d¦h±i¡A |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/8 ¤U¤È 01:12:45²Ä 1942 ½g¦^À³
|
20200415 ¼¶½Z¢¬¯Î©s·O¡]»O¤jÂå¾Ç°|Âå¾Ç¨t§U²z±Ð±Â¡^ ...ÄY«ªº°sºë©Ê¨xª¢¬Æ¦Ü¦b¶EÂ_«á90¤Ñ¤º¡A¦³°ª¹F75%ªº¦º¤`²v¡C¥Ø«eÄY««æ©Ê°sºë©Ê¨xª¢ªºªvÀø¥u¦³¥Ö½èÃþ©T¾J«j±j³Q»{¬°¥i¯à¦³®Ä¡C¨xŦ²¾´Ó¬O°ß¤@¥i¥Hªv¡ªºÀøªk¡A¦ýµ¥«Ý´«¨xªº¤H¤Ó¦h¡A¥u¦³¤Ö¼ÆÂå¾Ç¤¤¤ß¤Î¦³ªº±wªÌ¦³¾÷·|±µ¨ü¨xŦ²¾´Ó¡C www.liver.org.tw/journalView.php?cat=65&sid=878&page=1 ------------------------------------------------------------------------------------------------- ¥x¤jªº75%¦º¤`²v»P·s¥[©Y30%¦º¤`²v¡A2²Õ¼Æ¾Ú®t¶Z¦n¤j¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/8 ¤U¤È 01:03:58²Ä 1941 ½g¦^À³
|
§Ú¤§«e»´µø¤FSNP-630ªº[°sºë©Ê]¨xª¢¥«³õ!!! ·s¥[©YSZN-043¥HÄY«°sºë©Ê¨xª¢¬°ªvÀø¯f¯g( ¤£°µAPAP¤¤¬r¸ÑÃÄ) www.surrozen.com/programs/pipeline ¬ü°ê¨C¦~¬ù¦³ 100,000 ¤H¦][ÄY«°sºë©Ê] ¨xª¢¦í°|¡A³o¨Ç±wªÌ¦b 90 ¤Ñ¤ºªº¦º¤`²v¬ù¬° 30%¡AªvÀø¿ï¾Ü«Ü¤Ö¡C ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/2/7 ¤U¤È 11:04:17²Ä 1660 ½g¦^À³ ªYÄ£ºô¶: ²£«~¶i«×SNP-630:·sªvÀø¾AÀ³¯g±´°Q-°£¤F¹ï«D°sºë©Ê¯×ªÕ¨xª¢(NASH)¦³®Ä¡A¤]¦P®É¶i¦æ°Êª«¹êÅç¡A±´°QªvÀø°sºë©Ê¯×ªÕ¨xª¢(ASH)¤§Àø®Ä ................................................................................................ ¦³½ì¤F! µn¿ý¦b®×ªºASHÁ{§É©tªù¿W¥«´N1¥ó 1¥ó 1¥ó(ÁÙºM®ø¨S°õ¦æ)---³oªí¥ÜASHÀ³¸Ó¨S¥«³õ§a¡A¤£¸ÑªYÄ£·F¹À±´°Q??? clinicaltrials.gov/ct2/results?cond=ASH+alcoholic+Steatohepatitis&term=&cntry=&state=&city=&dist= ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/6/30 ¤U¤È 03:40:36²Ä 1257 ½g¦^À³ ...2021.6.25 (2021¦~°ê»Ú¨xŦ¤j·|™ 2021 (ILC)) Surrozen ¦b 2021 ¦~ Wnt ½Õ¸`§ÜÅé SZN-043 °ê»Ú¨xŦ·|ij¤W¤½§G¼Æ¾Ú¡¨ ¡§§ÚÌ´Á«Ý¦b 2022 ¦~±N¨ä±À¦VÁ{§É¬ã¨s®ÉÄ~Äòµû¦ô SZN-043¡C¡¨¦bÃD¬°¡§SZN-043¡A¤@ºØ¹v¦V R-spondin ªº¨x²ÓM¼ÒÀÀª«¡A¦b«æ©Ê¹ï¤A酰®ò°ò×ô»¤¾Éªº¨x·l¶Ë¼Ò«¬¤¤»¤¾É¨x²ÓM¼W´Þ¡¨ªº®ü³ø®i¥Ü¤¤¡A¼Æ¾Ú´£¨Ñ¤F¤ä«ùÃÒ¾Ú¡A§Y SZN-043 ¥i¥H»¤¾É¨x²ÓM¯S²§©Ê¦A¥Í¡C¹ï¤A酰®ò°ò×ô¹L¶q¡A¥i¥H§ïµ½¨x¥\¯à¡A¥i¥H´î¤ÖÃa¦º±¿n¡C |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/5/7 ¤U¤È 06:59:26²Ä 1940 ½g¦^À³
|
½Ð±Ð¤j®a¡A§Ú¬Ý¨ìªººÃ°Ý¦p¤U 1.Áp¹©¸ê¥»§ë¸ê¦³¦X¹Ù¡G¬O§_¬°·s¸³¨Æ 2.¼W¸ê°h¤F4eµ¹»{¤£¨ìªºµL½tªÑªF¡H |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2022/5/7 ¤U¤È 06:19:32²Ä 1939 ½g¦^À³
|
R¤j ªYÄ£¦Û¤v®Ú¥»µL¦æ¾P¯à¤O µL½×¬O¡u§C¨x¬r¡v¡B¡u·P«_ÃÄ¡v ¨S¸ÕÃĮĹLÃö¡A±ÂÅv¤jÃļt¦æ¾Pªº¸Ü¡I ³£¬O§@¹Ú¶¥¬q¡I ÃĮĸըº麽¤[¤F¡AÁöÁÙ¨S¦³§¹¦¨¥Ø¼Ð¡A¦ý¤j¤è¦VÀ³¸Ó¦³ÃФF¡C ¤u·~§½¬°¦óã¤F¦P·N¨ç¡H¤½¥qÀ³¸Ó¦³¸q°È§i¶DªÑªF̤~¹ï¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/7 ¤U¤È 12:23:54²Ä 1938 ½g¦^À³
|
¦pªG§Ú¬OIntercept¤½¥qCEO¡A¦b®³¨ì²Ä1±iNASHÃÄÃÒ«á¸êª÷¤ô¦ìº¡·¸¡AnµÛ¤âOcalivaªº¤U¤@¥N·sÃÄ(§ó¨ã¦w¥þ©Ê»PÀø®Ä)¡A¨º»òª½¨úSNP-630§@ÁpÃĶ}µo´N¬O³Ì¨Î³Ì§Ö³t¿ï¶µ¤§1 ! ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/7 ¤W¤È 09:45:43²Ä 1934 ½g¦^À³ ²×§½¤§¾Ô¦³¤H©ã¤F 4.05»õ¬ü¤¸!!! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/7 ¤U¤È 12:13:53²Ä 1937 ½g¦^À³
|
¤j¹Ú·Q®a¤jªº¹Ú·Q °_¯è! ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/6/21 ¤U¤È 06:24:47²Ä 1230 ½g¦^À³ ¦pªG¤j¶O©P³¹¥u®³¾Ç¦WÃÄÃÒ§ð¦û1¦¨¥«¦û²v(¾Ç¦WÃÄÃÒ·Q10%¥«¦û¤]¤£¥i¯à)¡A«hSNP-810¤j¹Ú¸Ó¿ô!!! ÁÙ¦³¥xÆW¤H©R¤£«ÜÈ¿ú... ------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/7 ¤W¤È 10:42:03²Ä 1936 ½g¦^À³ ....¤½¥q«áÄò¤´¦³³W¹º¹ï©ó¬ü°ê¥«°â 600ºØ§t¦³¤AñQÓi×ô¤§·P«_Ãĵ¥½Æ¤è¡AY¥Ñ SNP-810 ¨Ó´À´« |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/7 ¤W¤È 10:42:03²Ä 1936 ½g¦^À³
|
¤G) µL¨x¬r©Ê¤îµh·sÃÄ(OTC)¡G SNP-810 µ¦²¤¹B¥Î...¤§Äw½X¡C¦Ò¶qÅçÃÒ SNP-810 ¬°µL¨x¬r©Ê®É¶¡¸ûªø¡A§ÚÌpµe¤À¶¥¬q¨Ó§¹¦¨¡A²Ä¤@¶¥¬q¥ý¥H¡§§C¬r©Ê¤AñQÓi×ô¡¨¤W¥«¡A²Ä¤G¶¥¬q¦A¥H Phase IV¸ÕÅç¡A±À¼s¦Ü¡§µL¨x¬r©Ê¤AñQÓi×ô¡¨¡C (¤T) µL¨x¬r©Ê¤îµh½Æ¤è·sÃÄ(³B¤èÃÄ)¡G ...¤½¥q«áÄò¤´¦³³W¹º¹ï©ó¬ü°ê¥«°â 600ºØ§t¦³¤AñQÓi×ô¤§·P«_Ãĵ¥½Æ¤è¡AY¥Ñ SNP-810 ¨Ó´À´«¡A¥ç¥i¨ü°U¶i¦æÃİʤÎÃĮĸÕÅçÅçÃÒÀø®Ä¡C ------------------------------------------------------------------------------------------------ ¥þ±¶}¾Ô«Ü¯Ó®É¡A¯à¦¬Ã¬º¡º¡? «¥®a¡uÀY³£¬~¸¨¥h¨o¡AµL«c°L¨Ï±o¡C¡v¡A¬Ý¤U¥h... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/7 ¤W¤È 10:02:17²Ä 1935 ½g¦^À³
|
FDA¹ïOcalivaªººÃ¼{¦b¦w¥þ©Ê(¨x¬r)! Ocaliva +SNP-630ÁpÃĦ³ÅãµÛªº¨ó¦P§@¥Î¡AOcaliva ¾¯¶q°§C¡AÀø®Ä»P¦w¥þ©Ê§ó°ª§ó¨Î! SNP-610 / SNP-630 °Êª« PK/PD ¸ÕÅç ¦b SNP-630 ¨Ö¥Î¨ä¥L¤T´ÁÃĪ«ªº´ú¸Õ¤¤¡A§Ú̵o²{ SNP-630 »P¤T´ÁÃĪ« Ocaliva ¨Ö¥ÎªvÀø NASH ¤p¹«¡A¦b¦å¿}¡B¦åÁx©T¾J¡B¨xŦ¤T»Ä¥Ìªo¯×µ¥¶µ¥Øªº°§C®ÄªG¬ÒÀu©ó³æ¿W¨Ï¥Î Ocaliva ©Î SNP-630(p<0.05)¡A¦³ÅãµÛªº¨ó¦P§@¥Î¡AÅã¥Ü SNP-630 µo®i½Æ¤èÃĪ«ªº¼ç¤O¡C -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/11/20 ¤W¤È 11:34:58²Ä 1477 ½g¦^À³ ²×§½¤§¾Ô! 2021.8.2 Intercept ø»sOcalivaÀò±oNASH §å㪺·s³~®|:¥un«O«ù¦w¥þ©Ê |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/7 ¤W¤È 09:45:43²Ä 1934 ½g¦^À³
|
²×§½¤§¾Ô¦³¤H©ã¤F 4.05»õ¬ü¤¸!!! 1/18 16.56¤¸ ; 5/6 19.27¤¸ 2022.5.5 :Intercept Pharmaceuticals ±N¦VÁ`³¡¦ì©ó^°êªº Advanz Pharma ¥X°â¨ä¦b¬ü°ê¥H¥~ªº¨x¯fÃĪ« Ocaliva ªºÅv§Q¡A«áªÌ¦P·N¦b¨â®a¤½¥q¶g¥|«Å¥¬ªº¥æ©ö¤¤ [¹w¥I] Intercept 4.05 »õ¬ü¤¸ ----------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/18 ¤W¤È 07:49:34²Ä 1600 ½g¦^À³ ·Q[½ä]¤@©]P´I?³o®aIntercept pharmaceuticalsªº[²×§½¤§¾Ô]¦³¼Éº¦10~20¿ªº¹ê¤O»P¾÷·|?! ì¦]: 1.ªÑ»ù¾ú¥v°ª 2014.1.6 $497¡A¾ú¥v§C:2021.8.16 $11.6 2.¬Q¤é¦¬½Lº¦7.96% ¦¬$17.76----¬ü°ê§ë¸êªÌ¶}©l©ãª`Ocalivaªº[²×§½¤§¾Ô] 2022.1.7---2022 ¦~¤£¥i¿ù¹Lªº 3¶µ....¹ï©ó³o¨Ç»sÃÄ°Ó¨Ó»¡¡A³o¥i¯à¬O«D±`¿E°Ê¤H¤ßªº¤@¦~¡C 3.¤@¾Ô¨M¥Í¦º®É¶¡:2022¦~¤W¥b¦~ 2021.12.20 Intercept ¥i¯à·|¦b 2022 ¦~¤W¥b¦~»P FDA «·s´£¥æ·|ij¡C 4.Ó¤H¤£·|©ãª`³o³õ½ä§½¡A°lÂÜFDA§å㪺²Ä1¤äNASHÃĪ«¥Î¡C ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/11/20 ¤W¤È 11:34:58²Ä 1477 ½g¦^À³ ²×§½¤§¾Ô! 2021.8.2 Intercept ø»sOcalivaÀò±oNASH §å㪺·s³~®|:¥un«O«ù¦w¥þ©Ê www.fiercepharma.com/pharma/intercept-still-sees-fda-approval-pathway-for-nash-hopeful-ocaliva-as-long-as-safety-holds |
|
|
·|û¡G¾¾¹À©OÎN¹À«¡10150521 µoªí®É¶¡:2022/5/7 ¤W¤È 06:55:37²Ä 1933 ½g¦^À³
|
5/6¤w¤W¶Çij¨Æ¤â¥U¤Î·|ij¸É¥R¸ê®Æ¡A À³¸Ó´N¬O¦~³ø¤º®e¡C |
|
|
·|û¡G¶ø¥ì´µ¯S10031727 µoªí®É¶¡:2022/5/5 ¤U¤È 03:19:41²Ä 1932 ½g¦^À³
|
¸ò¤j¼tñªº 810 confirmation study ¡AY¼Æ¾Ú²Å¦X¤j¼tªº¹w´Á¡A«áÄò±ÂÅv½Í§Pªº§ð¨¾¡A¨ä¹êº¡¯Ó®Éªº¡C Ó¤H¬Oı±o¡A¦b IPO «eÀ³¸Ó¤£·|¦³µ²ªG¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/5/5 ¤W¤È 10:01:10²Ä 1931 ½g¦^À³
|
¨xª¢°Ê°_¨Ó¤F?! ©ñ±ó¤F¤îµh?! ÁÙ¬O¤îµh¦¨¥\¤F¡A¦æ¦³¾l¤O¨Ó¬Ý¨xª¢ 104·s¾¯Ê ¬ã¨sÅ@²z®v(Á{§É¸ÕÅç¬ãµo³B) 1.¨ó§UÁ{§É¸ÕÅ禬®×»P°õ¦æ¸ÕÅç¬ÛÃö¨Æ©y¡C 2.»Ý¦³Å@¤h/Å@²z®v/ÂåÀË®v°õ·Ó(¯à°t¦X©â¦å)¡C |
|
|
·|û¡G¾¾¹À©OÎN¹À«¡10150521 µoªí®É¶¡:2022/5/3 ¤U¤È 09:44:32²Ä 1930 ½g¦^À³
|
104·s¾¯Ê ¬ã¨sÅ@²z®v(Á{§É¸ÕÅç¬ãµo³B) 1.¨ó§UÁ{§É¸ÕÅ禬®×»P°õ¦æ¸ÕÅç¬ÛÃö¨Æ©y¡C 2.»Ý¦³Å@¤h/Å@²z®v/ÂåÀË®v°õ·Ó(¯à°t¦X©â¦å)¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/3 ¤W¤È 11:55:26²Ä 1929 ½g¦^À³
|
°ê¹©Pre-EUA·|ij»»»»µL´Á! VERU¤£¥Î1Ó¤ë±o¨ìFDA¦P·N¦b5/10¶}pre-EUA meeting. 2022.5.2 Veru Inc. (NASDAQ: VERU), a biopharmaceutical company, today announced that the FDA has granted the Company a pre-Emergency Use Authorization (EUA) meeting on May 10, 2022, finance.yahoo.com/news/fda-granted-veru-pre-emergency-123000144.html ---------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/12 ¤U¤È 03:04:48²Ä 1897 ½g¦^À³ ¬Q¤é¦A¼W1®a¤¤«×¦Ü««×¦í°|±wªÌ¤fªAÃÄ¥Ó½ÐEUA ¡A[°ß¿W°ê¹©¼B¸³«ÅºÙ¤£¥ÎPȹF¼Ð]!!! 2022.4.11 ¬ü°êÁÚªü±KVeru¤½¥q¤fªA§Ü¯f¬rÃĪ« sabizabulin¡A P3¤¤´Á¼Æ¾ÚÅã¥Ü¡A»P¦w¼¢¾¯¬Û¤ñ¡A¦b¤¤«×¦Ü««×¦í°|±wªÌ¤¤ªº¦º¤`²v°§C¤F 55%¡C¡]p=0.0029¡^µ²ªG³Q»{¬°¨ã¦³²Îp¾Ç·N¸q©M²Îp¾Ç·N¸q¡C -------------------------------------------------------------------------------------------- Veru ªí¥Ü¡A¥Ñ¤_¡§压Ë©Ê¡¨ªº¦³®Ä©Ê¡A该¬ã¨s¦b独¥ß数Õu监测©e员会ªº«Ø议¤U´£«e°±¤î¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/30 ¤U¤È 09:09:24²Ä 1928 ½g¦^À³
|
2022.4.19 ¥[®³¤jªº¬ã¨sµ²ªG»P¬ü°ê¬Û¦P¡A¼W´T¸û¤p¦Ó¤w¡C §ó§ï¼ÐÅÒ»P¥[µù¨x¬rĵ»y¨Ã¤£¯à¨¾¤î¹ï¤A酰®ò°ò×ô¹L¶q·N¥~!(»Ýn±Ä¨úÃB¥~±¹¬I¨Ó´î»´·N¥~¹ï¤A酰®ò°ò×ô¹L¶q) www.cmaj.ca/content/194/15/E542 ¥[®³¤j©ó 2009 ¦~ 10 ¤ë¹ï²£«~¼ÐÅÒ¶i¦æ¤F§ó§ï¡A¥Hĵ§i¥i¯à¦s¦b¨x·l¶Ëªº·ÀI¡C2016 ¦~¡A¥Ļó·s¤F¦w¥þ¾¯¶qªºªþ¥[¼ÐÅÒ¡A¨ÃÃѧO§t¦³¹ï¤A酰®ò°ò×ôªº²£«~¡C µM¦Ó¡A¦b³o¶µ°w¹ï 2004 ¦~¦Ü 2020 ¦~¶¡¥[®³¤j 9 Ó¬Ù©M 3 Ó¦a°Ïªº 12000 ¦h¨Ò¹ï¤A酰®ò°ò×ô·N¥~¹L¶q¤J°|ªº¬ã¨s¤¤¡A¬ã¨s¤Hûµo²{§ó·sªº¼ÐÅÒ¹ï¤J°|¨S¦³¼vÅT.... Ų©ó¹ï¤A酰®ò°ò×ô·N¥~¹L¶q¹ï¤½¦@½Ã¥Í©M½Ã¥Í¨t²Îªº¼vÅT¡A¥H¤Î¥þ²y¬Fµ¦¨î©wªÌ¹ï«P¶i¦w¥þ¨Ï¥Î¹ï¤A酰®ò°ò×ôªº¿³½ì¡A§Ú̪º¬ã¨sµ²ªGªí©ú¡A»Ýn±Ä¨úÃB¥~±¹¬I¨Ó¹w¨¾³o¨Ç¨Æ¥ó¡C ------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/23 ¤W¤È 10:18:43²Ä 1916 ½g¦^À³ §ó·s¹ï¤A酰®ò°ò×ôĵ§i¼ÐÅÒµL®Ä...2022.4.21---FDA ...¹ï¤A酰®ò°ò×ôĵ§i¼ÐÅÒµL®Ä |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/4/26 ¤U¤È 10:55:44²Ä 1927 ½g¦^À³
|
¬üªÑ¤S±Y¤F~` ©ú¤Ñ¨«µÛÁ@¤F |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/4/26 ¤U¤È 12:01:34²Ä 1926 ½g¦^À³
|
«¢«¢ º¦¨S¥÷¡A¶^¦³¥÷ ³oªi¨S·f¤W¡A¶^µ¥¨ì¤W¥««e |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/4/25 ¤W¤È 10:54:17²Ä 1925 ½g¦^À³
|
¦ý¬O¸ô¸³§Ú¤£´±e¦P¤H®æ(¬ì¾Ç¤W¥i¥H»{¦P)¡Aµ}ÄÀ¤]Ä묹¤F¬u²±ªÑªFªºÅv¯q!·íµM¦ÑÁó¦û¤jªÑ¡A¤pªÑªF¤]¬O»¡¤£¥X¸Ü¡A A 2019¦~3¤ë7¤é ¡X ¬°§§¤j·sÃĬãµo¹ê¤O¡A´£¤É°ê»Ú¥«³õÄvª§¤O¡A¤¤¤Ñ B 2019¦~¾P°âÃB¤w¹F23.2»õ¬üª÷¡A©Ò¥H¥þ²y³£¦b¬Ý³oÓ¾AÀ³¯g¡C ¡u¦X¤@¸òLEO Pharma¬O¦b¼¯®Ú¤j³qÂåÀø²£·~¤j·|¤W°t¹ïªº¡C§Ú̦bu¬ü°Ñ¥[¤§«e´N¦³±µ¤f¤£¤Ö¼t°Ó¡C¼¯®Ú¤j³q«D±`¤Íµ½¡AÀ°§ÚÌ°t¹ï§ë¸ê¤H»P¼t°Ó¡C¤@¤ëªì¸òLEO Pharma½Í§¹¤§«á¡A¥L̦^¥h¬ã¨s§ÚÌ´£¨Ñªº¸ê®Æ¡C¨º®ÉÔ§Ú̪º¤@´ÁÁ{§É¸ÕÅç©M¤HÅé±´¯Á¸ÕÅçµ²ªGªºÃÒ¾Ú¤w¸g«D±`©ú½T¡A¦P®ÉÁÉ |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/4/25 ¤W¤È 10:28:39²Ä 1924 ½g¦^À³
|
¥DnÁÙ¬O¤â¤W³¡¦ìªº°ÝÃD¡A¸êª÷°÷©ñªø·íµM¨S°ÝÃD¡C¸êª÷¤£¨¬´N~ ¤§«eÄ_0/¬u²±¨ì¦X¤@/¤O¿n¹q¡A¨ä¹êÁȨì¤jªiªº³£¬O©ñ¤[ªº¡C ¬Ý¨ìªÑ»ù¨Ó¨Ó¦^¦^¡A®e©ö§ìÀt¨«Å¾¡C §Æ±æ¦U¦ì«ù¦³¤H(¦³²´¥úªº¤H)¤jÁÈ¡C³o¼Ë¤~¦³¦¨´N·P¡C |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/4/25 ¤W¤È 09:53:53²Ä 1923 ½g¦^À³
|
dk¤j¡A§JªA¤ßÅ]¤§«á¡A¥¼¨Ó§ë¸ê·|¤@¦|·¶¶ªº; ¦³¤@¥y¸Ü»P§A¦@«j¡A§ë¸ê¬O¥H¦~¬°³æ¦ìªº; ³o½g¸ô¸³ªº±M³X±z¤]¥i¥H°Ñ¦Ò:www.qtumic.com/insights/1427825968822616064 |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/4/25 ¤W¤È 09:43:05²Ä 1922 ½g¦^À³
|
R¤j ¨ü±Ð¤F ¤ßÅ]Ãø¹L ¥u¯à§¤µ¥ÃD§÷µo»Ã¡A¤T¤ÑªÑªF¥i¥H¼W¥[1w¥H¤W¡C ±q¸ê¥»ÃB/ªÑªF¤H¼Æ:ªYÄ£(6.9»õ/ 2271¤H) :Ä_ÄÖ(8.5»õ/ 29736¤H):°ê¹©(14.2»õ/ 18372¤H):¦X¤@(38.8»õ/ 45737¤H) ¥Ø«e©úÅã¤H®ð¤£¨¬¡A«§Q´N¦b½G¥ÐµL¤H¯Ñ¡A¯Ñ¶}¦³¤Hª§(¤H¨ú§Ú±ó)! ¤H±ó§Ú¨úªº§NªùªÑ§ë¸êõ¾Ç ¦pªG§ë¸ê³£¸òµÛ¤j³¡¤À¤H°µ¤@¼Ëªº¨Æ±¡¡A¨ºªÖ©w¥u¯à±o¨ì¥±eªºªí²{¡A¦]¬°¤j³¡¤À¤H¥Nªíªº´N¬O¥§¡ÁZ®Ä¡CY§Æ±æ¯à¨ú±oÀu©ó¥§¡ªº³ø¹S¡A¦ÛµM¥²¶·´±©ó©M²³¤H¤Ï¦V¾Þ§@¡A³o¤]´N¬O¤Úµá¯S©Ò»¡ªº¡A¦b§O¤H³g°ý®É®£Äß¡A¦b§O¤H®£Ä߮ɳg°ý¡C¦P®É¡A¤H±ó§Ú¨ú¤]¬Onªí¹F¤@ºØ¿W¥ß¦Û¥Dªº¬ã¨sºë¯«¡A¦Ó¤£¬O¯S¥ß¿W¦æ¡A¬°¤F¤Ï¹ï¦Ó¤Ï¹ïªº§¾«Äºë¯«¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/25 ¤W¤È 09:32:32²Ä 1921 ½g¦^À³
|
¦X¤@SNS812¬OªvÀø»P¹w¨¾®ÄªG¡A½÷·ç»PÆQ³¥¸qªº¤fªAÃĬOªvÀø! ¬Ý¬ÝÆQ³¥¸q¬O¦nÃÄ(Àu©ó½÷·ç)¡A¬ü°ê¤]¶R³æ¡C MoneyDJ·s»D 2022-04-22 11:17:58 °OªÌ ½²©Ó±Ò ³ø¾É ¤é¥»ÆQ³¥¸q»sÃÄ(Shionogi¡B4507.JP)¬ãµo¤¤ªº¤fªA¦¡·s«aªÍª¢(COVID-19)ªvÀøÃĶǥX¬ü°ê¬F©²·Q¶R¡B¥¿©MÆQ³¥¸q¶i¦æ¨ó°Ó¡C¦ÓÆQ³¥¸qÃÒ¹ê¡A¡u¥¿©M¬ü°ê´N¥Í²£Åé¨î¡B¨ÑÀ³µ¥¨Æ¶µ¶i¦æ¨óij¡v¡A¿EÀy¤µ¤éªÑ»ùÅw¼y°f½Ä¡C ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/8 ¤U¤È 11:39:56²Ä 1882 ½g¦^À³ »´¤¤¯g¯à¤j´T´î¤Ö¯f¬r¶q´N¬O§Ö³t¨úÃÒ¤§¹D! 2022.4.6 ¡nÆQ³¥¸q»sÃĤfªAÁ{§ÉÀø®Ä§ó³Ó½÷·ç»PÀq§J¡I www.genetinfo.com/international-news/item/57850.html ...90%¥H¤Wªº¨ü¸ÕªÌ©ó²Ä4¤ÑÅ餺¤wÀË´ú¤£¥X¯f¬r¶q.... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/24 ¤U¤È 06:13:46²Ä 1920 ½g¦^À³
|
§ÚÀ£¦X¤@[»ó]Ãú¼Q¾¯ªº²z½×°ò¦ (Omicron¶Ý»ó©Ê·¥¤Ö«¯g¡A Delta¶ÝªÍ©Ê«¯g¦h) 2020.11.26 www.nature.com/articles/s41385-020-00359-2 °w¹ï¤W©I§l¹D·P¬V¡A¨¾·P¬V³Ì¨Îªº¬Ì]¬O¡u»ó¤º¬Ì]¡v¡A¦Ó¥Ø«eªº¡uª`®g«¬¬Ì]¡vÁöµM¥i¥H¹w¨¾«¯g¡A¦ý¤´Ãøªý¤î¤W©I§l¹D¶Ç¼½¡A¤£ºÞ´X¾¯¥[±j¡A¤j¬ù¹L¤F¥|Ó¤ë«á¡A´N·|¥¢®Ä¡A¨Ã¥i¶Ç¼½¥L¤H¡C ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/3 ¤W¤È 08:31:34²Ä 1853 ½g¦^À³ §ÚÀ£: 1.¥þ²yº¤ä[»óÃú¼Q¾¯] ¦X¤@SNS812¼s®Ä«¬§Ü·s«a¬y·P¤p®Ö»Ä·sÃÄ¡A¤wn¥Ó½ÐP1 2.¦A¯}¥xÆW·sÃıÂÅv¬ö¿ýªºON101 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/24 ¤U¤È 05:38:46²Ä 1919 ½g¦^À³
|
¤µ¤Ñ¤â¤W³o®a¥¼¤W¥«¤½¥q¦b¥²´Iºô¶R»ù128~129¡A½æ»ù150¡C(¹wp250¤¸¥H¤W¤H¨ú§Ú±ó) ³o®a¤½¥q¥h¦~µ|«áÁÈ6.8¤¸¡A¦¨ªø>100%¡A¶i¤JÀ禬Ãzµo´Á.... 9¦~«e«Ü¦h¤H¥ÎÁ«·l»ù½æ¥X¡A«Ü¦nij»ù¦b¤Q¶ôªì¦¨¥æ¡C ·|§ë¸ê³o®a¤½¥q¬Oª¾¹D¨ä²£«~ªùÂe·¥°ª(¥xÆW«ÜÃø¦A¦³²Ä2®a¥X²{)¡C (¿ù»~)ªº¨M©w---³o¬O±q¤µ¤ÑªºÀò§Q»PªÑ»ùµ²ªG¨Ó¬Ý¡A¦ý¦b·í®É¬O(¹ï)ªº¨M©w¡A¦]¬°¨S¦h¤[¶Ç¥XÁ`¸g²zµ¥¤HÂ÷¾... --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/6/20 ¤W¤È 10:58:06²Ä 1226 ½g¦^À³ ...²{¦b¤â¤W³o®a¥¼¤W¥«¤½¥q¦b¥²´Iºô¶R»ù65~70(§Ú±µ¹L2¦¸¹q¸Ü¥X~70¤¸¶R)¡A½æ»ù120~140¡C ¦pªG¤£¬O5¦~«e»P¤@¦ì¬ãµo¸g²z²á¤Ñ«á³B²z1¥b«ùªÑ(¿ù»~ªº¨M©w)¡A²{¦b¤â¤W>300±i¡C ------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/5/10 ¤W¤È 06:53:42²Ä 2536 ½g¦^À³ [·|û¡GROGER588910148151 µoªí®É¶¡:2019/11/11 ¤U¤È 04:33:19²Ä 1500 ½g¦^À³ ¥¢±Ñ¨Ã¤£¥i©È¡A¤ßºA¨M©w¤F§ÚÌ·|¦p¦ó¦^À³!§ë¸êµJÂI»P§ë¤J»ù¦ì¤£¦P¡A©Ò¯à©Ó¨üÀ£¤O´N¤£¤@P¡C .................................................................................... ´¿¸g¤â¤W«ù¦³3®a¥¼¤W¥«¤½¥q¡A¤@®a´ó·À(·l¥¢15¸U)¡C2019¦~¤@®a¤W¿³Âd(«ù¦³18¦~Åo¡A§ë¤J¦¨¥»¦®³¦^¡A»P´ó·À¨º®a¤½¥q¦P¤@²£·~)¡C²{¦b¤â¤WÁÙ«ù¦³1¤ä¥¼¤W¥«¤½¥q(«ù¦³6¦~¡A§ë¤J¦¨¥»¤]¦®³¦^)¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/24 ¤U¤È 05:12:20²Ä 1918 ½g¦^À³
|
±q¸ê¥»ÃB/ªÑªF¤H¼Æ:ªYÄ£(6.9»õ/ 2271¤H) :Ä_ÄÖ(8.5»õ/ 29736¤H):°ê¹©(14.2»õ/ 18372¤H):¦X¤@(38.8»õ/ 45737¤H) ¥Ø«e©úÅã¤H®ð¤£¨¬¡A«§Q´N¦b½G¥ÐµL¤H¯Ñ¡A¯Ñ¶}¦³¤Hª§(¤H¨ú§Ú±ó)! ¤H±ó§Ú¨úªº§NªùªÑ§ë¸êõ¾Ç ¦pªG§ë¸ê³£¸òµÛ¤j³¡¤À¤H°µ¤@¼Ëªº¨Æ±¡¡A¨ºªÖ©w¥u¯à±o¨ì¥±eªºªí²{¡A¦]¬°¤j³¡¤À¤H¥Nªíªº´N¬O¥§¡ÁZ®Ä¡CY§Æ±æ¯à¨ú±oÀu©ó¥§¡ªº³ø¹S¡A¦ÛµM¥²¶·´±©ó©M²³¤H¤Ï¦V¾Þ§@¡A³o¤]´N¬O¤Úµá¯S©Ò»¡ªº¡A¦b§O¤H³g°ý®É®£Äß¡A¦b§O¤H®£Ä߮ɳg°ý¡C¦P®É¡A¤H±ó§Ú¨ú¤]¬Onªí¹F¤@ºØ¿W¥ß¦Û¥Dªº¬ã¨sºë¯«¡A¦Ó¤£¬O¯S¥ß¿W¦æ¡A¬°¤F¤Ï¹ï¦Ó¤Ï¹ïªº§¾«Äºë¯«¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/4/24 ¤U¤È 04:09:55²Ä 1917 ½g¦^À³
|
¤H®ð¤£¨¬´N¬O¤£¨¬ ÃD§÷³£¨Sµo´§¨ì ±µ¤U¨Ó¯}¸U«Üªñ¤F ²{¦b¤£º¦«Ý¦ó®É |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/23 ¤W¤È 10:18:43²Ä 1916 ½g¦^À³
|
§ó·s¹ï¤A酰®ò°ò×ôĵ§i¼ÐÅÒµL®Ä!!! 2009¦~7¤ë¡A¬ü°êFDA«Å¥¬¹ï¤A酰®ò°ò×ô¥[µùĵ§i¼ÐÅÒ¡A¥H´î¤Ö¥i¯à³y¦¨¹L¶qªAÃĪº±¡§Î¡Aµ²ªG¤£¨}¨Æ¥ó±q2009~2021¤´²r¼W440%!!! ------------------------------------------------------------------------------------------------- 2022.4.21---FDA ĵ§i¯kµh¸É¥R¾¯§t¦³¥¼¥Ó³øªºÃĪ« ...¹ï¤A酰®ò°ò×ôĵ§i¼ÐÅÒµL®Ä ...2009 ¦~¡AFDA ´N¹ï¤A酰®ò°ò×ô¾ÉP¨x·l¶Ëªº·ÀIĵ§i¬ü°ê®ø¶OªÌ...³o¨Ç¦æ°Ê¹ï¹w¨¾¹ï¤A酰®ò°ò×ôªº¤£¨}¤ÏÀ³§@¥Î¬Æ·L¡C®Ú¾ÚFDA ªº¤£¨}¨Æ¥ó³ø§i¨t²Î¡A2009 ¦~³ø§i¤Fªñ 2,800 °_¯A¤Î¹ï¤A酰®ò°ò×ôªº¤£¨}¨Æ¥ó¡C¨ì 2021 ¦~¡A¤£¨}¨Æ¥óªº¼Æ¶q¤w¼Wªø¨ì 15,000 ¦h°_¡A¼Wªø¤F 440%¡C±q 2009 ¦~¨ì 2021 ¦~¡A³ø§i¤F¶W¹L 27,000 ¨Ò¯A¤Î¹ï¤A酰®ò°ò×ôªºÃĪ«¦º¤`¡C www.painnewsnetwork.org/stories/category/Pain+Medication |
|
|
·|û¡Gonly10135877 µoªí®É¶¡:2022/4/21 ¤W¤È 10:49:02²Ä 1915 ½g¦^À³
|
¤îµhÃĪº¬G¨Æ www.youtube.com/watch?v=obRnwe68VR4 |
|
|
·|û¡GNtumgk10151447 µoªí®É¶¡:2022/4/21 ¤W¤È 09:46:49²Ä 1914 ½g¦^À³
|
ªYÄ£©|»Ý¤º³¡±±¨î±M®×¼f¬d³ø§i¤~¯à¥Ó½Ð¤WÂd¡A¤º±±Án©ú®Ñ¬O¨CÓ·|p¦~«×²×¤F®É³£n¥Ó³øªº¶µ¥Ø¡AY¥h¬d¸ß¨ä¥L®a¤½¥q¤]¯àµo²{¤j¦h¼Æ©ó4¤ë«e³£·|§ó·s¡ã©Ò¥H·Ç½T¤£¯à»¡¬O¤WÂd¦³·s¶i®i |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/4/20 ¤U¤È 10:55:46²Ä 1913 ½g¦^À³
|
¬Ý¨Ó¨S¤H¤F¸Ñ ¨S¤Hª£ ªYÄ£¤]ºâ¨¾¬Ì·§©ÀªÑ°Ú. µL½×¥´¬ÌÐt©Î¬V¬Ì³£·|¥Î¨ì¤îµhÃÄ |
|
|
·|û¡G¤p¨k¤H10151116 µoªí®É¶¡:2022/4/20 ¤U¤È 04:02:40²Ä 1912 ½g¦^À³
|
¤½¥q³£¦³¦b¤@¨B¤@¨B¬°¤WÂd°µ·Ç³Æ¡A¤j®a¦w¤ßµ¥«Ý; ˬO§Ú¤ñ¸û¦n©_630ªº¤G´ÁÁ{§É¦ó®É·|¶}©l?¦³¤H¦³¸ê°T¶Ü? ----------------------------------------------------------------------------- ¤½¥q¥N¸¹ ¤½¥q²ºÙ ¤½§i¤é´Á ¤º±±Án©ú®Ñ¤§Ãþ«¬ ¥D¦® 6634 ªYÄ£ 111/03/30 Án©ú¤º³¡±±¨î¨î«×³]p¤Î°õ¦æ§¡¦³®Ä-¿í´`ªk¥O³W³¹³¡¤À±Ä¥þ³¡ªk¥O³W³¹§¡Án©ú 110¦~«×¤º³¡±±¨î¨î«×Án©ú®Ñ¤½§i |
|
|
·|û¡Gonly10135877 µoªí®É¶¡:2022/4/20 ¤U¤È 03:07:52²Ä 1911 ½g¦^À³
|
ªYÄ£¤]ºâ¨¾¬Ì·§©ÀªÑ°Ú. µL½×¥´¬ÌÐt©Î¬V¬Ì³£·|¥Î¨ì¤îµhÃÄ |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2022/4/20 ¤U¤È 02:00:54²Ä 1910 ½g¦^À³
|
¨¾¬Ì·§©À³£¤W¤Ñ¤F¡A·sÃÄÁÙ¦b¦aªO¨S·R ¯u·Ð§r~~~ |
|
|
|